2019


  1. Breitfeld J, Wiele N, Gutsmann B, Stumvoll M, Bluher M, Scholz M, Kovacs P, Tonjes A (2019). Circulating Adipokine VASPIN Is Associated with Serum Lipid Profiles in Humans. Lipids, 54, 203-210.
     
  2. Puschel J, Miehle K, Muller K, Villringer A, Stumvoll M, Fasshauer M, Schlogl H (2019). Beneficial effects of leptin substitution on impaired eating behavior in lipodystrophy are sustained beyond 150?weeks of treatment. Cytokine, 113, 400-404.
     
  3. Tonjes A, Kralisch S, Hoffmann A, Schleinitz D, Kratzsch J, Bluher M, Stumvoll M, Kovacs P, Fasshauer M, Ebert T (2019). Circulating Pro-Neurotensin in gestational diabetes mellitus. Nutr Metab Cardiovasc Dis, 29, 23-29.
     
  4. Hoffmann A, Ebert T, Kloting N, Kolb M, Gericke M, Jeromin F, Jessnitzer B, Lossner U, Burkhardt R, Stumvoll M, Fasshauer M, Kralisch S (2019). Leptin decreases circulating inflammatory IL-6 and MCP-1 in mice. Biofactors, 45(1), 43-48.
     
  5. Ottlewski I, Munch J, Wagner T, Schonauer R, Bachmann A, Weimann A, Hentschel J, Lindner TH, Seehofer D, Bergmann C, Jamra RA, Halbritter J (2019). Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease. Kidney Int, 96, 222-230.
     
  6. Petzold F, Bachmann A, Bergmann C, Helmchen U, Halbritter J (2019). Retrospective genetic analysis illustrates the spectrum of autosomal Alport syndrome in a case of living-related donor kidney transplantation. BMC Nephrol, 20, 340-345.
     
  7. Bluher M (2019). Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol, 15, 288-298.
     
  8. Justice AE, Karaderi T, Highland HM, Young KL, Graff M, Lu Y, Turcot V, Auer PL, Fine RS, Guo X, Schurmann C, Lempradl A, Marouli E, Mahajan A, Winkler TW, Locke AE, Medina-Gomez C, Esko T, Vedantam S (2019). Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution. Nat Genet, 51, 452-469.
     
  9. Karlsson Linner R, Biroli P, Kong E, Meddens SFW, Wedow R, Fontana MA, Lebreton M, Tino SP, Abdellaoui A, Hammerschlag AR, Nivard MG, Okbay A, Rietveld CA, Timshel PN, Trzaskowski M, Vlaming R, Zund C (2019). Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences. Nat Genet, 51, 245-257.
     
  10. Matthews DR, Paldanius PM, Proot P, Foley JE, Stumvoll M, Del Prato S (2019). Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin-metformin combination in newly diagnosed Type 2 diabetes. Diabet Med, 36, 505-513.
     
  11. Hoffmann A, Ebert T, Kloting N, Kolb M, Gericke M, Jeromin F, Jessnitzer B, Lossner U, Burkhardt R, Stumvoll M, Fasshauer M, Kralisch S (2019). Leptin decreases circulating inflammatory IL-6 and MCP-1 in mice. Biofactors, 45, 43-48.
     
  12. Kruger J, Berger C, Weidle K, Schleinitz D, Tonjes A, Stumvoll M, Bluher M, Kovacs P, Kloting N (2019). Metabolic effects of genetic variation in the human REPIN1 gene. Int J Obes (Lond), 43, 821-831.
     
  13. Amar A, Majmundar AJ, Ullah I, Afzal A, Braun DA, Shril S, Daga A, Jobst-Schwan T, Ahmad M, Sayer JA, Gee HY, Halbritter J, Knopfel T, Hernando N, Werner A, Wagner C, Khaliq S, Hildebrandt F (2019). Gene panel sequencing identifies a likely monogenic cause in 7% of 235 Pakistani families with nephrolithiasis. Hum Genet, 138, 211-219.
     
  14. Choi YJ, Halbritter J, Braun DA, Schueler M, Schapiro D, Rim JH, Nandadasa S, Choi WI, Widmeier E, Shril S, Korber F, Sethi SK, Lifton RP, Beck BB, Apte SS, Gee HY, Hildebrandt F (2019). Mutations of ADAMTS9 Cause Nephronophthisis-Related Ciliopathy. Am J Hum Genet, 104, 45-54.
     
  15. Teumer A, Li Y, Ghasemi S, Prins BP, Wuttke M, Hermle T, Giri A, Sieber KB, Qiu C, Kirsten H, Tin A, Chu AY, Bansal N, Feitosa MF, Wang L, Chai JF, Cocca M, Fuchsberger C, Gorski M, Hoppmann A, Horn K, Li M, Marten J, Noce D, Nutile T, Sedaghat S, Sveinbjornsson G, Tayo BO, van der Most PJ, Xu Y, Yu Z, Gerstner L, Arnlov J, Bakker SJL, Baptista D, Biggs ML, Boerwinkle E, Brenner H, Burkhardt R, Carroll RJ, Chee ML, Chee ML, Chen M, Cheng CY, Cook JP, Coresh J, Corre T, Danesh J, de Borst MH, De (2019). Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria. Nat Commun, 10, 4130-4149.
     
  16. Spracklen CN, Karaderi T, Yaghootkar H, Schurmann C, Fine RS, Kutalik Z, Preuss MH, Lu Y, Wittemans LBL, Adair LS, Allison M, Amin N, Auer PL, Bartz TM, Bluher M, Boehnke M, Borja JB, Bork-Jensen J, Broer L, Chasman DI, Chen YI, Chirstofidou P, Demirkan A, van Duijn CM, Feitosa MF, Garcia ME, Graff M, Grallert H, Grarup N, Guo X, Haesser J, Hansen T, Harris TB, Highland HM, Hong J, Ikram MA, Ingelsson E, Jackson R, Jousilahti P, Kahonen M, Kizer JR, Kovacs P, Kriebel J, Laakso M, Lange LA, Lehti (2019). Exome-Derived Adiponectin-Associated Variants Implicate Obesity and Lipid Biology. Am J Hum Genet, 105, 670-671.
     
  17. Zaharia OP, Strassburger K, Strom A, Bonhof GJ, Karusheva Y, Antoniou S, Bodis K, Markgraf DF, Burkart V, Mussig K, Hwang JH, Asplund O, Groop L, Ahlqvist E, Seissler J, Nawroth P, Kopf S, Schmid SM, Stumvoll M, Pfeiffer AFH, Kabisch S, Tselmin S, Haring HU, Ziegler D, Kuss O, Szendroedi J, Roden M (2019). Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol, 7, 684-694.
     
  18. Spracklen CN, Karaderi T, Yaghootkar H, Schurmann C, Fine RS, Kutalik Z, Preuss MH, Lu Y, Wittemans LBL, Adair LS, Allison M, Amin N, Auer PL, Bartz TM, Bluher M, Boehnke M, Borja JB, Bork-Jensen J, Broer L, Chasman DI, Chen YI, Chirstofidou P, Demirkan A, van Duijn CM, Feitosa MF, Garcia ME, Graff M, Grallert H, Grarup N, Guo X, Haesser J, Hansen T, Harris TB, Highland HM, Hong J, Ikram MA, Ingelsson E, Jackson R, Jousilahti P, Kahonen M, Kizer JR, Kovacs P, Kriebel J, Laakso M, Lange LA, Lehti (2019). Exome-Derived Adiponectin-Associated Variants Implicate Obesity and Lipid Biology. Am J Hum Genet, 105, 15-28.
     
  19. Turcot V, Lu Y, Highland HM, Schurmann C, Justice AE, Fine RS, Bradfield JP, Esko T, Giri A, Graff M, Guo X, Hendricks AE, Karaderi T, Lempradl A, Locke AE, Mahajan A, Marouli E, Sivapalaratnam S, Young KL, Alfred T, Feitosa MF, Masca NGD, Manning AK, Medina-Gomez C, Mudgal P, Ng MCY, Reiner AP, Vedantam S, Willems SM, Winkler TW, Abecasis G, Aben KK, Alam DS, Alharthi SE, Allison M, Amouyel P, Asselbergs FW, Auer PL, Balkau B, Bang LE, Barroso I, Bastarache L, Benn M, Bergmann S, Bielak LF, Blu (2019). Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet, 51, 1191-1192.
     
  20. Rohde K, Keller M, la Cour Poulsen L, Ronningen T, Stumvoll M, Tonjes A, Kovacs P, Horstmann A, Villringer A, Bluher M, Bottcher Y (2019). (Epi)genetic regulation of CRTC1 in human eating behaviour and fat distribution. EBioMedicine, 44, 476-488.
     
  21. Wuttke M, Li Y, Li M, Sieber KB, Feitosa MF, Gorski M, Tin A, Wang L, Chu AY, Hoppmann A, Kirsten H, Giri A, Chai JF, Sveinbjornsson G, Tayo BO, Nutile T, Fuchsberger C, Marten J, Cocca M, Ghasemi S, Xu Y, Horn K, Noce D, van der Most PJ, Sedaghat S, Yu Z, Akiyama M, Afaq S, Ahluwalia TS, Almgren P, Amin N, Arnlov J, Bakker SJL, Bansal N, Baptista D, Bergmann S, Biggs ML, Biino G, Boehnke M, Boerwinkle E, Boissel M, Bottinger EP, Boutin TS, Brenner H, Brumat M, Burkhardt R, Butterworth AS, Campa (2019). A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat Genet, 51, 957-972.
     
  22. Matthews DR, Paldanius PM, Stumvoll M, Han J, Bader G, Chiang Y, Proot P, Del Prato S (2019). A pre-specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM. Diabetes Obes Metab, 21, 2240-2247.
     
  23. Zelicha H, Kaplan A, Yaskolka Meir A, Tsaban G, Rinott E, Shelef I, Tirosh A, Brikner D, Pupkin E, Qi L, Thiery J, Stumvoll M, Kloting N, von Bergen M, Ceglarek U, Bluher M, Stampfer MJ, Shai I (2019). The Effect of Wolffia globosa Mankai, a Green Aquatic Plant, on Postprandial Glycemic Response: A Randomized Crossover Controlled Trial. Diabetes Care, 42, 1162-1169.
     
  24. Gepner Y, Shelef I, Komy O, Cohen N, Schwarzfuchs D, Bril N, Rein M, Serfaty D, Kenigsbuch S, Zelicha H, Yaskolka Meir A, Tene L, Bilitzky A, Tsaban G, Chassidim Y, Sarusy B, Ceglarek U, Thiery J, Stumvoll M, Bluher M, Stampfer MJ, Rudich A, Shai I (2019). The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content. J Hepatol, 71, 379-388.
     
  25. Warrington NM, Beaumont RN, Horikoshi M, Day FR, Helgeland O, Laurin C, Bacelis J, Peng S, Hao K, Feenstra B, Wood AR, Mahajan A, Tyrrell J, Robertson NR, Rayner NW, Qiao Z, Moen GH, Vaudel M, Marsit CJ, Chen J, Nodzenski M, Schnurr TM, Zafarmand MH, Bradfield JP, Grarup N, Kooijman MN, Li-Gao R, Geller F, Ahluwalia TS, Paternoster L, Rueedi R, Huikari V, Hottenga JJ, Lyytikainen LP, Cavadino A, Metrustry S, Cousminer DL, Wu Y, Thiering E, Wang CA, Have CT, Vilor-Tejedor N, Joshi PK, Painter JN, (2019). Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors. Nat Genet, 51, 804-814.
     
  26. Yaskolka Meir A, Tsaban G, Zelicha H, Rinott E, Kaplan A, Youngster I, Rudich A, Shelef I, Tirosh A, Brikner D, Pupkin E, Sarusi B, Bluher M, Stumvoll M, Thiery J, Ceglarek U, Stampfer MJ, Shai I (2019). A Green-Mediterranean Diet, Supplemented with Mankai Duckweed, Preserves Iron-Homeostasis in Humans and Is Efficient in Reversal of Anemia in Rats. J Nutr, 149, 1004-1011.
     
  27. Beyer F, Garcia-Garcia I, Heinrich M, Schroeter ML, Sacher J, Luck T, Riedel-Heller SG, Stumvoll M, Villringer A, Witte AV (2019). Neuroanatomical correlates of food addiction symptoms and body mass index in the general population. Hum Brain Mapp, 40, 2747-2758.
     
  28. Cansby E, Kulkarni NM, Magnusson E, Kurhe Y, Amrutkar M, Nerstedt A, Stahlman M, Sihlbom C, Marschall HU, Boren J, Bluher M, Mahlapuu M (2019). Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans. FASEB J, 33, 9974-9989.
     
  29. Schmidleithner L, Thabet Y, Schonfeld E, Kohne M, Sommer D, Abdullah Z, Sadlon T, Osei-Sarpong C, Subbaramaiah K, Copperi F, Haendler K, Varga T, Schanz O, Bourry S, Bassler K, Krebs W, Peters AE, Baumgart AK, Schneeweiss M, Klee K, Schmidt SV, Nussing S, Sander J, Ohkura N, Waha A, Sparwasser T, Wunderlich FT, Forster I, Ulas T, Weighardt H, Sakaguchi S, Pfeifer A, Bluher M, Dannenberg AJ, Ferreiros N, Muglia LJ, Wickenhauser C, Barry SC, Schultze JL, Beyer M (2019). Enzymatic Activity of HPGD in Treg Cells Suppresses Tconv Cells to Maintain Adipose Tissue Homeostasis and Prevent Metabolic Dysfunction. Immunity, 50, 1232-1248.
     
  30. Paeschke S, Baum P, Toyka KV, Bluher M, Koj S, Kloting N, Bechmann I, Thiery J, Kosacka J, Nowicki M (2019). The Role of Iron and Nerve Inflammation in Diabetes Mellitus Type 2-Induced Peripheral Neuropathy. Neuroscience, 406, 496-509.
     
  31. Mancini G, Pirruccio K, Yang X, Bluher M, Rodeheffer M, Horvath TL (2019). Mitofusin 2 in Mature Adipocytes Controls Adiposity and Body Weight. Cell Rep, 26, 2849-2858.
     
  32. Justice AE, Karaderi T, Highland HM, Young KL, Graff M, Lu Y, Turcot V, Auer PL, Fine RS, Guo X, Schurmann C, Lempradl A, Marouli E, Mahajan A, Winkler TW, Locke AE, Medina-Gomez C, Esko T, Vedantam S, Giri A, Lo KS, Alfred T, Mudgal P, Ng MCY, Heard-Costa NL, Feitosa MF, Manning AK, Willems SM, Sivapalaratnam S, Abecasis G, Alam DS, Allison M, Amouyel P, Arzumanyan Z, Balkau B, Bastarache L, Bergmann S, Bielak LF, Bluher M, Boehnke M, Boeing H, Boerwinkle E, Boger CA, Bork-Jensen J, Bottinger E (2019). Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution. Nat Genet, 51, 452-469.
     
  33. Glantschnig C, Koenen M, Gil-Lozano M, Karbiener M, Pickrahn I, Williams-Dautovich J, Patel R, Cummins CL, Giroud M, Hartleben G, Vogl E, Bluher M, Tuckermann J, Uhlenhaut H, Herzig S, Scheideler M (2019). A miR-29a-driven negative feedback loop regulates peripheral glucocorticoid receptor signaling. FASEB J, 33, 5924-5941.
     
  34. Goldstein N, Haim Y, Mattar P, Hadadi-Bechor S, Maixner N, Kovacs P, Bluher M, Rudich A (2019). Leptin stimulates autophagy/lysosome-related degradation of long-lived proteins in adipocytes. Adipocyte, 8, 51-60.
     
  35. Schwenke M, Welzel FD, Luck-Sikorski C, Pabst A, Kersting A, Bluher M, Konig HH, Riedel-Heller SG, Stein J (2019). Psychometric properties of the Patient Assessment of Chronic Illness Care measure (PACIC-5A) among patients with obesity. BMC Health Serv Res, 19, 61-72.
     
  36. Schwenke M, Welzel FD, Luck-Sikorski C, Pabst A, Kersting A, Bluher M, Konig HH, Riedel-Heller SG, Stein J (2019). Psychometric properties of the Patient Assessment of Chronic Illness Care measure (PACIC-5A) among patients with obesity. BMC Health Serv Res, 19, 61-72.
     
  37. Kosacka J, Woidt K, Toyka KV, Paeschke S, Kloting N, Bechmann I, Bluher M, Thiery J, Ossmann S, Baum P, Nowicki M (2019). The role of dietary non-heme iron load and peripheral nerve inflammation in the development of peripheral neuropathy (PN) in obese non-diabetic leptin-deficient ob/ob mice. Neurol Res, 41, 341-353.
     
  38. Dong S, Bluher M, Zhang Y, Wu H, Alahari SK (2019). Development of insulin resistance in Nischarin mutant female mice. Int J Obes (Lond), 43, 1046-1057.
     
  39. Schindler C, Birkenfeld AL, Hanefeld M, Schatz U, Kohler C, Gruneberg M, Tschope D, Bluher M, Hasslacher C, Bornstein SR (2019). Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol. Diabetes Ther, 10, 329-331.
     
  40. Rohde K, Keller M, la Cour Poulsen L, Bluher M, Kovacs P, Bottcher Y (2019). Genetics and epigenetics in obesity. Metabolism, 92, 37-50.
     
  41. Schinke C, Hesse S, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K, Meyer PM, Orthgiess J, Bluher M, Kratzsch J, Ding YS, Then Bergh F, Sabri O (2019). Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls. Stress, 22, 93-102.
     
  42. Eder M, Schwarz C, Kammer M, Jacobsen N, Stavroula ML, Cowan MJ, Chongkrairatanakul T, Gaston R, Ravanan R, Ishida H, Bachmann A, Alvarez S, Koch M, Garrouste C, Duffner UA, Cullis B, Schaap N, Medinger M, Sorensen SS, Dauber EM, Bohmig G, Regele H, Berlakovich GA, Wekerle T, Oberbauer R (2019). Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis. Am J Transplant, 19, 475-487.
     
  43. Ziemann M, Altermann W, Angert K, Arns W, Bachmann A, Bakchoul T, Banas B, von Borstel A, Budde K, Ditt V, Einecke G, Eisenberger U, Feldkamp T, Gorg S, Guthoff M, Habicht A, Hallensleben M, Heinemann FM, Hessler N, Hugo C, Kaufmann M, Kauke T, Koch M, Konig IR, Kurschat C, Lehmann C, Marget M, Muhlfeld A, Nitschke M, Pego da Silva L, Quick C, Rahmel A, Rath T, Reinke P, Renders L, Sommer F, Spriewald B, Staeck O, Stippel D, Susal C, Thiele B, Zecher D, Lachmann N (2019). Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study. Clin J Am Soc Nephrol, 14, 1056-1066.
     


  44. 2018


  45. Baerwald C, Manger B, Hueber A (2018). [Depression as comorbidity of rheumatoid arthritis]. Z Rheumatol, 28, 1-6.
     
  46. Krasselt M, Baerwald C (2018). [Fibromyalgia: current recommendations for diagnosis and therapy]. Dtsch Med Wochenschr, 143(15), 1103-1108.
     
  47. Neubauer AS, Minartz C, Herrmann KH, Baerwald CGO (2018). Cost-effectiveness of early treatment of ACPA-positive rheumatoid arthritis patients with abatacept. Clin Exp Rheumatol, 36(3), 448-454.
     
  48. Krasselt M, Baerwald C, Seifert O (2018). Insufficient vaccination rates in patients with systemic lupus erythematosus in a German outpatient clinic. Z Rheumatol, 77(8), 727-734.
     
  49. Tonjes A, Scholz M, Kruger J, Krause K, Schleinitz D, Kirsten H, Gebhardt C, Marzi C, Grallert H, Ladenvall C, Heyne H, Laurila E, Kriebel J, Meisinger C, Rathmann W, Gieger C, Groop L, Prokopenko I, Isomaa B, Beutner F, Kratzsch J, Fischer-Rosinsky A, Pfeiffer A, Krohn K, Spranger J, Thiery J, Bluher M, Stumvoll M, Kovacs P (2018). Genome-wide meta-analysis identifies novel determinants of circulating serum progranulin. Hum Mol Genet, 27, 546-558.
     
  50. Kralisch S, Hoffmann A, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M, Ebert T (2018). The brown-fat-secreted adipokine neuregulin 4 is decreased in gestational diabetes mellitus. Diabetes Metab, 44, 150-154.
     
  51. Miehle K, Ebert T, Kralisch S, Hoffmann A, Kratzsch J, Schlogl H, Stumvoll M, Fasshauer M (2018). Serum concentrations of fetuin B in lipodystrophic patients. Cytokine, 106, 165-168.
     
  52. Ebert T, Gebhardt C, Scholz M, Wohland T, Schleinitz D, Fasshauer M, Bluher M, Stumvoll M, Kovacs P, Tonjes A (2018). Relationship Between 12 Adipocytokines and Distinct Components of the Metabolic Syndrome. J Clin Endocrinol Metab, 103, 1015-1023.
     
  53. Fenske W, Refardt J, Chifu I, Schnyder I, Winzeler B, Drummond J, Ribeiro-Oliveira A Jr, Drescher T, Bilz S, Vogt DR, Malzahn U, Kroiss M, Christ E, Henzen C, Fischli S, Tonjes A, Mueller B, Schopohl J, Flitsch J, Brabant G, Fassnacht M, Christ-Crain M (2018). A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus. N Engl J Med, 379, 428-439.
     
  54. Fenske WK, Schnyder I, Koch G, Walti C, Pfister M, Kopp P, Fassnacht M, Strauss K, Christ-Crain M (2018). Release and Decay Kinetics of Copeptin vs AVP in Response to Osmotic Alterations in Healthy Volunteers. J Clin Endocrinol Metab, 103, 505-513.
     
  55. Halbritter J, Seidel A, Muller L, Schonauer R, Hoppe B (2018). Update on Hereditary Kidney Stone Disease and Introduction of a New Clinical Patient Registry in Germany. Front Pediatr, 6, 47.
     
  56. Rasche FM, Joel C, Ebert T, Frese T, Barinka F, Busch V, Rasche WG, Lindner TH, Schneider J, Schiekofer S (2018). Dual RAAS Blockade with Aliskiren in Patients with Severely Impaired Chronic Kidney Disease. Exp Clin Endocrinol Diabetes, 126(1), 39-52.
     
  57. Rasche FM, Rettig R, Frese T, Rasche WG, Barinka F, Roesl G, Keller F, Lindner TH, Schneider JG, Beige J, Ebert T, Schiekofer S (2018). The Pituitary-Thyroid Axis and Prolactin Secretion in Hemodialysis Patients in Two Endemic Regions of Eastern Germany. Exp Clin Endocrinol Diabetes, 126(6), 349-356.
     
  58. Kosacka J, Nowicki M, Paeschke S, Baum P, Bluher M, Kloting N (2018). Up-regulated autophagy: as a protective factor in adipose tissue of WOKW rats with metabolic syndrome. Diabetol Metab Syndr, 10, 13.
     
  59. Schmalz G, Dietl M, Vasko R, Muller GA, Rothermund L, Keller F, Ziebolz D, Rasche FM (2018). Dialysis vintage time has the strongest correlation to psychosocial pattern of oral health-related quality of life - a multicentre cross-sectional study. Med Oral Patol Oral Cir Bucal, 23, 698-706.
     
  60. Seidel A, Müller L, Schönauer R, Halbritter J (2018). Genetik und Mechanismen der Nierensteinbildung ? neu geschaffenes Register für hereditäre Nierensteinleiden und Nephrokalzinose. Nieren- und Hochdruckkrankheiten, 9, 464-471.
     
  61. Langhardt J, Flehmig G, Kloting N, Lehmann S, Ebert T, Kern M, Schon MR, Gartner D, Lohmann T, Dressler M, Fasshauer M, Kovacs P, Stumvoll M, Dietrich A, Bluher M (2018). Effects of Weight Loss on Glutathione Peroxidase 3 Serum Concentrations and Adipose Tissue Expression in Human Obesity. Obes Facts, 11, 475-490.
     
  62. Stumvoll M, Tschop M (2018). Twice the benefits with twincretins? Lancet, 392, 2142-2144.
     
  63. Refardt J, Kling B, Krausert K, Fassnacht M, von Felten S, Christ-Crain M, Fenske W (2018). Impact of chronic hyponatremia on neurocognitive and neuromuscular function. Eur J Clin Invest, 48, 1-9.
     
  64. Chifu I, Fenske W (2018). [New Diagnostic Standard in Diabetes Insipidus]. Dtsch Med Wochenschr, 143, 1739-1744.
     
  65. Abshagen K, Degenhardt B, Liebig M, Wendt A, Genz B, Schaeper U, Stumvoll M, Hofmann U, Frank M, Vollmar B, Kloting N (2018). Liver-specific Repin1 deficiency impairs transient hepatic steatosis in liver regeneration. Sci Rep, 8(1), 16858-16873.
     
  66. Rosendahl J, Kirsten H, Hegyi E, Kovacs P, Weiss FU, Laumen H, Lichtner P, Ruffert C, Chen JM, Masson E, Beer S, Zimmer C, Seltsam K, Algul H, Buhler F, Bruno MJ, Bugert P, Burkhardt R, Cavestro GM, C (2018). Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis. Gut, 67, 1855-1863.
     
  67. Zieger K, Weiner J, Krause K, Schwarz M, Kohn M, Stumvoll M, Bluher M, Heiker JT (2018). Vaspin suppresses cytokine-induced inflammation in 3T3-L1 adipocytes via inhibition of NF?B pathway. Mol Cell Endocrinol, 460, 181-188.
     
  68. Turcot V, Lu Y, Highland HM, Schurmann C, Justice AE, Fine RS, Bradfield JP, Esko T, Giri A, Graff M, Guo X, Hendricks AE, Karaderi T, Lempradl A, Locke AE, Mahajan A, Marouli E, Sivapalaratnam S, You (2018). Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet, 50, 26-41.
     
  69. Daga A, Majmundar AJ, Braun DA, Gee HY, Lawson JA, Shril S, Jobst-Schwan T, Vivante A, Schapiro D, Tan W, Warejko JK, Widmeier E, Nelson CP, Fathy HM, Gucev Z, Soliman NA, Hashmi S, Halbritter J, Halt (2018). Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int, 93(1), 204-213.
     
  70. Schindler C, Birkenfeld AL, Hanefeld M, Schatz U, Kohler C, Gruneberg M, Tschope D, Bluher M, Hasslacher C, Bornstein SR (2018). Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol. Diabetes Ther, 9, 37-47.
     
  71. Zieger K, Weiner J, Kunath A, Gericke M, Krause K, Kern M, Stumvoll M, Kloting N, Bluher M, Heiker JT (2018). Ablation of kallikrein 7 (KLK7) in adipose tissue ameliorates metabolic consequences of high fat diet-induced obesity by counteracting adipose tissue inflammation in vivo. Cell Mol Life Sci, 75, 727-742.
     
  72. Kharabian Masouleh S, Beyer F, Lampe L, Loeffler M, Luck T, Riedel-Heller SG, Schroeter ML, Stumvoll M, Villringer A, Witte AV (2018). Gray matter structural networks are associated with cardiovascular risk factors in healthy older adults. J Cereb Blood Flow Metab, 38, 360-372.
     
  73. Gepner Y, Shelef I, Schwarzfuchs D, Zelicha H, Tene L, Yaskolka Meir A, Tsaban G, Cohen N, Bril N, Rein M, Serfaty D, Kenigsbuch S, Komy O, Wolak A, Chassidim Y, Golan R, Avni-Hassid H, Bilitzky A, Sa (2018). Effect of Distinct Lifestyle Interventions on Mobilization of Fat Storage Pools: CENTRAL Magnetic Resonance Imaging Randomized Controlled Trial. Circulation, 137, 1143-1157.
     
  74. Zhang R, Beyer F, Lampe L, Luck T, Riedel-Heller SG, Loeffler M, Schroeter ML, Stumvoll M, Villringer A, Witte AV (2018). White matter microstructural variability mediates the relation between obesity and cognition in healthy adults. Neuroimage, 172, 239-249.
     
  75. Golan R, Shai I, Gepner Y, Harman-Boehm I, Schwarzfuchs D, Spence JD, Parraga G, Buchanan D, Witkow S, Friger M, Liberty IF, Sarusi B, Ben-Avraham S, Sefarty D, Bril N, Rein M, Cohen N, Ceglarek U, Th (2018). Effect of wine on carotid atherosclerosis in type 2 diabetes: a 2-year randomized controlled trial. Eur J Clin Nutr, 72, 871-878.
     
  76. Scheffler L, Crane A, Heyne H, Tonjes A, Schleinitz D, Ihling CH, Stumvoll M, Freire R, Fiorentino M, Fasano A, Kovacs P, Heiker JT (2018). Widely Used Commercial ELISA Does Not Detect Precursor of Haptoglobin2, but Recognizes Properdin as a Potential Second Member of the Zonulin Family. Front Endocrinol (Lausanne), 9, 22.
     
  77. Huhn S, Beyer F, Zhang R, Lampe L, Grothe J, Kratzsch J, Willenberg A, Breitfeld J, Kovacs P, Stumvoll M, Trampel R, Bazin PL, Villringer A, Witte AV (2018). Effects of resveratrol on memory performance, hippocampus connectivity and microstructure in older adults - A randomized controlled trial. Neuroimage, 174, 177-190.
     
  78. Turcot V, Lu Y, Highland HM, Schurmann C, Justice AE, Fine RS, Bradfield JP, Esko T, Giri A, Graff M, Guo X, Hendricks AE, Karaderi T, Lempradl A, Locke AE, Mahajan A, Marouli E, Sivapalaratnam S, You (2018). Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet, 50, 765-766.
     
  79. Turcot V, Lu Y, Highland HM, Schurmann C, Justice AE, Fine RS, Bradfield JP, Esko T, Giri A, Graff M, Guo X, Hendricks AE, Karaderi T, Lempradl A, Locke AE, Mahajan A, Marouli E, Sivapalaratnam S, You (2018). Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet, 50, 766-767.
     
  80. Tene L, Shelef I, Schwarzfuchs D, Gepner Y, Yaskolka Meir A, Tsaban G, Zelicha H, Bilitzky A, Komy O, Cohen N, Bril N, Rein M, Serfaty D, Kenigsbuch S, Chassidim Y, Sarusy B, Ceglarek U, Stumvoll M, B (2018). The effect of long-term weight-loss intervention strategies on the dynamics of pancreatic-fat and morphology: An MRI RCT study. Clin Nutr ESPEN, 24, 82-89.
     
  81. Vettermann FJ, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Meyer PM, McLeod A, Brendel M, Bluher M, Stumvoll M, Hilbert A, Ding YS, Sabri O, Hesse S (2018). Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults. Eur J Nucl Med Mol Imaging, 45, 1618-1625.
     
  82. Mahajan A, Wessel J, Willems SM, Zhao W, Robertson NR, Chu AY, Gan W, Kitajima H, Taliun D, Rayner NW, Guo X, Lu Y, Li M, Jensen RA, Hu Y, Huo S, Lohman KK, Zhang W, Cook JP, Prins BP, Flannick J, Gra (2018). Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. Nat Genet, 50, 559-571.
     
  83. Qi T, Wu Y, Zeng J, Zhang F, Xue A, Jiang L, Zhu Z, Kemper K, Yengo L, Zheng Z, Marioni RE, Montgomery GW, Deary IJ, Wray NR, Visscher PM, McRae AF, Yang J (2018). Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood. Nat Commun, 9, 2282.
     
  84. Ambery P, Parker VE, Stumvoll M, Posch MG, Heise T, Plum-Moerschel L, Tsai LF, Robertson D, Jain M, Petrone M, Rondinone C, Hirshberg B, Jermutus L (2018). MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study. Lancet, 391, 2607-2618.
     
  85. Xue A, Wu Y, Zhu Z, Zhang F, Kemper KE, Zheng Z, Yengo L, Lloyd-Jones LR, Sidorenko J, Wu Y, McRae AF, Visscher PM, Zeng J, Yang J (2018). Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun, 9, 2941.
     
  86. Fahnert J, Stumpp P, Kahn T, Keller F, Schiekofer S, Petros S, Halbritter J, Lindner TH, Rasche FM (2018). Early Flow Disturbances of Tunnelled Haemodialysis Catheters and Topographic Landmarks in Chest X-Ray. Blood Purif, 46, 70-76.
     
  87. Knaup KX, Hackenbeck T, Popp B, Stoeckert J, Wenzel A, Buttner-Herold M, Pfister F, Schueler M, Seven D, May AM, Halbritter J, Grone HJ, Reis A, Beck BB, Amann K, Ekici AB, Wiesener MS (2018). Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition. J Am Soc Nephrol, 29, 2298-2309.
     
  88. Fearn A, Allison B, Rice SJ, Edwards N, Halbritter J, Bourgeois S, Pastor-Arroyo EM, Hildebrandt F, Tasic V, Wagner CA, Hernando N, Sayer JA, Werner A (2018). Clinical, biochemical, and pathophysiological analysis of SLC34A1 mutations. Physiol Rep, 6, 13715-13722.
     
  89. Rasche FM, Joel C, Ebert T, Frese T, Barinka F, Busch V, Rasche WG, Lindner TH, Schneider J, Schiekofer S (2018). Dual RAAS Blockade with Aliskiren in Patients with Severely Impaired Chronic Kidney Disease. Exp Clin Endocrinol Diabetes, 126, 39-52.
     
  90. Rasche FM, Rettig R, Frese T, Rasche WG, Barinka F, Roesl G, Keller F, Lindner TH, Schneider JG, Beige J, Ebert T, Schiekofer S (2018). The Pituitary-Thyroid Axis and Prolactin Secretion in Hemodialysis Patients in Two Endemic Regions of Eastern Germany. Exp Clin Endocrinol Diabetes, 126, 349-356.
     
  91. Price H, Bluher M, Prager R, Phan TM, Thorsted BL, Schultes B (2018). Use and effectiveness of a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) in a real-world population with type 2 diabetes: Results from a European, multicentre, retrospective chart review study. Diabetes Obes Metab, 20, 954-962.
     
  92. Lee NS, Kim HS, Park SE, Bluher M, Park CY, Youn BS (2018). Development of a mouse IgA monoclonal antibody-based enzyme-linked immunosorbent sandwich assay for the analyses of RBP4. Sci Rep, 8, 2578.
     
  93. Stadion M, Schwerbel K, Graja A, Baumeier C, Rodiger M, Jonas W, Wolfrum C, Staiger H, Fritsche A, Haring HU, Kloting N, Bluher M, Fischer-Posovszky P, Schulz TJ, Joost HG, Vogel H, Schurmann A (2018). Increased Ifi202b/IFI16 expression stimulates adipogenesis in mice and humans. Diabetologia, 61, 1167-1179.
     
  94. Kosacka J, Nowicki M, Paeschke S, Baum P, Bluher M, Kloting N (2018). Up-regulated autophagy: as a protective factor in adipose tissue of WOKW rats with metabolic syndrome. Diabetol Metab Syndr, 10, 13.
     
  95. Ghorpade DS, Ozcan L, Zheng Z, Nicoloro SM, Shen Y, Chen E, Bluher M, Czech MP, Tabas I (2018). Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. Nature, 555, 673-677.
     
  96. Gottmann P, Ouni M, Saussenthaler S, Roos J, Stirm L, Jahnert M, Kamitz A, Hallahan N, Jonas W, Fritsche A, Haring HU, Staiger H, Bluher M, Fischer-Posovszky P, Vogel H, Schurmann A (2018). A computational biology approach of a genome-wide screen connected miRNAs to obesity and type 2 diabetes. Mol Metab, 11, 145-159.
     
  97. Petroff D, Bluher M, Wiegand J (2018). Knowledge and practice regarding the German and the EASL-EASD-EASO NAFLD-guidelines among members of the German Obesity Society. Dig Liver Dis, 50, 731-733.
     
  98. Vogel H, Kamitz A, Hallahan N, Lebek S, Schallschmidt T, Jonas W, Jahnert M, Gottmann P, Zellner L, Kanzleiter T, Damen M, Altenhofen D, Burkhardt R, Renner S, Dahlhoff M, Wolf E, Muller TD, Bluher M, (2018). A collective diabetes cross in combination with a computational framework to dissect the genetics of human obesity and Type 2 diabetes. Hum Mol Genet, 27, 3099-3112.
     
  99. Debedat J, Sokolovska N, Coupaye M, Panunzi S, Chakaroun R, Genser L, de Turenne G, Bouillot JL, Poitou C, Oppert JM, Bluher M, Stumvoll M, Mingrone G, Ledoux S, Zucker JD, Clement K, Aron-Wisnewsky J (2018). Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance. Diabetes Care, 41, 2086-2095.
     
  100. Eifler L, Hoffmann A, Wagner IV, Kloting N, Sahlin L, Ebert T, Jessnitzer B, Lossner U, Stumvoll M, Soder O, Fasshauer M, Kralisch S (2018). Leptin restores markers of female fertility in lipodystrophy. Biochim Biophys Acta Mol Basis Dis, 1864, 3292-3297.
     
  101. Rasche FM, Rettig R, Frese T, Rasche WG, Barinka F, Roesl G, Keller F, Lindner TH, Schneider JG, Beige J, Ebert T, Schiekofer S (2018). The Pituitary-Thyroid Axis and Prolactin Secretion in Hemodialysis Patients in Two Endemic Regions of Eastern Germany. Exp Clin Endocrinol Diabetes, 126, 349-356.
     
  102. Giusepponi ME, Kern M, Chakaroun R, Wohland T, Kovacs P, Dietrich A, Schon MR, Krohn K, Pucci M, Polidori C, Micioni Di Bonaventura MV, Stumvoll M, Bluher M, Cifani C, Kloting N (2018). Gene expression profiling in adipose tissue of Sprague Dawley rats identifies olfactory receptor 984 as a potential obesity treatment target. Biochem Biophys Res Commun, 505, 801-806.
     
  103. Aprile M, Cataldi S, Ambrosio MR, D'Esposito V, Lim K, Dietrich A, Bluher M, Savage DB, Formisano P, Ciccodicola A, Costa V (2018). PPAR??5, a Naturally Occurring Dominant-Negative Splice Isoform, Impairs PPAR? Function and Adipocyte Differentiation. Cell Rep, 25, 1577-1592.
     
  104. Schmidt E, Dhaouadi I, Gaziano I, Oliverio M, Klemm P, Awazawa M, Mitterer G, Fernandez-Rebollo E, Pradas-Juni M, Wagner W, Hammerschmidt P, Loureiro R, Kiefer C, Hansmeier NR, Khani S, Bergami M, Hei (2018). LincRNA H19 protects from dietary obesity by constraining expression of monoallelic genes in brown fat. Nat Commun, 9, 3622-3638.
     
  105. Wagenhauser MU, Schellinger IN, Yoshino T, Toyama K, Kayama Y, Deng A, Guenther SP, Petzold A, Mulorz J, Mulorz P, Hasenfuss G, Ibing W, Elvers M, Schuster A, Ramasubramanian AK, Adam M, Schelzig H, S (2018). Chronic Nicotine Exposure Induces Murine Aortic Remodeling and Stiffness Segmentation-Implications for Abdominal Aortic Aneurysm Susceptibility. Front Physiol, 9, 1459-1470.
     
  106. Haunschild J, Schellinger IN, Etz CD (2018). Standardization within the groups is necessary (Reply). Ann Thorac Surg, 18, 31691-31696.
     
  107. Fiehn C, Holle J, Iking-Konert C, Leipe J, Weseloh C, Frerix M, Alten R, Behrens F, Baerwald C, Braun J, Burkhardt H, Burmester G, Detert J, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Krause A, K (2018). [S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs]. Z Rheumatol, 77, 35-53.
     
  108. Kivitz AJ, Wagner U, Dokoupilova E, Supronik J, Martin R, Talloczy Z, Richards HB, Porter B (2018). Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study. Rheumatol Ther, 5(2), 447-462.
     
  109. Braun J, Lorenz HM, Muller-Ladner U, Schneider M, Schulze-Koops H, Specker C, Strangfeld A, Wagner U, Dorner T (2018). [Revised version of the statement by the DGRh on biosimilars-update 2017]. Z Rheumatol, 77(1), 81-90.
     
  110. Schleinitz D, Seidel A, Stassart R, Klammt J, Hirrlinger PG, Winkler U, Kohler S, Heiker JT, Schonauer R, Bialek J, Krohn K, Hoffmann K, Kovacs P, Hirrlinger J (2018). Novel Mutations in the Asparagine Synthetase Gene (ASNS) Associated With Microcephaly. Front Genet, 9, 245-255.
     
  111. Eder M, Schwarz C, Kammer M, Jacobsen N, Stavroula ML, Cowan MJ, Chongkrairatanakul T, Gaston R, Ravanan R, Ishida H, Bachmann A, Alvarez S, Koch M, Garrouste C, Duffner UA, Cullis B, Schaap N, Meding (2018). Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis. Am J Transplant, 13, 1-13.
     
  112. Hoff S, Epting D, Falk N, Schroda S, Braun DA, Halbritter J, Hildebrandt F, Kramer-Zucker A, Bergmann C, Walz G, Lienkamp SS (2018). The nucleoside-diphosphate kinase NME3 associates with nephronophthisis proteins and is required for ciliary function during renal development. J Biol Chem, 293, 15243-15255.
     
  113. Paschke L, Lincke T, Muhlberg KS, Jabs WJ, Lindner TH, Paschke R (2018). Anti VEGF-TKI Treatment and New Renal Adverse Events Not Reported in Phase III Trials. Eur Thyroid J, 7, 308-312.
     
  114. Langhardt J, Flehmig G, Kloting N, Lehmann S, Ebert T, Kern M, Schon MR, Gartner D, Lohmann T, Dressler M, Fasshauer M, Kovacs P, Stumvoll M, Dietrich A, Bluher M (2018). Effects of Weight Loss on Glutathione Peroxidase 3 Serum Concentrations and Adipose Tissue Expression in Human Obesity. Obes Facts, 11, 475-490.
     
  115. Graja A, Garcia-Carrizo F, Jank AM, Gohlke S, Ambrosi TH, Jonas W, Ussar S, Kern M, Schurmann A, Aleksandrova K, Bluher M, Schulz TJ (2018). Loss of periostin occurs in aging adipose tissue of mice and its genetic ablation impairs adipose tissue lipid metabolism. Aging Cell, 17, 12810.
     
  116. Hollenbach M, Kloting N, Sommerer I, Lorenz J, Heindl M, Kern M, Mossner J, Bluher M, Hoffmeister A (2018). p8 deficiency leads to elevated pancreatic beta cell mass but does not contribute to insulin resistance in mice fed with high-fat diet. PLoS One, 13, 1-16.
     
  117. Kosacka J, Nowicki M, Paeschke S, Baum P, Bluher M, Kloting N (2018). Up-regulated autophagy: as a protective factor in adipose tissue of WOKW rats with metabolic syndrome. Diabetol Metab Syndr, 10, 1-15.
     
  118. Moulla Y, Lyros O, Bluher M, Simon P, Dietrich A (2018). Feasibility and Safety of Bariatric Surgery in High-Risk Patients: A Single-Center Experience. J Obes, 2018, 1-6.
     
  119. Picke AK, Campbell GM, Bluher M, Krugel U, Schmidt FN, Tsourdi E, Winzer M, Rauner M, Vukicevic V, Busse B, Salbach-Hirsch J, Tuckermann JP, Simon JC, Anderegg U, Hofbauer LC, Saalbach A (2018). Thy-1 (CD90) promotes bone formation and protects against obesity. Sci Transl Med, 10, 1-12.
     
  120. Picke AK, Sylow L, Moller LLV, Kjobsted R, Schmidt FN, Steejn MW, Salbach-Hirsch J, Hofbauer C, Bluher M, Saalbach A, Busse B, Rauner M, Hofbauer LC (2018). Differential effects of high-fat diet and exercise training on bone and energy metabolism. Bone, 116, 120-134.
     
  121. Schmidt E, Dhaouadi I, Gaziano I, Oliverio M, Klemm P, Awazawa M, Mitterer G, Fernandez-Rebollo E, Pradas-Juni M, Wagner W, Hammerschmidt P, Loureiro R, Kiefer C, Hansmeier NR, Khani S, Bergami M, Hei (2018). LincRNA H19 protects from dietary obesity by constraining expression of monoallelic genes in brown fat. Nat Commun, 9, 3622-3638.
     
  122. Spiller S, Bluher M, Hoffmann R (2018). Plasma levels of free fatty acids correlate with type 2 diabetes mellitus. Diabetes Obes Metab, 20, 2661-2669.
     
  123. Spiller S, Li Y, Bluher M, Welch L, Hoffmann R (2018). Diagnostic Accuracy of Protein Glycation Sites in Long-Term Controlled Patients with Type 2 Diabetes Mellitus and Their Prognostic Potential for Early Diagnosis. Pharmaceuticals (Basel), 11, 1-13.
     
  124. Schwarz AC, Billeter AT, Scheurlen KM, Bluher M, Muller-Stich BP (2018). Comorbidities as an Indication for Metabolic Surgery. Visc Med, 34, 381-387.
     
  125. Welzel FD, Stein J, Pabst A, Luppa M, Kersting A, Bluher M, Luck-Sikorski C, Konig HH, Riedel-Heller SG (2018). Five A's counseling in weight management of obese patients in primary care: a cluster-randomized controlled trial (INTERACT). BMC Fam Pract, 19, 97-106.
     
  126. Kolb H, Stumvoll M, Kramer W, Kempf K, Martin S (2018). Insulin translates unfavourable lifestyle into obesity. BMC Med, 16, 1-10.
     
  127. Refardt J, Sailer CO, Winzeler B, Betz MJ, Chifu I, Schnyder I, Fassnacht M, Fenske W, Christ-Crain M (2018). FGF-21 levels in polyuria-polydipsia syndrome. Endocr Connect, 7, 1501-1506.
     
  128. Fuss CT, Treitl M, Rayes N, Podrabsky P, Fenske WK, Heinrich DA, Reincke M, Petersen TO, Fassnach M, Quinkler M, Kickuth R, Hahner S (2018). Radiation exposure of adrenal vein sampling: a German Multicenter Study Eur J Endocrinol, 179, 261-267.
     


  129. 2017


  130. Kralisch S, Hoffmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M, Ebert T (2017). Regulation of the novel adipokines/ hepatokines fetuin A and fetuin B in gestational diabetes mellitus. Metabolism, 68, 88-94.
     
  131. Miehle K, Ebert T, Kralisch S, Hoffmann A, Kratzsch J, Schlogl H, Stumvoll M, Fasshauer M (2017). Adipocyte and epidermal fatty acid-binding protein serum concentrations in patients with lipodystrophy. Cytokine, 92, 20-23.
     
  132. Hankir MK, Seyfried F, Hintschich CA, Diep TA, Kleberg K, Kranz M, Deuther-Conrad W, Tellez LA, Rullmann M, Patt M, Teichert J, Hesse S, Sabri O, Brust P, Hansen HS, de Araujo IE, Krugel U, Fenske WK (2017). Gastric Bypass Surgery Recruits a Gut PPAR-?-Striatal D1R Pathway to Reduce Fat Appetite in Obese Rats. Cell Metab, 25(2), 335-344.
     
  133. Krasselt M, Pierer M, Amann K, Bachmann A, Lindner TH (2017). [Clinical Course of an Early Childhood-Onset Granulomatosis with Polyangiitis]. Dtsch Med Wochenschr, 142(12), 904-908.
     
  134. Rasche FM, Ebert T, Beckmann J, Busch V, Barinka F, Rasche WG, Lindner TH, Schneider JG, Schiekofer S (2017). Influence of Erythropoiesis-Stimulating Agents on HbA1c and Fructosamine in Patients with Haemodialysis. Exp Clin Endocrinol Diabetes, 125(6), 384-391.
     
  135. Rasche FM, Stoebe S, Ebert T, Feige S, Hagendorff A, Rasche WG, Barinka F, Busch V, Sack U, Schneider JG, Schiekofer S (2017). Modern peptide biomarkers and echocardiography in cardiac healthy haemodialysis patients. BMC Nephrol, 18(1), 175.
     
  136. Hauner H, Hastreiter L, Werdier D, Chen-Stute A, Scholze J, Bluher M (2017). Efficacy and Safety of Cathine (Nor-Pseudoephedrine) in the Treatment of Obesity: A Randomized Dose-Finding Study. Obes Facts, 10(4), 407-419.
     
  137. Sedaghat S, Heshmati ES, Frese T, Rasche WG, Barinka F, Fahr F, Beige J, Schiekofer S, Rasche FM (2017). Endemic influences of political regimes, healthcare systems, and preferences on the frequencies and incidences of nephropathies in eastern Saxony, Germany?. Clin Nephrol, 88(12), 317-327.
     
  138. Miehle K, Stumvoll M, Fasshauer M, Hierl T (2017). Facial soft tissue volume decreases during metreleptin treatment in patients with partial and generalized lipodystrophy. Endocrine, 58(2), 262-266.
     
  139. Weiner J, Hankir M, Heiker JT, Fenske W, Krause K (2017). Thyroid hormones and browning of adipose tissue. Mol Cell Endocrinol, 458, 156-159.
     
  140. Fenske W (2017). [Hyponatremia in emergency admissions - often dangerous]. Internist (Berl), 58, 1042-1052.
     
  141. Kralisch S, Hoffmann A, Kloting N, Bachmann A, Kratzsch J, Stolzenburg JU, Dietel A, Beige J, Anders M, Bast I, Bluher M, Zhang MZ, Harris RC, Stumvoll M, Fasshauer M, Ebert T (2017). FSTL3 is increased in renal dysfunction. Nephrol Dial Transplant, 32(10), 1637-1644.
     
  142. Kralisch S, Hoffmann A, Kloting N, Bachmann A, Kratzsch J, Bluher M, Zhang MZ, Harris RC, Stumvoll M, Fasshauer M, Ebert T (2017). The novel adipokine/hepatokine fetuin B in severe human and murine diabetic kidney disease. Diabetes Metab, 43(5), 465-468.
     
  143. Bluher M (2017). Obesity: The myth of innocent obesity. Nat Rev Endocrinol, 13(12), 691-692.
     
  144. Munch J, Bachmann A, Grohmann M, Mayer C, Kirschfink M, Lindner TH, Bergmann C, Halbritter J (2017). Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies. Clin Kidney J, 10(6), 742-746.
     
  145. Ebert T, Linder N, Schaudinn A, Busse H, Berger J, Lichtinghagen R, Keim V, Wiegand J, Karlas T (2017). Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease. Endocrine, 58(2), 246-252.
     
  146. Hankir MK, Kranz M, Keipert S, Weiner J, Andreasen SG, Kern M, Patt M, Kloting N, Heiker JT, Brust P, Hesse S, Jastroch M, Fenske WK (2017). Dissociation Between Brown Adipose Tissue 18F-FDG Uptake and Thermogenesis in Uncoupling Protein 1-Deficient Mice. J Nucl Med, 58(7), 1100-1103.
     
  147. Marouli E, Graff M, Medina-Gomez C, Lo KS, Wood AR, Kjaer TR, Fine RS, Lu Y, Schurmann C, Highland HM, Rueger S, Thorleifsson G, Justice AE, Lamparter D, Stirrups KE, Turcot V, Young KL, Winkler TW, E (2017). Rare and low-frequency coding variants alter human adult height. Nature, 542(7640), 186-190.
     
  148. Golan R, Shelef I, Shemesh E, Henkin Y, Schwarzfuchs D, Gepner Y, Harman-Boehm I, Witkow S, Friger M, Chassidim Y, Liberty IF, Sarusi B, Serfaty D, Bril N, Rein M, Cohen N, Ben-Avraham S, Ceglarek U, (2017). Effects of initiating moderate wine intake on abdominal adipose tissue in adults with type 2 diabetes: a 2-year randomized controlled trial. Public Health Nutr, 20(3), 549-555.
     
  149. Macia MS, Halbritter J, Delous M, Bredrup C, Gutter A, Filhol E, Mellgren AE, Leh S, Bizet A, Braun DA, Gee HY, Silbermann F, Henry C, Krug P, Bole-Feysot C, Nitschke P, Joly D, Nicoud P, Paget A, Hau (2017). Mutations in MAPKBP1 Cause Juvenile or Late-Onset Cilia-Independent Nephronophthisis. Am J Hum Genet, 100(2), 323-333.
     
  150. Schinke C, Hesse S, Stoppe M, Meyer K, Schmidt E, Orthgiess J, Bechmann L, Bresch A, Rullmann M, Luthardt J, Sabri O, Bluher M, Kratzsch J, Then Bergh F (2017). Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity. Psychoneuroendocrinology, 78, 39-47.
     
  151. Sanyal A, Naumann J, Hoffmann LS, Chabowska-Kita A, Ehrlund A, Schlitzer A, Arner P, Bluher M, Pfeifer A (2017). Interplay between Obesity-Induced Inflammation and cGMP Signaling in White Adipose Tissue. Cell Rep, 18(1), 225-236.
     
  152. Hesse S, Becker GA, Rullmann M, Bresch A, Luthardt J, Hankir MK, Zientek F, Reissig G, Patt M, Arelin K, Lobsien D, Muller U, Baldofski S, Meyer PM, Bluher M, Fasshauer M, Fenske WK, Stumvoll M, Hilbe (2017). Central noradrenaline transporter availability in highly obese, non-depressed individuals. Eur J Nucl Med Mol Imaging, 44(6), 1056-1064.
     
  153. Hinney A, Kesselmeier M, Jall S, Volckmar AL, Focker M, Antel J, Heid IM, Winkler TW, Grant SF, Guo Y, Bergen AW, Kaye W, Berrettini W, Hakonarson H, Herpertz-Dahlmann B, de Zwaan M, Herzog W, Ehrlich (2017). Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index. Mol Psychiatry, 22(2), 192-201.
     
  154. Lynes MD, Leiria LO, Lundh M, Bartelt A, Shamsi F, Huang TL, Takahashi H, Hirshman MF, Schlein C, Lee A, Baer LA, May FJ, Gao F, Narain NR, Chen EY, Kiebish MA, Cypess AM, Bluher M, Goodyear LJ, Hotam (2017). The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue. Nat Med, 23(5), 631-637.
     
  155. le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DC, Van Gaal L, Ortiz RV, Wilding JP, Skjoth TV, Manning LS, Pi-Sunyer X (2017). 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet, 389(10077), 1399-1409.
     
  156. Braune J, Weyer U, Matz-Soja M, Hobusch C, Kern M, Kunath A, Kloting N, Kralisch S, Bluher M, Gebhardt R, Zavros Y, Bechmann I, Gericke M (2017). Hedgehog signalling in myeloid cells impacts on body weight, adipose tissue inflammation and glucose metabolism. Diabetologia, 60(5), 889-899.
     
  157. Macia MS, Halbritter J, Delous M, Bredrup C, Gutter A, Filhol E, Mellgren AE, Leh S, Bizet A, Braun DA, Gee HY, Silbermann F, Henry C, Krug P, Bole-Feysot C, Nitschke P, Joly D, Nicoud P, Paget A, Hau (2017). Mutations in MAPKBP1 Cause Juvenile or Late-Onset Cilia-Independent Nephronophthisis. Correction. Am J Hum Genet, 100(2), 372.
     
  158. Weiner J, Rohde K, Krause K, Zieger K, Kloting N, Kralisch S, Kovacs P, Stumvoll M, Bluher M, Bottcher Y, Heiker JT (2017). Brown adipose tissue (BAT) specific vaspin expression is increased after obesogenic diets and cold exposure and linked to acute changes in DNA-methylation. Mol Metab, 6(6), 482-493.
     
  159. Verger EO, Armstrong P, Nielsen T, Chakaroun R, Aron-Wisnewsky J, Gobel RJ, Schutz T, Delaere F, Gausseres N, Clement K, Holmes BA (2017). Dietary Assessment in the MetaCardis Study: Development and Relative Validity of an Online Food Frequency Questionnaire. J Acad Nutr Diet, 117(6), 878-888.
     
  160. Yaskolka Meir A, Tene L, Cohen N, Shelef I, Schwarzfuchs D, Gepner Y, Zelicha H, Rein M, Bril N, Serfaty D, Kenigsbuch S, Chassidim Y, Sarusy B, Dicker D, Thiery J, Ceglarek U, Stumvoll M, Bluher M, S (2017). Intrahepatic fat, abdominal adipose tissues, and metabolic state: magnetic resonance imaging study. Diabetes Metab Res Rev, 33(5), 1-8.
     
  161. Hosel M, Huber A, Bohlen S, Lucifora J, Ronzitti G, Puzzo F, Boisgerault F, Hacker UT, Kwanten WJ, Kloting N, Bluher M, Gluschko A, Schramm M, Utermohlen O, Bloch W, Mingozzi F, Krut O, Buning H (2017). Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors. Hepatology, 66(1), 252-265.
     
  162. Spiller S, Li Y, Bluher M, Welch L, Hoffmann R (2017). Glycated lysine-141 in haptoglobin improves the diagnostic accuracy for type 2 diabetes mellitus in combination with glycated hemoglobin HbA1c and fasting plasma glucose. Clin Proteomics, 14, 10.
     
  163. Chung KJ, Chatzigeorgiou A, Economopoulou M, Garcia-Martin R, Alexaki VI, Mitroulis I, Nati M, Gebler J, Ziemssen T, Goelz SE, Phieler J, Lim JH, Karalis KP, Papayannopoulou T, Bluher M, Hajishengalli (2017). A self-sustained loop of inflammation-driven inhibition of beige adipogenesis in obesity. Nat Immunol, 18(6), 654-664.
     
  164. Hesse S, Muller U, Rullmann M, Luthardt J, Bresch A, Becker GA, Zientek F, Patt M, Meyer PM, Bluher M, Strauss M, Fenske W, Hankir M, Ding YS, Hilbert A, Sabri O (2017). The association between in vivo central noradrenaline transporter availability and trait impulsivity. Psychiatry Res, 267, 9-14.
     
  165. Herder C, Kannenberg JM, Niersmann C, Huth C, Carstensen-Kirberg M, Wittenbecher C, Schulze M, Bluher M, Rathmann W, Peters A, Roden M, Meisinger C, Thorand B (2017). Independent and opposite associations of serum levels of omentin-1 and adiponectin with increases of glycaemia and incident type 2 diabetes in an older population: KORA F4/FF4 study. Eur J Endocrinol, 177(4), 277-286.
     
  166. Haim Y, Bluher M, Konrad D, Goldstein N, Kloting N, Harman-Boehm I, Kirshtein B, Ginsberg D, Tarnovscki T, Gepner Y, Shai I, Rudich A (2017). ASK1 (MAP3K5) is transcriptionally upregulated by E2F1 in adipose tissue in obesity, molecularly defining a human dys-metabolic obese phenotype. Mol Metab, 6(7), 725-736.
     
  167. Mardinoglu A, Stancakova A, Lotta LA, Kuusisto J, Boren J, Bluher M, Wareham NJ, Ferrannini E, Groop PH, Laakso M, Langenberg C, Smith U (2017). Plasma Mannose Levels Are Associated with Incident Type 2 Diabetes and Cardiovascular Disease. Cell Metab, 26(2), 281-283.
     
  168. Niopek K, Ustunel BE, Seitz S, Sakurai M, Zota A, Mattijssen F, Wang X, Sijmonsma T, Feuchter Y, Gail AM, Leuchs B, Niopek D, Staufer O, Brune M, Sticht C, Gretz N, Muller-Decker K, Hammes HP, Nawroth (2017). A Hepatic GAbp-AMPK Axis Links Inflammatory Signaling to Systemic Vascular Damage. Cell Rep, 20(6), 1422-1434.
     
  169. Kalin S, Becker M, Ott VB, Serr I, Hosp F, Mollah MMH, Keipert S, Lamp D, Rohner-Jeanrenaud F, Flynn VK, Scherm MG, Nascimento LFR, Gerlach K, Popp V, Dietzen S, Bopp T, Krishnamurthy P, Kaplan MH, Se (2017). A Stat6/Pten Axis Links Regulatory T Cells with Adipose Tissue Function. Cell Metab, 26(3), 475-492.
     
  170. Loffler A, Luck T, Then FS, Luck-Sikorski C, Pabst A, Kovacs P, Bottcher Y, Breitfeld J, Tonjes A, Horstmann A, Loffler M, Engel C, Thiery J, Villringer A, Stumvoll M, Riedel-Heller SG (2017). Effects of psychological eating behaviour domains on the association between socio-economic status and BMI. Public Health Nutr, 20(15), 2706-2712.
     
  171. Gepner Y, Shelef I, Schwarzfuchs D, Cohen N, Bril N, Rein M, Tsaban G, Zelicha H, Yaskolka Meir A, Tene L, Sarusy B, Rosen P, Hoffman JR, Stout JR, Thiery J, Ceglarek U, Stumvoll M, Bluher M, Stampfer (2017). Intramyocellular triacylglycerol accumulation across weight loss strategies; Sub-study of the CENTRAL trial. PLoS One, 12(11), e0188431.
     
  172. Rohde K, Klos M, Hopp L, Liu X, Keller M, Stumvoll M, Dietrich A, Schon MR, Gartner D, Lohmann T, Dressler M, Kovacs P, Binder H, Bluher M, Bottcher Y (2017). IRS1 DNA promoter methylation and expression in human adipose tissue are related to fat distribution and metabolic traits. Sci Rep, 7(1), 12369.
     
  173. Tsaban G, Wolak A, Avni-Hassid H, Gepner Y, Shelef I, Henkin Y, Schwarzfuchs D, Cohen N, Bril N, Rein M, Serfaty D, Kenigsbuch S, Tene L, Zelicha H, Yaskolka-Meir A, Komy O, Bilitzky A, Chassidim Y, C (2017). Dynamics of intrapericardial and extrapericardial fat tissues during long-term, dietary-induced, moderate weight loss. Am J Clin Nutr, 106(4), 984-995.
     
  174. Drabe M, Rullmann M, Luthardt J, Boettcher Y, Regenthal R, Ploetz T, Becker GA, Patt M, Schinke C, Bergh FT, Zientek F, Hilbert A, Bresch A, Fenske W, Hankir MK, Sabri O, Hesse S (2017). Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity. Transl Psychiatry, 7(7), e1167.
     
  175. Polyakova M, Schlogl H, Sacher J, Schmidt-Kassow M, Kaiser J, Stumvoll M, Kratzsch J, Schroeter ML (2017). Stability of BDNF in Human Samples Stored Up to 6 Months and Correlations of Serum and EDTA-Plasma Concentrations. Int J Mol Sci, 18(6), E1189.
     
  176. Lee KY, Sharma R, Gase G, Ussar S, Li Y, Welch L, Berryman DE, Kispert A, Bluher M, Kahn CR (2017). Tbx15 Defines a Glycolytic Subpopulation and White Adipocyte Heterogeneity. Diabetes, 66(11), 2822-2829.
     
  177. Moreno-Navarrete JM, Moreno M, Ortega F, Xifra G, Hong S, Asara JM, Serrano JCE, Jove M, Pissios P, Bluher M, Ricart W, Portero-Otin M, Fernandez-Real JM (2017). TSHB mRNA is linked to cholesterol metabolism in adipose tissue. FASEB J, 31(10), 4482-4491.
     
  178. Awazawa M, Gabel P, Tsaousidou E, Nolte H, Kruger M, Schmitz J, Ackermann PJ, Brandt C, Altmuller J, Motameny S, Wunderlich FT, Kornfeld JW, Bluher M, Bruning JC (2017). A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes to obesity-induced insulin resistance in skeletal muscle. Nat Med, 23(12), 1466-1473.
     
  179. Hesselbarth N, Kunath A, Kern M, Gericke M, Mejhert N, Ryden M, Stumvoll M, Bluher M, Kloting N (2017). Repin1 deficiency in adipose tissue improves whole-body insulin sensitivity, and lipid metabolism. Int J Obes (Lond), 41(12), 1815-1823.
     
  180. Vencio S, Paldanius PM, Bluher M, Giannella-Neto D, Caiado-Vencio R, Strain WD (2017). Understanding the barriers and improving care in type 2 diabetes: Brazilian perspective in time to do more in diabetes. Diabetol Metab Syndr, 9, 46.
     
  181. Gross A, Tonjes A, Scholz M (2017). On the impact of relatedness on SNP association analysis. BMC Genet, 18(1), 104.
     
  182. Schofl C, Petroff D, Tonjes A, Grussendorf M, Droste M, Stalla G, Jaursch-Hancke C, Stormann S, Schopohl J (2017). Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry. Pituitary, 20(6), 635-642.
     
  183. Scott RA, Scott LJ, Magi R, Marullo L, Gaulton KJ, Kaakinen M, Pervjakova N, Pers TH, Johnson AD, Eicher JD, Jackson AU, Ferreira T, Lee Y, Ma C, Steinthorsdottir V, Thorleifsson G, Qi L, Van Zuydam N (2017). An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans. Diabetes, 66(11), 2888-2902.
     
  184. Schiekofer S, Kleber ME, Maerz W, Rasche FM, Schneider JG (2017). The Proline 7 Substitution in the Preproneuropeptide Y Is Associated with Higher Hepatic Lipase Activity In Vivo. Int J Endocrinol, 2017, 2869090.
     
  185. Haertle L, Maierhofer A, Bock J, Lehnen H, Bottcher Y, Bluher M, Schorsch M, Potabattula R, El Hajj N, Appenzeller S, Haaf T (2017). Hypermethylation of the non-imprinted maternal MEG3 and paternal MEST alleles is highly variable among normal individuals. PLoS One, 12(8), e0184030.
     
  186. Mardinoglu A, Gogg S, Lotta LA, Stancakova A, Nerstedt A, Boren J, Bluher M, Ferrannini E, Langenberg C, Wareham NJ, Laakso M, Smith U (2017). Elevated Plasma Levels of 3-Hydroxyisobutyric Acid Are Associated With Incident Type 2 Diabetes. EBioMedicine, 00, 00.
     
  187. Lynes MD, Leiria LO, Lundh M, Bartelt A, Shamsi F, Huang TL, Takahashi H, Hirshman MF, Schlein C, Lee A, Baer LA, May FJ, Gao F, Narain NR, Chen EY, Kiebish MA, Cypess AM, Bluher M, Goodyear LJ, Hotam (2017). Corrigendum: The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue. Nat Med, 23(11), 1384.
     
  188. Zelicha H, Schwarzfuchs D, Shelef I, Gepner Y, Tsaban G, Tene L, Yaskolka Meir A, Bilitzky A, Komy O, Cohen N, Bril N, Rein M, Serfaty D, Kenigsbuch S, Chassidim Y, Sarusi B, Thiery J, Ceglarek U, Stu (2017). Changes of renal sinus fat and renal parenchymal fat during an 18-month randomized weight loss trial. Clin Nutr, 00, 00.
     


  189. 2016


  190. Miehle K, Ebert T, Kralisch S, Hoffmann A, Kratzsch J, Schlogl H, Stumvoll M, Fasshauer M (2016). Progranulin is increased in human and murine lipodystrophy. Diabetes Res Clin Pract, 120, 1-7.
     
  191. Schlogl H, Muller K, Horstmann A, Miehle K, Puschel J, Villringer A, Pleger B, Stumvoll M, Fasshauer M (2016). Leptin Substitution in Patients With Lipodystrophy: Neural Correlates for Long-term Success in the Normalization of Eating Behavior. Diabetes, 65(8), 2179-2186.
     
  192. Miehle K, Ebert T, Kralisch S, Hoffmann A, Kratzsch J, Schlogl H, Stumvoll M, Fasshauer M (2016). Serum concentrations of fibroblast growth factor 21 are elevated in patients with congenital or acquired lipodystrophy. Cytokine, 83, 239-244.
     
  193. Schlogl H, Horstmann A, Villringer A, Stumvoll M (2016). Functional neuroimaging in obesity and the potential for development of novel treatments. Lancet Diabetes Endocrinol, 4(8), 695-705.
     
  194. Ebert T, Platz M, Kralisch S, Lossner U, Jessnitzer B, Richter J, Bluher M, Stumvoll M, Fasshauer M (2016). Serum Levels of Copeptin are Decreased in Gestational Diabetes Mellitus. Exp Clin Endocrinol Diabetes, 124(4), 257-260.
     
  195. Miehle K, Ebert T, Kralisch S, Hoffmann A, Kratzsch J, Schlogl H, Stumvoll M, Fasshauer M (2016). Circulating serum chemerin levels are elevated in lipodystrophy. Clin Endocrinol (Oxf), 84(6), 932-938.
     
  196. Ebert T, Kralisch S, Wurst U, Scholz M, Stumvoll M, Kovacs P, Fasshauer M, Tonjes A (2016). Association of metabolic parameters and rs726344 in FNDC5 with serum irisin concentrations. Int J Obes (Lond), 40(2), 260-265.
     
  197. Miehle K, Porrmann J, Mitter D, Stumvoll M, Glaser C, Fasshauer M, Hoffmann K (2016). Novel peroxisome proliferator-activated receptor gamma mutation in a family with familial partial lipodystrophy type 3. Clin Endocrinol (Oxf), 84(1), 141-148.
     
  198. Anders R, Grohmann M, Lindner TH, Bergmann C, Halbritter J (2016). [Hemolytic kidney failure and transient ischemic attack in a 32-year-old female]. Internist (Berl), 57(10), 1022-1028.
     
  199. Munch J, Grohmann M, Lindner TH, Bergmann C, Halbritter J (2016). Diagnosing FSGS without kidney biopsy - a novel INF2-mutation in a family with ESRD of unknown origin. BMC Med Genet, 17(1), 73.
     
  200. Rasche FM, Keller F, Rasche WG, Schiekofer S, Kahn T, Fahnert J (2016). Sequential therapy with cyclophosphamide and mycophenolic acid in patients with progressive immunoglobulin A nephropathy: a long-term follow-up. Clin Exp Immunol, 183(2), 307-316.
     
  201. Rasche FM, Keller F, Rasche WG, Schiekofer S, Boldt A, Sack U, Fahnert J (2016). Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy? Clin Exp Immunol, 186(2), 115-133.
     
  202. Hoffmann A, Manjowk GM, Wagner IV, Kloting N, Ebert T, Jessnitzer B, Lossner U, Stukenborg JB, Bluher M, Stumvoll M, Soder O, Svechnikov K, Fasshauer M, Kralisch S (2016). Leptin Within the Subphysiological to Physiological Range Dose Dependently Improves Male Reproductive Function in an Obesity Mouse Model. Endocrinology, 157(6), 2461-2468.
     
  203. Bluher M (2016). Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance? Clin Sci (Lond), 130(18), 1603-1614.
     
  204. Kern M, Kloting N, Mark M, Mayoux E, Klein T, Bluher M (2016). The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin. Metabolism, 65(2), 114-123.
     
  205. Stokowy T, Wojtas B, Jarzab B, Krohn K, Fredman D, Dralle H, Musholt T, Hauptmann S, Lange D, Hegedus L, Paschke R, Eszlinger M (2016). Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity. Endocrine, 54(2), 440-447.
     
  206. Brune JE, Kern M, Kunath A, Flehmig G, Schon MR, Lohmann T, Dressler M, Dietrich A, Fasshauer M, Kovacs P, Stumvoll M, Bluher M, Kloting N (2016). Fat depot-specific expression of HOXC9 and HOXC10 may contribute to adverse fat distribution and related metabolic traits. Obesity (Silver Spring), 24(1), 51-59.
     
  207. Weingarten A, Turchetti L, Krohn K, Kloting I, Kern M, Kovacs P, Stumvoll M, Bluher M, Kloting N (2016). Novel genes on rat chromosome 10 are linked to body fat mass, preadipocyte number and adipocyte size. Int J Obes (Lond), 40(12), 1832-1840.
     
  208. Barban N, Jansen R, de Vlaming R, Vaez A, Mandemakers JJ, Tropf FC, Shen X, Wilson JF, Chasman DI, Nolte IM, Tragante V, van der Laan SW, Perry JR, Kong A, Ahluwalia TS, Albrecht E, Yerges-Armstrong L (2016). Genome-wide analysis identifies 12 loci influencing human reproductive behavior. Nat Genet, 48(12), 1462-1472.
     
  209. Horikoshi M, Beaumont RN, Day FR, Warrington NM, Kooijman MN, Fernandez-Tajes J, Feenstra B, van Zuydam NR, Gaulton KJ, Grarup N, Bradfield JP, Strachan DP, Li-Gao R, Ahluwalia TS, Kreiner E, Rueedi R (2016). Genome-wide associations for birth weight and correlations with adult disease. Nature, 538(7624), 248-252.
     
  210. Guiu-Jurado E, Unthan M, Bohler N, Kern M, Landgraf K, Dietrich A, Schleinitz D, Ruschke K, Kloting N, Fasshauer M, Tonjes A, Stumvoll M, Korner A, Kovacs P, Bluher M (2016). Bone morphogenetic protein 2 (BMP2) may contribute to partition of energy storage into visceral and subcutaneous fat depots. Obesity (Silver Spring), 24(10), 2092-2100.
     
  211. Lazaridis I, Nadel D, Rollefson G, Merrett DC, Rohland N, Mallick S, Fernandes D, Novak M, Gamarra B, Sirak K, Connell S, Stewardson K, Harney E, Fu Q, Gonzalez-Fortes G, Jones ER, Roodenberg SA, Leng (2016). Genomic insights into the origin of farming in the ancient Near East. Nature, 536(7617), 419-424.
     
  212. Walford GA, Gustafsson S, Rybin D, Stancakova A, Chen H, Liu CT, Hong J, Jensen RA, Rice K, Morris AP, Magi R, Tonjes A, Prokopenko I, Kleber ME, Delgado G, Silbernagel G, Jackson AU, Appel EV, Grarup (2016). Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci. Diabetes, 65(10), 3200-3211.
     
  213. Kunath A, Hesselbarth N, Gericke M, Kern M, Dommel S, Kovacs P, Stumvoll M, Bluher M, Kloting N (2016). Repin1 deficiency improves insulin sensitivity and glucose metabolism in db/db mice by reducing adipose tissue mass and inflammation. Biochem Biophys Res Commun, 478(1), 398-402.
     
  214. Grellmann C, Neumann J, Bitzer S, Kovacs P, Tonjes A, Westlye LT, Andreassen OA, Stumvoll M, Villringer A, Horstmann A (2016). Random Projection for Fast and Efficient Multivariate Correlation Analysis of High-Dimensional Data: A New Approach. Front Genet, 7, 102.
     
  215. Winkler TW, Justice AE, Graff M, Barata L, Feitosa MF, Chu S, Czajkowski J, Esko T, Fall T, Kilpelainen TO, Lu Y, Magi R, Mihailov E, Pers TH, Rueger S, Teumer A, Ehret GB, Ferreira T, Heard-Costa NL, (2016). Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study. PLoS Genet, 12(6), 1006166.
     
  216. Wagner IV, Flehmig G, Scheuermann K, Loffler D, Korner A, Kiess W, Stumvoll M, Dietrich A, Bluher M, Kloting N, Soder O, Svechnikov K (2016). Insulin-Like Peptide 5 Interacts with Sex Hormones and Metabolic Parameters in a Gender and Adiposity Dependent Manner in Humans. Horm Metab Res, 48(9), 589-594.
     
  217. Teumer A, Qi Q, Nethander M, Aschard H, Bandinelli S, Beekman M, Berndt SI, Bidlingmaier M, Broer L, Cappola A, Ceda GP, Chanock S, Chen MH, Chen TC, Chen YD, Chung J, Del Greco Miglianico F, Eriksson (2016). Genomewide meta-analysis identifies loci associated with IGF-I and IGFBP-3 levels with impact on age-related traits. Aging Cell, 15(5), 811-824.
     
  218. Tschop MH, Stumvoll M, Ristow M (2016). Opposing Effects of Antidiabetic Interventions on Malignant Growth and Metastasis. Cell Metab, 23(6), 959-960.
     
  219. Prasad RB, Lessmark A, Almgren P, Kovacs G, Hansson O, Oskolkov N, Vitai M, Ladenvall C, Kovacs P, Fadista J, Lachmann M, Zhou Y, Sonestedt E, Poon W, Wollheim CB, Orho-Melander M, Stumvoll M, Tuomi T (2016). Excess maternal transmission of variants in the THADA gene to offspring with type 2 diabetes. Diabetologia, 59(8), 1702-1713.
     
  220. Melasch J, Rullmann M, Hilbert A, Luthardt J, Becker GA, Patt M, Stumvoll M, Bluher M, Villringer A, Arelin K, Meyer PM, Bresch A, Sabri O, Hesse S, Pleger B (2016). Sex differences in serotonin-hypothalamic connections underpin a diminished sense of emotional well-being with increasing body weight. Int J Obes (Lond), 40(8), 1268-1277.
     
  221. Masouleh SK, Arelin K, Horstmann A, Lampe L, Kipping JA, Luck T, Riedel-Heller SG, Schroeter ML, Stumvoll M, Villringer A, Witte AV (2016). Higher body mass index in older adults is associated with lower gray matter volume: implications for memory performance. Neurobiol Aging, 40, 1-10.
     
  222. Mueller T, Fischer J, Gessner R, Rosendahl J, Bohm S, van Bommel F, Knop V, Sarrazin C, Witt H, Marques AM, Kovacs P, Schleinitz D, Stumvoll M, Bluher M, Bugert P, Schott E, Berg T (2016). Apolipoprotein E allele frequencies in chronic and self-limited hepatitis C suggest a protective effect of APOE4 in the course of hepatitis C virus infection. Liver Int, 36(9), 1267-1274.
     
  223. Lu Y, Day FR, Gustafsson S, Buchkovich ML, Na J, Bataille V, Cousminer DL, Dastani Z, Drong AW, Esko T, Evans DM, Falchi M, Feitosa MF, Ferreira T, Hedman AK, Haring R, Hysi PG, Iles MM, Justice AE, K (2016). New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk. Nat Commun, 7, 10495.
     
  224. Pattaro C, Teumer A, Gorski M, Chu AY, Li M, Mijatovic V, Garnaas M, Tin A, Sorice R, Li Y, Taliun D, Olden M, Foster M, Yang Q, Chen MH, Pers TH, Johnson AD, Ko YA, Fuchsberger C, Tayo B, Nalls M, Fe (2016). Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat Commun, 7, 10023.
     
  225. Hesse S, Rullmann M, Luthardt J, Winter K, Hankir MK, Becker GA, Zientek F, Reissig G, Regenthal R, Drabe M, Schinke C, Bresch A, Arelin K, Lobsien D, Patt M, Meyer PM, Fasshauer M, Fenske WK, Bluher (2016). Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study. Eur J Nucl Med Mol Imaging, 43(6), 1096-1104.
     
  226. Trump S, Bieg M, Gu Z, Thurmann L, Bauer T, Bauer M, Ishaque N, Roder S, Gu L, Herberth G, Lawerenz C, Borte M, Schlesner M, Plass C, Diessl N, Eszlinger M, Mucke O, Elvers HD, Wissenbach DK, von Berg (2016). Prenatal maternal stress and wheeze in children: novel insights into epigenetic regulation. Sci Rep, 6, 28616.
     
  227. Calebiro D, Grassi ES, Eszlinger M, Ronchi CL, Godbole A, Bathon K, Guizzardi F, de Filippis T, Krohn K, Jaeschke H, Schwarzmayr T, Bircan R, Gozu HI, Sancak S, Niedziela M, Strom TM, Fassnacht M, Per (2016). Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas. J Clin Invest, 126(9), 3383-3388.
     
  228. Zschiedrich S, Budde K, Nurnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, Hoerl WH, Obermuller N, Arns W, Pavenstadt H, Gaedeke J, Lindner TH, Faerber L, Wimmer P, Stork R, Eckardt KU, Walz G (2016). Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney disease. Nephrol Dial Transplant, 31(2), 284-289.
     
  229. Miernik A, Hein S, Adams F, Halbritter J, Schoenthaler M (2016). [Stone treatment tomorrow and the day after]. Urologe A, 55(10), 1309-1316.
     
  230. Gee HY, Jun I, Braun DA, Lawson JA, Halbritter J, Shril S, Nelson CP, Tan W, Stein D, Wassner AJ, Ferguson MA, Gucev Z, Sayer JA, Milosevic D, Baum M, Tasic V, Lee MG, Hildebrandt F (2016). Mutations in SLC26A1 Cause Nephrolithiasis. Am J Hum Genet, 98(6), 1228-1234.
     
  231. Dieckow J, Rasche W, Sterker I, Schob S, Rasche FM, Wiedemann P (2016). [A 70-year-old patient with painful exophthalmos and double vision]. Ophthalmologe, 113(1), 78-80.
     
  232. Hoffmann A, Ebert T, Kloting N, Dokas J, Jeromin F, Jessnitzer B, Burkhardt R, Fasshauer M, Kralisch S (2016). Leptin dose-dependently decreases atherosclerosis by attenuation of hypercholesterolemia and induction of adiponectin. Biochim Biophys Acta, 1862(1), 113-120.
     
  233. Pfeiffer S, Kruger J, Maierhofer A, Bottcher Y, Kloting N, El Hajj N, Schleinitz D, Schon MR, Dietrich A, Fasshauer M, Lohmann T, Dressler M, Stumvoll M, Haaf T, Bluher M, Kovacs P (2016). Hypoxia-inducible factor 3A gene expression and methylation in adipose tissue is related to adipose tissue dysfunction. Sci Rep, 6, 27969.
     
  234. Weiner J, Kranz M, Kloting N, Kunath A, Steinhoff K, Rijntjes E, Kohrle J, Zeisig V, Hankir M, Gebhardt C, Deuther-Conrad W, Heiker JT, Kralisch S, Stumvoll M, Bluher M, Sabri O, Hesse S, Brust P, Ton (2016). Thyroid hormone status defines brown adipose tissue activity and browning of white adipose tissues in mice. Sci Rep, 6, 38124.
     
  235. Runkel N, Bluher M, Aberle J (2016). Metabolic Syndrome: An Interdisciplinary Approach. Editorial. Visc Med, 32, 316.
     
  236. Hankir MK, Kranz M, Gnad T, Weiner J, Wagner S, Deuther-Conrad W, Bronisch F, Steinhoff K, Luthardt J, Kloting N, Hesse S, Seibyl JP, Sabri O, Heiker JT, Bluher M, Pfeifer A, Brust P, Fenske WK (2016). A novel thermoregulatory role for PDE10A in mouse and human adipocytes. EMBO Mol Med, 8(7), 796-812.
     
  237. Stelzner K, Herbert D, Popkova Y, Lorz A, Schiller J, Gericke M, Kloting N, Bluher M, Franz S, Simon JC, Saalbach A (2016). Free fatty acids sensitize dendritic cells to amplify TH1/TH17-immune responses. Eur J Immunol, 46(8), 2043-2053.
     
  238. Baum P, Kosacka J, Estrela-Lopis I, Woidt K, Serke H, Paeschke S, Stockinger M, Kloting N, Bluher M, Dorn M, Classen J, Thiery J, Bechmann I, Toyka KV, Nowicki M (2016). The role of nerve inflammation and exogenous iron load in experimental peripheral diabetic neuropathy (PDN). Metabolism, 65(4), 391-405.
     
  239. Kilian TM, Kloting N, Bluher M, Beck-Sickinger AG (2016). Prenatal notch1 receptor blockade by protein delta homolog 1 (DLK1) modulates adipocyte size in vivo. Int J Obes (Lond), 40(4), 698-705.
     
  240. Ried JS, Jeff M J, Chu AY, Bragg-Gresham JL, van Dongen J, Huffman JE, Ahluwalia TS, Cadby G, Eklund N, Eriksson J, Esko T, Feitosa MF, Goel A, Gorski M, Hayward C, Heard-Costa NL, Jackson AU, Jokinen (2016). A principal component meta-analysis on multiple anthropometric traits identifies novel loci for body shape. Nat Commun, 7, 13357.
     
  241. Ekim Ustunel B, Friedrich K, Maida A, Wang X, Krones-Herzig A, Seibert O, Sommerfeld A, Jones A, Sijmonsma TP, Sticht C, Gretz N, Fleming T, Nawroth PP, Stremmel W, Rose AJ, Berriel-Diaz M, Bluher M, (2016). Control of diabetic hyperglycaemia and insulin resistance through TSC22D4. Nat Commun, 7, 13267.
     
  242. Kramer I, Bluher M, Kuhlmann MK, Heinemann L (2016). [Practical aspects in the use of biosimilar insulins]. Dtsch Med Wochenschr, 141(21), 1565-1568.
     
  243. Rohm M, Schafer M, Laurent V, Ustunel BE, Niopek K, Algire C, Hautzinger O, Sijmonsma TP, Zota A, Medrikova D, Pellegata NS, Ryden M, Kulyte A, Dahlman I, Arner P, Petrovic N, Cannon B, Amri EZ, Kemp (2016). An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice. Nat Med, 22(10), 1120-1130.
     
  244. Amrutkar M, Chursa U, Kern M, Nunez-Duran E, Stahlman M, Sutt S, Boren J, Johansson BR, Marschall HU, Bluher M, Mahlapuu M (2016). STK25 is a critical determinant in nonalcoholic steatohepatitis. FASEB J, 30(10), 3628-3643.
     
  245. De Luca M, Angrisani L, Himpens J, Busetto L, Scopinaro N, Weiner R, Sartori A, Stier C, Lakdawala M, Bhasker AG, Buchwald H, Dixon J, Chiappetta S, Kolberg HC, Fruhbeck G, Sarwer DB, Suter M, Soricel (2016). Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg, 26(8), 1659-1696.
     
  246. Yaskolka Meir A, Shelef I, Schwarzfuchs D, Gepner Y, Tene L, Zelicha H, Tsaban G, Bilitzky A, Komy O, Cohen N, Bril N, Rein M, Serfaty D, Kenigsbuch S, Chassidim Y, Zeller L, Ceglarek U, Stumvoll M, B (2016). Intermuscular adipose tissue and thigh muscle area dynamics during an 18-month randomized weight loss trial. J Appl Physiol (1985), 121(2), 518-527.
     
  247. Feisthammel J, Bluher M, Mossner J, Hoffmeister A (2016). [Endoscopic treatment of obesity and complications following bariatric surgery]. Internist (Berl), 57(8), 748-754.
     
  248. Lee S, Zhang C, Kilicarslan M, Piening BD, Bjornson E, Hallstrom BM, Groen AK, Ferrannini E, Laakso M, Snyder M, Bluher M, Uhlen M, Nielsen J, Smith U, Serlie MJ, Boren J, Mardinoglu A (2016). Integrated Network Analysis Reveals an Association between Plasma Mannose Levels and Insulin Resistance. Cell Metab, 24(1), 172-184.
     
  249. Gautheron J, Vucur M, Schneider AT, Severi I, Roderburg C, Roy S, Bartneck M, Schrammen P, Diaz MB, Ehling J, Gremse F, Heymann F, Koppe C, Lammers T, Kiessling F, Van Best N, Pabst O, Courtois G, Lin (2016). The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance. Nat Commun, 7, 11869.
     
  250. Schmidt V, Schulz N, Yan X, Schurmann A, Kempa S, Kern M, Bluher M, Poy MN, Olivecrona G, Willnow TE (2016). SORLA facilitates insulin receptor signaling in adipocytes and exacerbates obesity. J Clin Invest, 126(7), 2706-2720.
     
  251. Greifenhagen U, Frolov A, Bluher M, Hoffmann R (2016). Site-specific analysis of advanced glycation end products in plasma proteins of type 2 diabetes mellitus patients. Anal Bioanal Chem, 408(20), 5557-5566.
     
  252. Feldkamp J, Schott M, Gogol M, Quinkler M, Bluher M, Diederich S, Reincke M (2016). [The Choosing Wisely Initiative of the German Society of Internal Medicine : Recommendations of the German Society for Endocrinology and the German Society for Geriatrics]. Internist (Berl), 57(6), 532-539.
     
  253. Schmitz J, Evers N, Awazawa M, Nicholls HT, Bronneke HS, Dietrich A, Mauer J, Bluher M, Bruning JC (2016). Obesogenic memory can confer long-term increases in adipose tissue but not liver inflammation and insulin resistance after weight loss. Mol Metab, 5(5), 328-339.
     
  254. Fuhrmeister J, Zota A, Sijmonsma TP, Seibert O, Cingir S, Schmidt K, Vallon N, de Guia RM, Niopek K, Berriel Diaz M, Maida A, Bluher M, Okun JG, Herzig S, Rose AJ (2016). Fasting-induced liver GADD45ß restrains hepatic fatty acid uptake and improves metabolic health. EMBO Mol Med, 8(6), 654-669.
     
  255. Hinderberger P, Rullmann M, Drabe M, Luthardt J, Becker GA, Bluher M, Regenthal R, Sabri O, Hesse S (2016). The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study. Neuropharmacology, 110(PtA), 530-536.
     
  256. Qiang G, Kong HW, Fang D, McCann M, Yang X, Du G, Bluher M, Zhu J, Liew CW (2016). The obesity-induced transcriptional regulator TRIP-Br2 mediates visceral fat endoplasmic reticulum stress-induced inflammation. Nat Commun, 7, 11378.
     
  257. Dinca M, Serban MC, Sahebkar A, Mikhailidis DP, Toth PP, Martin SS, Blaha MJ, Bluher M, Gurban C, Penson P, Michos ED, Hernandez AV, Jones SR, Banach M (2016). Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res, 107, 360-371.
     
  258. Linder N, Schaudinn A, Garnov N, Bluher M, Dietrich A, Schutz T, Lehmann S, Retschlag U, Karlas T, Kahn T, Busse H (2016). Age and gender specific estimation of visceral adipose tissue amounts from radiological images in morbidly obese patients. Sci Rep, 6, 22261.
     
  259. Klepac K, Kilic A, Gnad T, Brown LM, Herrmann B, Wilderman A, Balkow A, Glode A, Simon K, Lidell ME, Betz MJ, Enerback S, Wess J, Freichel M, Bluher M, Konig G, Kostenis E, Insel PA, Pfeifer A (2016). The Gq signalling pathway inhibits brown and beige adipose tissue. Nat Commun, 7, 10895.
     
  260. Greifenhagen U, Frolov A, Bluher M, Hoffmann R (2016). Plasma Proteins Modified by Advanced Glycation End Products (AGEs) Reveal Site-specific Susceptibilities to Glycemic Control in Patients with Type 2 Diabetes. J Biol Chem, 291(18), 9610-9616.
     
  261. Tiaden AN, Bahrenberg G, Mirsaidi A, Glanz S, Bluher M, Richards PJ (2016). Novel Function of Serine Protease HTRA1 in Inhibiting Adipogenic Differentiation of Human Mesenchymal Stem Cells via MAP Kinase-Mediated MMP Upregulation. Stem Cells, 34(6), 1601-1614.
     
  262. Slutsky N, Vatarescu M, Haim Y, Goldstein N, Kirshtein B, Harman-Boehm I, Gepner Y, Shai I, Bashan N, Bluher M, Rudich A (2016). Decreased adiponectin links elevated adipose tissue autophagy with adipocyte endocrine dysfunction in obesity. Int J Obes (Lond), 40(6), 912-920.
     
  263. Wueest S, Item F, Lucchini FC, Challa TD, Muller W, Bluher M, Konrad D (2016). Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance. Diabetes, 65(1), 140-148.
     
  264. Gartner D, Ernst A, Fedtke K, Jenkner J, Schottler A, Reimer P, Bluher M, Schon MR (2016). [Routine fluoroscopic investigations after primary bariatric surgery]. Chirurg, 87(3), 241-246.
     
  265. Choi SH, Ruggiero D, Sorice R, Song C, Nutile T, Vernon Smith A, Concas MP, Traglia M, Barbieri C, Ndiaye NC, Stathopoulou MG, Lagou V, Maestrale GB, Sala C, Debette S, Kovacs P, Lind L, Lamont J, Fit (2016). Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies. PLoS Genet, 12(2), e1005874.
     
  266. Schaarschmidt J, Nagel MB, Huth S, Jaeschke H, Moretti R, Hintze V, von Bergen M, Kalkhof S, Meiler J, Paschke R (2016). Rearrangement of the Extracellular Domain/Extracellular Loop 1 Interface Is Critical for Thyrotropin Receptor Activation. J Biol Chem, 291(27), 14095-14108.
     


  267. 2015


  268. Wurst U, Ebert T, Kralisch S, Stumvoll M, Fasshauer M (2015). Serum levels of the adipokine Pref-1 in gestational diabetes mellitus. Cytokine, 71(2), 161-164.
     
  269. Bluher M (2015). [Conservative obesity treatment - when and how?]. Dtsch Med Wochenschr, 140(1), 24-28.
     
  270. Bluher M, Mantzoros CS (2015). From leptin to other adipokines in health and disease: Facts and expectations at the beginning of the 21st century. Metabolism, 64(1), 131-145.
     
  271. Stokowy T, Wojtas B, Krajewska J, Stobiecka E, Dralle H, Musholt T, Hauptmann S, Lange D, Hegedus L, Jarzab B, Krohn K, Paschke R, Eszlinger M (2015). A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas. Mol Cell Endocrinol, 399, 43-49.
     
  272. Kralisch S, Kloting N, Ebert T, Kern M, Hoffmann A, Krause K, Jessnitzer B, Lossner U, Sommerer I, Stumvoll M, Fasshauer M (2015). Circulating adipocyte fatty acid-binding protein induces insulin resistance in mice in vivo. Obesity (Silver Spring), 23(5), 1007-1013.
     
  273. Knigge A, Kloting N, Schon MR, Dietrich A, Fasshauer M, Gartner D, Lohmann T, Dressler M, Stumvoll M, Kovacs P, Bluher M (2015). ADCY5 gene expression in adipose tissue is related to obesity in men and mice. PLoS One, 10(3), e0120742.
     
  274. Eszlinger M, Piana S, Moll A, Bosenberg E, Bisagni A, Ciarrocchi A, Ragazzi M, Paschke R (2015). Molecular testing of thyroid fine-needle aspirations improves presurgical diagnosis and supports the histologic identification of minimally invasive follicular thyroid carcinomas. Thyroid, 25(4), 401-409.
     
  275. Kannt A, Pfenninger A, Teichert L, Tonjes A, Dietrich A, Schon MR, Kloting N, Bluher M (2015). Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. Diabetologia, 58(4), 799-808.
     
  276. Lakowa N, Trieu N, Flehmig G, Lohmann T, Schon MR, Dietrich A, Zeplin PH, Langer S, Stumvoll M, Bluher M, Kloting N (2015). Telomere length differences between subcutaneous and visceral adipose tissue in humans. Biochem Biophys Res Commun, 457(3), 426-432.
     
  277. Schrey S, Wurst U, Ebert T, Kralisch S, Drewlo S, Stepan H, Lossner U, Platz M, Kratzsch J, Stumvoll M, Fasshauer M (2015). The adipokine preadipocyte factor-1 is downregulated in preeclampsia and expressed in placenta. Cytokine, 75(2), 338-343.
     
  278. Fasshauer M, Bluher M (2015). Adipokines in health and disease. Trends Pharmacol Sci, 36(7), 461-470.
     
  279. Kosacka J, Kern M, Kloting N, Paeschke S, Rudich A, Haim Y, Gericke M, Serke H, Stumvoll M, Bechmann I, Nowicki M, Bluher M (2015). Autophagy in adipose tissue of patients with obesity and type 2 diabetes. Mol Cell Endocrinol, 409, 21-32.
     
  280. Kannt A, Pfenninger A, Tonjes A, Bluher M (2015). Management of nicotinamide N-methyltransferase overexpression: inhibit the enzyme or reduce nicotinamide intake? Reply to Zhou S, Li D, Zhou Y [letter]. Diabetologia, 58(9), 2193-2194.
     
  281. Paschke R, Lincke T, Muller SP, Kreissl MC, Dralle H, Fassnacht M (2015). The Treatment of Well-Differentiated Thyroid Carcinoma. Dtsch Arztebl Int, 112(26), 452-458.
     
  282. Krane JF, Cibas ES, Alexander EK, Paschke R, Eszlinger M (2015). Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity. Cancer Cytopathol, 123(6), 356-361.
     
  283. Kloting N, Hesselbarth N, Gericke M, Kunath A, Biemann R, Chakaroun R, Kosacka J, Kovacs P, Kern M, Stumvoll M, Fischer B, Rolle-Kampczyk U, Feltens R, Otto W, Wissenbach DK, von Bergen M, Bluher M (2015). Di-(2-Ethylhexyl)-Phthalate (DEHP) Causes Impaired Adipocyte Function and Alters Serum Metabolites. PLoS One, 10, 0143190.
     
  284. Mardinoglu A, Heiker JT, Gartner D, Bjornson E, Schon MR, Flehmig G, Kloting N, Krohn K, Fasshauer M, Stumvoll M, Nielsen J, Bluher M (2015). Extensive weight loss reveals distinct gene expression changes in human subcutaneous and visceral adipose tissue. Sci Rep, 5, 14841.
     
  285. Schuetz CA, Ong SH, Bluher M (2015). Clinical trial simulation methods for estimating the impact of DPP-4 inhibitors on cardiovascular disease. Clinicoecon Outcomes Res, 7, 313-323.
     
  286. Bluher M, Kurz I, Dannenmaier S, Dworak M (2015). Pill Burden in Patients With Type 2 Diabetes in Germany: Subanalysis From the Prospective, Noninterventional PROVIL Study. Clin Diabetes, 33(2), 55-61.
     
  287. Bluher M (2015). Pharmacological therapy versus bariatric surgery for patients with obesity and type 2 diabetes. Internist (Berl), 56(2), 143-150.
     
  288. Ebert T, Kralisch S, Kloting N, Hoffmann A, Bluher M, Zhang MZ, Harris RC, Stumvoll M, Fasshauer M (2015). Circulating progranulin but not renal progranulin expression is increased in renal dysfunction. Kidney Int, 88(5), 1197-1198.
     
  289. Krause K, Weiner J, Hones S, Kloting N, Rijntjes E, Heiker JT, Gebhardt C, Kohrle J, Fuhrer D, Steinhoff K, Hesse S, Moeller LC, Tonjes A (2015). The Effects of Thyroid Hormones on Gene Expression of Acyl-Coenzyme A Thioesterases in Adipose Tissue and Liver of Mice. Eur Thyroid J, 4(Suppl 1), 59-66.
     
  290. Paschke R, Dralle H (2015). In Reply. Dtsch Arztebl Int, 112(42), 722.
     
  291. Halbritter J, Baum M, Hynes AM, Rice SJ, Thwaites DT, Gucev ZS, Fisher B, Spaneas L, Porath JD, Braun DA, Wassner AJ, Nelson CP, Tasic V, Sayer JA, Hildebrandt F (2015). Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol, 26(3), 543-551.
     
  292. Rasche FM, Schmidt S, Kretzschmar C, Mertens M, Thiel J, Groschup MH, Schlegel M, Mayer C, Lindner TH, Schiekofer S, Ulrich RG (2015). Autochthonous Dobrava-Belgrade virus infection in Eastern Germany. Clin Nephrol, 83(2), 111-116.
     
  293. Platz M, Stepan H, Schrey S, Kralisch S, Wurst U, Lossner U, Jessnitzer B, Kratzsch J, Stumvoll M, Fasshauer M, Ebert T (2015). Serum levels of sclerostin in cardiometabolic disorders during pregnancy. Cytokine, 76(2), 591-593.
     
  294. Mai M, Kovacs P, Stumvoll M, Rosendahl J, Tonjes A (2015). Association between genetic variants in PNPLA3 and serum adiponectin. Liver Int, 35(2), 679-680.
     
  295. Liu X, Weidle K, Schrock K, Tonjes A, Schleinitz D, Breitfeld J, Stumvoll M, Bottcher Y, Schoneberg T, Kovacs P (2015). Signatures of natural selection at the FTO (fat mass and obesity associated) locus in human populations. PLoS One, 10(2), e0117093.
     
  296. Liu X, Hinney A, Scholz M, Scherag A, Tonjes A, Stumvoll M, Stadler PF, Hebebrand J, Bottcher Y (2015). Indications for potential parent-of-origin effects within the FTO gene. PLoS One, 10(3), e0119206.
     
  297. Burkhardt S, Gesing J, Kapellen TM, Kovacs P, Kratzsch J, Schlicke M, Stobbe H, Tonjes A, Klammt J, Pfaffle R (2015). Novel heterozygous IGF1R mutation in two brothers with developing impaired glucose tolerance. J Pediatr Endocrinol Metab, 28(1-2), 217-225.
     
  298. Schueler M, Braun DA, Chandrasekar G, Gee HY, Klasson TD, Halbritter J, Bieder A, Porath JD, Airik R, Zhou W, LoTurco JJ, Che A, Otto EA, Bockenhauer D, Sebire NJ, Honzik T, Harris PC, Koon SJ, Gunay- (2015). DCDC2 Mutations Cause a Renal-Hepatic Ciliopathy by Disrupting Wnt Signaling. Am J Hum Genet, 96(1), 81-92.
     
  299. Loffler A, Luck T, Then FS, Sikorski C, Kovacs P, Bottcher Y, Breitfeld J, Tonjes A, Horstmann A, Loffler M, Engel C, Thiery J, Villringer A, Stumvoll M, Riedel-Heller SG (2015). Eating Behaviour in the General Population: An Analysis of the Factor Structure of the German Version of the Three-Factor-Eating-Questionnaire (TFEQ) and Its Association with the Body Mass Index. PLoS One, 10(7), e0133977.
     
  300. Schmidt FM, Weschenfelder J, Sander C, Minkwitz J, Thormann J, Chittka T, Mergl R, Kirkby KC, Fasshauer M, Stumvoll M, Holdt LM, Teupser D, Hegerl U, Himmerich H (2015). Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS One, 10(3), e0121971.
     
  301. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, Powell C, Vedantam S, Buchkovich ML, Yang J, Croteau-Chonka DC, Esko T, Fall T, Ferreira T, Gustafsson S, Kutalik Z, Luan J, Magi R, Randall (2015). Genetic studies of body mass index yield new insights for obesity biology. Nature, 518(7538), 197-206.
     
  302. Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Magi R, Strawbridge RJ, Pers TH, Fischer K, Justice AE, Workalemahu T, Wu JM, Buchkovich ML, Heard-Costa NL, Roman TS, Drong AW, Song C, (2015). New genetic loci link adipose and insulin biology to body fat distribution. Nature, 518(7538), 187-196.
     
  303. Schofl C, Grussendorf M, Honegger J, Tonjes A, Thyroke-Gronostay D, Mayr B, Schopohl J (2015). Failure to achieve disease control in acromegaly: cause analysis by a registry-based survey. Eur J Endocrinol, 172(4), 351-356.
     
  304. Cornelis MC, Byrne EM, Esko T, Nalls MA, Ganna A, Paynter N, Monda KL, Amin N, Fischer K, Renstrom F, Ngwa JS, Huikari V, Cavadino A, Nolte IM, Teumer A, Yu K, Marques-Vidal P, Rawal R, Manichaikul A, (2015). Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Mol Psychiatry, 20(5), 647-656.
     
  305. Rohde K, Federbusch M, Horstmann A, Keller M, Villringer A, Stumvoll M, Tonjes A, Kovacs P, Bottcher Y (2015). Genetic variants in AKR1B10 associate with human eating behavior. BMC Genet, 16, 31.
     
  306. Rohde K, Keller M, Horstmann A, Liu X, Eichelmann F, Stumvoll M, Villringer A, Kovacs P, Tonjes A, Bottcher Y (2015). Role of genetic variants in ADIPOQ in human eating behavior. Genes Nutr, 10(1), 449.
     
  307. Hesselbarth N, Pettinelli C, Gericke M, Berger C, Kunath A, Stumvoll M, Bluher M, Kloting N (2015). Tamoxifen affects glucose and lipid metabolism parameters, causes browning of subcutaneous adipose tissue and transient body composition changes in C57BL/6NTac mice. Biochem Biophys Res Commun, 464(3), 724-729.
     
  308. Loffler A, Luck T, Then FS, Luppa M, Sikorski C, Kovacs P, Tonjes A, Bottcher Y, Breitfeld J, Horstmann A, Loffler M, Engel C, Thiery J, Stumvoll M, Riedel-Heller SG (2015). Age- and gender-specific norms for the German version of the Three-Factor Eating-Questionnaire (TFEQ). Appetite, 91, 241-247.
     
  309. de Biase D, Gandolfi G, Ragazzi M, Eszlinger M, Sancisi V, Gugnoni M, Visani M, Pession A, Casadei G, Durante C, Costante G, Bruno R, Torlontano M, Paschke R, Filetti S, Piana S, Frasoldati A, Tallini (2015). TERT Promoter Mutations in Papillary Thyroid Microcarcinomas. Thyroid, 25(9), 1013-1019.
     
  310. Schuster A, Stahnke VC, Unterberg-Buchwald C, Kowallick JT, Lamata P, Steinmetz M, Kutty S, Fasshauer M, Staab W, Sohns JM, Bigalke B, Ritter C, Hasenfuss G, Beerbaum P, Lotz J (2015). Cardiovascular magnetic resonance feature-tracking assessment of myocardial mechanics: Intervendor agreement and considerations regarding reproducibility. Clin Radiol, 70(9), 989-998.
     
  311. Joshi PK, Esko T, Mattsson H, Eklund N, Gandin I, Nutile T, Jackson AU, Schurmann C, Smith AV, Zhang W, Okada Y, Stancakova A, Faul JD, Zhao W, Bartz TM, Concas MP, Franceschini N, Enroth S, Vitart V, (2015). Directional dominance on stature and cognition in diverse human populations. Nature, 523(7561), 459-462.
     
  312. Steinhoff KG, Hankir M, Krause K, Tonjes A, Fenske WK, Sabri O, Hesse S (2015). Interaction of thyroid hormone with brown adipose tissue. Lessons learned from PET-CT. Nuklearmedizin, 54(3), 82-87.
     
  313. Gepner Y, Golan R, Harman-Boehm I, Henkin Y, Schwarzfuchs D, Shelef I, Durst R, Kovsan J, Bolotin A, Leitersdorf E, Shpitzen S, Balag S, Shemesh E, Witkow S, Tangi-Rosental O, Chassidim Y, Liberty IF, (2015). Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial. Ann Intern Med, 163(8), 569-579.
     
  314. Winkler TW, Justice AE, Graff M, Barata L, Feitosa MF, Chu S, Czajkowski J, Esko T, Fall T, Kilpelainen TO, Lu Y, Magi R, Mihailov E, Pers TH, Rueger S, Teumer A, Ehret GB, Ferreira T, Heard-Costa NL, (2015). The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study. PLoS Genet, 11(10), e1005378.
     
  315. Schunter JA, Loffler D, Wiesner T, Kovacs P, Badenhoop K, Aust G, Tonjes A, Muller P, Baber R, Simon JC, Fuhrer D, Pfaffle RW, Thiery J, Stumvoll M, Kiess W, Kratzsch J, Korner A (2015). A novel FoxD3 Variant Is Associated With Vitiligo and Elevated Thyroid Auto-Antibodies. J Clin Endocrinol Metab, 100(10), e1335-1342.
     
  316. McInnes G, Evans M, Del Prato S, Stumvoll M, Schweizer A, Lukashevich V, Shao Q, Kothny W (2015). Cardiovascular and heart failure safety profile of vildagliptin: a meta-analysis of 17000 patients. Diabetes Obes Metab, 17(11), 1085-1092.
     
  317. Huhn S, Kharabian Masouleh S, Stumvoll M, Villringer A, Witte AV (2015). Components of a Mediterranean diet and their impact on cognitive functions in aging. Front Aging Neurosci, 7, 132.
     
  318. Bongiovanni M, Molinari F, Eszlinger M, Paschke R, Barizzi J, Merlo E, Giovanella L, Fasolini F, Cattaneo F, Ramelli F, Mazzucchelli L, Frattini M (2015). Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience. Cytopathology, 26(5), 288-296.
     
  319. Hilger AC, Halbritter J, Pennimpede T, van der Ven A, Sarma G, Braun DA, Porath JD, Kohl S, Hwang DY, Dworschak GC, Hermann BG, Pavlova A, El-Maarri O, Nothen MM, Ludwig M, Reutter H, Hildebrandt F (2015). Targeted Resequencing of 29 Candidate Genes and Mouse Expression Studies Implicate ZIC3 and FOXF1 in Human VATER/VACTERL Association. Hum Mutat, 36(12), 1150-1154.
     
  320. Perrault I, Halbritter J, Porath JD, Gerard X, Braun DA, Gee HY, Fathy HM, Saunier S, Cormier-Daire V, Thomas S, Attie-Bitach T, Boddaert N, Taschner M, Schueler M, Lorentzen E, Lifton RP, Lawson JA, (2015). IFT81, encoding an IFT-B core protein, as a very rare cause of a ciliopathy phenotype. J Med Genet, 52(10), 657-665.
     
  321. Garcia-Martin R, Alexaki VI, Qin N, Rubin de Celis MF, Economopoulou M, Ziogas A, Gercken B, Kotlabova K, Phieler J, Ehrhart-Bornstein M, Bornstein SR, Eisenhofer G, Breier G, Bluher M, Hampe J, El-Ar (2015). Adipocyte-Specific Hypoxia-Inducible Factor 2? Deficiency Exacerbates Obesity-Induced Brown Adipose Tissue Dysfunction and Metabolic Dysregulation. Mol Cell Biol, 36(3), 376-393.
     
  322. Voisin S, Almen MS, Zheleznyakova GY, Lundberg L, Zarei S, Castillo S, Eriksson FE, Nilsson EK, Bluher M, Bottcher Y, Kovacs P, Klovins J, Rask-Andersen M, Schioth HB (2015). Many obesity-associated SNPs strongly associate with DNA methylation changes at proximal promoters and enhancers. Genome Med, 7(1), 103.
     
  323. Cheng YS, Seibert O, Kloting N, Dietrich A, Strassburger K, Fernandez-Veledo S, Vendrell JJ, Zorzano A, Bluher M, Herzig S, Berriel Diaz M, Teleman AA (2015). PPP2R5C Couples Hepatic Glucose and Lipid Homeostasis. PLoS Genet, 11(10), e1005561.
     
  324. Haim Y, Bluher M, Slutsky N, Goldstein N, Kloting N, Harman-Boehm I, Kirshtein B, Ginsberg D, Gericke M, Guiu Jurado E, Kovsan J, Tarnovscki T, Kachko L, Bashan N, Gepner Y, Shai I, Rudich A (2015). Elevated autophagy gene expression in adipose tissue of obese humans: A potential non-cell-cycle-dependent function of E2F1. Autophagy, 11(10), 2074-2088.
     
  325. Galimov A, Hartung A, Trepp R, Mader A, Fluck M, Linke A, Bluher M, Christ E, Krutzfeldt J (2015). Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance. J Mol Med (Berl), 93(12), 1369-1379.
     
  326. Mueller K, Moller HE, Horstmann A, Busse F, Lepsien J, Bluher M, Stumvoll M, Villringer A, Pleger B (2015). Physical exercise in overweight to obese individuals induces metabolic- and neurotrophic-related structural brain plasticity. Front Hum Neurosci, 9, 372.
     
  327. Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med, 373(1), 11-22.
     
  328. Landgraf K, Rockstroh D, Wagner IV, Weise S, Tauscher R, Schwartze JT, Loffler D, Buhligen U, Wojan M, Till H, Kratzsch J, Kiess W, Bluher M, Korner A (2015). Evidence of early alterations in adipose tissue biology and function and its association with obesity-related inflammation and insulin resistance in children. Diabetes, 64(4), 1249-1261.
     
  329. Rockstroh D, Landgraf K, Wagner IV, Gesing J, Tauscher R, Lakowa N, Kiess W, Buhligen U, Wojan M, Till H, Bluher M, Korner A (2015). Direct evidence of brown adipocytes in different fat depots in children. PLoS One, 10(2), e0117841.
     
  330. Schaudinn A, Linder N, Garnov N, Kerlikowsky F, Bluher M, Dietrich A, Schutz T, Karlas T, Kahn T, Busse H (2015). Predictive accuracy of single- and multi-slice MRI for the estimation of total visceral adipose tissue in overweight to severely obese patients. NMR Biomed, 28(5), 583-590.
     
  331. Pers TH, Karjalainen JM, Chan Y, Westra HJ, Wood AR, Yang J, Lui JC, Vedantam S, Gustafsson S, Esko T, Frayling T, Speliotes EK, Boehnke M, Raychaudhuri S, Fehrmann RS, Hirschhorn JN, Franke L (2015). Biological interpretation of genome-wide association studies using predicted gene functions. Nat Commun, 6, 5890.
     
  332. de Guia RM, Rose AJ, Sommerfeld A, Seibert O, Strzoda D, Zota A, Feuchter Y, Krones-Herzig A, Sijmonsma T, Kirilov M, Sticht C, Gretz N, Dallinga-Thie G, Diederichs S, Kloting N, Bluher M, Berriel Dia (2015). microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis. EMBO J, 34(3), 344-360.
     
  333. Murahovschi V, Pivovarova O, Ilkavets I, Dmitrieva RM, Docke S, Keyhani-Nejad F, Gogebakan O, Osterhoff M, Kemper M, Hornemann S, Markova M, Kloting N, Stockmann M, Weickert MO, Lamounier-Zepter V, Ne (2015). WISP1 is a novel adipokine linked to inflammation in obesity. Diabetes, 64(3), 856-866.
     
  334. Derikx MH, Kovacs P, Scholz M, Masson E, Chen JM, Ruffert C, Lichtner P, Te Morsche RH, Cavestro GM, Ferec C, Drenth JP, Witt H, Rosendahl J (2015). Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study. Gut, 64(9), 1426-1433.
     
  335. Dittrich M, Jahreis G, Bothor K, Drechsel C, Kiehntopf M, Bluher M, Dawczynski C (2015). Benefits of foods supplemented with vegetable oils rich in ?-linolenic, stearidonic or docosahexaenoic acid in hypertriglyceridemic subjects: a double-blind, randomized, controlled trail. Eur J Nutr, 54(6), 881-893.
     
  336. Gaulton KJ, Ferreira T, Lee Y, Raimondo A, Magi R, Reschen ME, Mahajan A, Locke A, William Rayner N, Robertson N, Scott RA, Prokopenko I, Scott LJ, Green T, Sparso T, Thuillier D, Yengo L, Grallert H, (2015). Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet, 47(12), 1415-1425.
     
  337. Burkhardt R, Kirsten H, Beutner F, Holdt LM, Gross A, Teren A, Tonjes A, Becker S, Krohn K, Kovacs P, Stumvoll M, Teupser D, Thiery J, Ceglarek U, Scholz M (2015). Integration of Genome-Wide SNP Data and Gene-Expression Profiles Reveals Six Novel Loci and Regulatory Mechanisms for Amino Acids and Acylcarnitines in Whole Blood. PLoS Genet, 11(9), e1005510.
     
  338. Petroff D, Tonjes A, Grussendorf M, Droste M, Dimopoulou C, Stalla G, Jaursch-Hancke C, Mai M, Schopohl J, Schofl C (2015). The Incidence of Cancer Among Acromegaly Patients: Results From the German Acromegaly Registry. J Clin Endocrinol Metab, 100(10), 3894-3902.
     
  339. Howitt BE, Chang S, Eszlinger M, Paschke R, Drage MG, Krane JF, Barletta JA (2015). Fine-Needle Aspiration Diagnoses of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma. Am J Clin Pathol, 144(6), 850-857.
     
  340. Roberson EC, Dowdle WE, Ozanturk A, Garcia-Gonzalo FR, Li C, Halbritter J, Elkhartoufi N, Porath JD, Cope H, Ashley-Koch A, Gregory S, Thomas S, Sayer JA, Saunier S, Otto EA, Katsanis N, Davis EE, Att (2015). TMEM231, mutated in orofaciodigital and Meckel syndromes, organizes the ciliary transition zone. J Cell Biol, 209(1), 129-142.
     
  341. Sadowski CE, Lovric S, Ashraf S, Pabst WL, Gee HY, Kohl S, Engelmann S, Vega-Warner V, Fang H, Halbritter J, Somers MJ, Tan W, Shril S, Fessi I, Lifton RP, Bockenhauer D, El-Desoky S, Kari JA, Zenker (2015). A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol, 26(6), 1279-1289.
     
  342. de Corbiere P, Ritzel K, Cazabat L, Ropers J, Schott M, Libe R, Koschker AC, Leboulleux S, Deutschbein T, Do Cao C, Hahner S, Drui D, Miehle K, Caron P, Waldmann J, Chabre O, Quinkler M, Touraine P, V (2015). Pregnancy in Women Previously Treated for an Adrenocortical Carcinoma. J Clin Endocrinol Metab, 100(12), 4604-4611.
     
  343. Rohde K, Keller M, Stumvoll M, Dietrich A, Bluher M, Bottcher Y (2015). DNA 5-hydroxymethylation in human adipose tissue differs between subcutaneous and visceral adipose tissue depots. Epigenomics, 7(6), 911-920.
     
  344. Berger T, Kaiser T, Scholz M, Bachmann A, Ceglarek U, Hesse G, Hagemeyer B, Stumvoll M, Thiery J, Dietz A (2015). Fibrinogen is not a prognostic factor for response to HELP-apheresis in sudden sensorineural hearing loss (SSHL). Eur Arch Otorhinolaryngol, 272(12), 3693-3703.
     
  345. Karlas T, Berger J, Garnov N, Lindner F, Busse H, Linder N, Schaudinn A, Relke B, Chakaroun R, Troltzsch M, Wiegand J, Keim V (2015). Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques. World J Gastroenterol, 21(16), 4894-4902.
     
  346. Blüher M, Körner A, Kiess W, Stumvoll M (2015). Metabolisches Syndrom und Diabetes mellitus. In: Hendrik Lehnert, Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. (S. 425-433), Stuttgart: Georg Thieme Verlag.
     
  347. Stumvoll M, Miehle K, Stefan N, Fritsche A, Gallwitz B, Müssig K, Kiess W, Ziegler A, Hummel M, Körner A, Chmiel R (2015). Diabetes mellitus. In: Hendrik Lehnert, Rationelle Diagnsotik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. (S. 433-475), Stuttgart: Georg Thieme Verlag KG.
     
  348. Miehle K, Stumvoll M (2015). Lipodystrophie. In: Hendrik Lehnert, Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. (S. 488-492), Stuttgart: Gerog Thieme Verlag KG.
     
  349. Paschke R, Lincke T, Lamesch P, Dralle H, Ruschenburg I (2015). Struma diffusa und Knotenstruma. In: Hendrik Lehnert, Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. (S. 127-133), Stuttgart: Georg Thieme Verlag KG.
     


  350. 2014


  351. Ebert T, Focke D, Petroff D, Wurst U, Richter J, Bachmann A, Lossner U, Kralisch S, Kratzsch J, Beige J, Bast I, Anders M, Bluher M, Stumvoll M, Fasshauer M (2014). Serum levels of the myokine irisin in relation to metabolic and renal function. Eur J Endocrinol, 170(4), 501-506.
     
  352. Ebert T, Stepan H, Schrey S, Kralisch S, Hindricks J, Hopf L, Platz M, Lossner U, Jessnitzer B, Drewlo S, Bluher M, Stumvoll M, Fasshauer M (2014). Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery. Cytokine, 65(2), 153-158.
     
  353. Bluher M, Kloting N, Wueest S, Schoenle EJ, Schon MR, Dietrich A, Fasshauer M, Stumvoll M, Konrad D (2014). Fas and FasL expression in human adipose tissue is related to obesity, insulin resistance, and type 2 diabetes. J Clin Endocrinol Metab, 99(1), 36-44.
     
  354. Ebert T, Roth I, Richter J, Tonjes A, Kralisch S, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2014). Different associations of adipokines in lean and healthy adults. Horm Metab Res, 46(1), 41-47.
     
  355. Eszlinger M, Neustadt M, Ruschenburg I, Neumann A, Franzius C, Adam S, Bacher K, Hach A, Hammoser R, Langvogt C, Molwitz T, Paschke R (2014). [Fine-needle aspiration cytology of thyroid nodules: molecular diagnostics in a routine diagnostic setting]. Dtsch Med Wochenschr, 139(10), 476-480.
     
  356. Stokowy T, Wojtas B, Fujarewicz K, Jarzab B, Eszlinger M, Paschke R (2014). miRNAs with the Potential to Distinguish Follicular Thyroid Carcinomas from Benign Follicular Thyroid Tumors: Results of a Meta-analysis. Horm Metab Res, 46(3), 171-180.
     
  357. Eszlinger M, Krogdahl A, Munz S, Rehfeld C, Precht Jensen EM, Ferraz C, Bosenberg E, Drieschner N, Scholz M, Hegedus L, Paschke R (2014). Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules. Thyroid, 24(2), 305-313.
     
  358. Paschke R (2014). In reply. Dtsch Arztebl Int, 111(16), 289-290.
     
  359. Bluher M (2014). Adipokines - removing road blocks to obesity and diabetes therapy. Mol Metab, 3(3), 230-240.
     
  360. Fasshauer M, Bluher M, Stumvoll M (2014). Adipokines in gestational diabetes. Lancet Diabetes Endocrinol, 2(6), 488-499.
     
  361. Bluher M (2014). [Predisposition - obesity phenotype]. Dtsch Med Wochenschr, 139(21), 1116-1120.
     
  362. Hindricks J, Ebert T, Bachmann A, Kralisch S, Lossner U, Kratzsch J, Stolzenburg JU, Dietel A, Beige J, Anders M, Bast I, Bluher M, Stumvoll M, Fasshauer M (2014). Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction. Clin Endocrinol (Oxf), 80(6), 918-924.
     
  363. Eszlinger M, Niedziela M, Typlt E, Jaeschke H, Huth S, Schaarschmidt J, Aigner T, Trejster E, Krohn K, Bosenberg E, Paschke R (2014). Somatic mutations in 33 benign and malignant hot thyroid nodules in children and adolescents. Mol Cell Endocrinol, 393(1-2), 39-45.
     
  364. Huth S, Jaeschke H, Schaarschmidt J, Paschke R (2014). Controversial Constitutive TSHR Activity: Patients, Physiology, and In Vitro Characterization. Horm Metab Res, 46(7), 453-461.
     
  365. Schaarschmidt J, Huth S, Meier R, Paschke R, Jaeschke H (2014). Influence of the hinge region and its adjacent domains on binding and signaling patterns of the thyrotropin and follitropin receptor. PLoS One, 9(10), e111570.
     
  366. Eszlinger M, Hegedus L, Paschke R (2014). Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodules. Best Pract Res Clin Endocrinol Metab, 28(4), 545-557.
     
  367. Jaeschke H, Schaarschmidt J, Eszlinger M, Huth S, Puttinger R, Rittinger O, Meiler J, Paschke R (2014). A Newly Discovered TSHR Variant (L665F) Associated With Nonautoimmune Hyperthyroidism in an Austrian Family Induces Constitutive TSHR Activation by Steric Repulsion Between TM1 and TM7. J Clin Endocrinol Metab, 99(10), E2051-2059.
     
  368. Breitfeld J, Sandvoss R, Schleinitz D, Bottcher Y, Fasshauer M, Bluher M, Stumvoll M, Kovacs P, Wittenburg H, Tonjes A (2014). Serum Adiponectin and Progranulin Levels are Associated with Gallstone Disease. Exp Clin Endocrinol Diabetes, 122(10), 559-563.
     
  369. Ebert T, Kralisch S, Loessner U, Jessnitzer B, Stumvoll M, Fasshauer M, Tonjes A (2014). Relationship between serum levels of angiopoietin-related growth factor and metabolic risk factors. Horm Metab Res, 46(10), 685-690.
     
  370. Flehmig G, Scholz M, Kloting N, Fasshauer M, Tonjes A, Stumvoll M, Youn BS, Bluher M (2014). Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS One, 9(6), e99785.
     
  371. Ebert T, Hopf LM, Wurst U, Bachmann A, Kralisch S, Lossner U, Platz M, Kratzsch J, Stolzenburg JU, Dietel A, Grisk O, Beige J, Anders M, Bast I, Kloting N, Bluher M, Stumvoll M, Fasshauer M (2014). Circulating adipocyte fatty acid binding protein is increased in chronic and acute renal dysfunction. Nutr Metab Cardiovasc Dis, 24(9), 1027-1034.
     
  372. Ebert T, Hindricks J, Kralisch S, Lossner U, Jessnitzer B, Richter J, Bluher M, Stumvoll M, Fasshauer M (2014). Serum levels of fractalkine are associated with markers of insulin resistance in gestational diabetes. Diabet Med, 31(8), 1014-1017.
     
  373. Karger S, Wiesner T, Kersting A, Braun M, Ebert T, Wurst U, Kratzsch J, Stumvoll M, Fasshauer M (2014). Increased chromogranin a and carcinoid syndrome-like symptoms in a patient treated with duloxetine. Endocr Pract, 20(11), e215-218.
     
  374. Bluher M, Schweizer A, Bader G, Foley JE (2014). Changes in body weight after 24 weeks of vildagliptin therapy as a function of fasting glucose levels in patients with type 2 diabetes. Vasc Health Risk Manag, 10, 661-664.
     
  375. Kloting N, Bluher M (2014). Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord, 15(4), 277-287.
     
  376. Ebert T, Kralisch S, Hoffmann A, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Tonjes A, Fasshauer M (2014). Circulating Angiopoietin-like Protein 8 Is Independently Associated With Fasting Plasma Glucose and Type 2 Diabetes Mellitus. J Clin Endocrinol Metab, 99(12), 2510-2517.
     
  377. Bluher M (2014). [Insulin or surgery? : the perspective of a diabetologist]. Chirurg, 85(11), 957-962.
     
  378. Bluher M (2014). [Adipose tissue-an endocrine organ]. Internist (Berl), 55(6), 687-697.
     
  379. Kralisch S, Ebert T, Lossner U, Jessnitzer B, Stumvoll M, Fasshauer M (2014). Adipocyte fatty acid-binding protein is released from adipocytes by a non-conventional mechanism. Int J Obes (Lond), 38(9), 1251-1254.
     
  380. Tonjes A, Scholz M, Breitfeld J, Marzi C, Grallert H, Gross A, Ladenvall C, Schleinitz D, Krause K, Kirsten H, Laurila E, Kriebel J, Thorand B, Rathmann W, Groop L, Prokopenko I, Isomaa B, Beutner F, Kratzsch J, Thiery J, Fasshauer M, Kloting N, Gieger C, Bluher M, Stumvoll M, Kovacs P (2014). Genome Wide Meta-analysis Highlights the Role of Genetic Variation in RARRES2 in the Regulation of Circulating Serum Chemerin. PLoS Genet, 10(12), e1004854.
     
  381. Prokopenko I, Poon W, Magi R, Prasad B R, Salehi SA, Almgren P, Osmark P, Bouatia-Naji N, Wierup N, Fall T, Stancakova A, Barker A, Lagou V, Osmond C, Xie W, Lahti J, Jackson AU, Cheng YC, et al. (2014). A central role for GRB10 in regulation of islet function in man. PLoS Genet, 10(4), e1004235.
     
  382. Claussnitzer M, Dankel SN, Klocke B, Grallert H, Glunk V, Berulava T, Lee H, Oskolkov N, Fadista J, Ehlers K, Wahl S, Hoffmann C, Qian K, Ronn T, Riess H, Muller-Nurasyid M, Bretschneider N, Schroeder (2014). Leveraging cross-species transcription factor binding site patterns: from diabetes risk loci to disease mechanisms. Cell, 156(1-2), 343-358.
     
  383. Schleinitz D, Kloting N, Lindgren CM, Breitfeld J, Dietrich A, Schon MR, Lohmann T, Dressler M, Stumvoll M, McCarthy MI, Bluher M, Kovacs P (2014). Fat depot-specific mRNA expression of novel loci associated with waist-hip ratio. Int J Obes (Lond), 38(1), 120-125.
     
  384. Haase J, Weyer U, Immig K, Kloting N, Bluher M, Eilers J, Bechmann I, Gericke M (2014). Local proliferation of macrophages in adipose tissue during obesity-induced inflammation. Diabetologia, 57(3), 562-571.
     
  385. Wueest S, Mueller R, Bluher M, Item F, Chin AS, Wiedemann MS, Takizawa H, Kovtonyuk L, Chervonsky AV, Schoenle EJ, Manz MG, Konrad D (2014). Fas (CD95) expression in myeloid cells promotes obesity€induced muscle insulin resistance. EMBO Mol Med, 6(1), 43-56.
     
  386. Fink LN, Costford SR, Lee YS, Jensen TE, Bilan PJ, Oberbach A, Bluher M, Olefsky JM, Sams A, Klip A (2014). Pro-Inflammatory macrophages increase in skeletal muscle of high fat-Fed mice and correlate with metabolic risk markers in humans. Obesity (Silver Spring), 22(3), 747-757.
     
  387. Stefanov T, Bluher M, Vekova A, Bonova I, Tzvetkov S, Kurktschiev D, Temelkova-Kurktschiev T (2014). Circulating chemerin decreases in response to a combined strength and endurance training. Endocrine, 45(3), 382-391.
     
  388. Darr R, Pamporaki C, Peitzsch M, Miehle K, Prejbisz A, Peczkowska M, Weismann D, Beuschlein F, Sinnott R, Bornstein SR, Neumann HP, Januszewicz A, Lenders J, Eisenhofer G (2014). Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions. Clin Endocrinol (Oxf), 80(4), 478-486.
     
  389. Quinque EM, Karger S, Arelin K, Schroeter ML, Kratzsch J, Villringer A (2014). Structural and functional MRI study of the brain, cognition and mood in long-term adequately treated Hashimotos thyroiditis. Psychoneuroendocrinology, 42, 188-198.
     
  390. Lo JC, Ljubicic S, Leibiger B, Kern M, Leibiger IB, Moede T, Kelly ME, Chatterjee Bhowmick D, Murano I, Cohen P, Banks AS, Khandekar MJ, Dietrich A, Flier JS, Cinti S, Bluher M, Danial NN, Berggren PO (2014). Adipsin Is an Adipokine that Improves ? Cell Function in Diabetes. Cell, 158(1), 41-53.
     
  391. Hau HM, Tautenhahn HM, Schmelzle M, Krenzien F, Schoenberg MB, Morgul MH, Uhlmann D, Wiltberger G, Rasche M, Bachmann A, Jonas S, Bartels M (2014). Management of urologic complications in renal transplantation: a single-center experience. Transplant Proc, 46(5), 1332-1339.
     
  392. Schmidt FM, Lichtblau N, Minkwitz J, Chittka T, Thormann J, Kirkby KC, Sander C, Mergl R, Fasshauer M, Stumvoll M, Holdt LM, Teupser D, Hegerl U, Himmerich H (2014). Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity. J Psychiatr Res, 55, 29-34.
     
  393. Heiker JT, Kunath A, Kosacka J, Flehmig G, Knigge A, Kern M, Stumvoll M, Kovacs P, Bluher M, Kloting N (2014). Identification of genetic loci associated with different responses to high-fat diet-induced obesity in C57BL/6N and C57BL/6J substrains. Physiol Genomics, 46(11), 377-384.
     
  394. Dimas AS, Lagou V, Barker A, Knowles JW, Magi R, Hivert MF, Benazzo A, Rybin D, Jackson AU, Stringham HM, Song C, Fischer-Rosinsky A, Boesgaard TW, Grarup N, Abbasi FA, ... Stumvoll M et al. (2014). Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes, 63(6), 2158-2171.
     
  395. Winkler TW, Day FR, Croteau-Chonka DC, Wood AR, Locke AE, Magi R, Ferreira T, Fall T, Graff M, Justice AE, Luan J, Gustafsson S, Randall JC, Vedantam S, Workalemahu T, Kilpelainen TO, Scherag A, Esko (2014). Quality control and conduct of genome-wide association meta-analyses. Nat Protoc, 9(5), 1192-1212.
     
  396. Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S, Chu AY, Estrada K, Luan J, Kutalik Z, Amin N, Buchkovich ML, Croteau-Chonka DC, Day FR, Duan Y, Fall T, Fehrmann R, Ferreira T, Jackson AU, (2014). Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet, 46(11), 1173-1186.
     
  397. Keller M, Kralisch S, Rohde K, Schleinitz D, Dietrich A, Schon MR, Gartner D, Lohmann T, Dressler M, Tonjes A, Stumvoll M, Kovacs P, Fasshauer M, Bluher M, Bottcher Y (2014). Global DNA methylation levels in human adipose tissue are related to fat distribution and glucose homeostasis. Diabetologia, 57(11), 2374-2383.
     
  398. Del Prato S, Foley JE, Kothny W, Kozlovski P, Stumvoll M, Paldanius PM, Matthews DR (2014). Study to determine the durability of glycaemic control with early treatment with a vildagliptin-metformin combination regimen vs. standard-of-care metformin monotherapy-the VERIFY trial: a randomized double-blind trial. Diabet Med, 31(10), 1178-1184.
     
  399. Rohde K, Keller M, Klos M, Schleinitz D, Dietrich A, Schon MR, Gartner D, Lohmann T, Dressler M, Stumvoll M, Kovacs P, Bluher M, Bottcher Y (2014). Adipose tissue depot specific promoter methylation of TMEM18. J Mol Med (Berl), 92(8), 881-888.
     
  400. Kern M, Kosacka J, Hesselbarth N, Bruckner J, Heiker JT, Flehmig G, Kloting I, Kovacs P, Matz-Soja M, Gebhardt R, Krohn K, Sales S, Abshagen K, Shevchenko A, Stumvoll M, Bluher M, Kloting N (2014). Liver-restricted Repin1 deficiency improves whole-body insulin sensitivity, alters lipid metabolism, and causes secondary changes in adipose tissue in mice. Diabetes, 63(10), 3295-3309.
     
  401. Ponisch W, Holzvogt B, Plotze M, Andrea M, Bourgeois M, Heyn S, Zehrfeld T, Hammerschmidt D, Schwarz M, Edelmann T, Becker C, Hoffmann FA, Schwarzer A, Kreibich U, Gutsche K, Reifenrath K, Winkelmann (2014). Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma. J Cancer Res Clin Oncol, 140(11), 1947-1956.
     
  402. Boldt A, Kahlenberg F, Fricke S, Rasche FM, Sack U (2014). Flow cytometric phenotyping of lymphocytes in patients with systemic lupus erythematosus. Cytometry A, 85(7), 567-569.
     
  403. Wang GX, Zhao XY, Meng ZX, Kern M, Dietrich A, Chen Z, Cozacov Z, Zhou D, Okunade AL, Su X, Li S, Bluher M, Lin JD (2014). The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nat Med, 20(12), 1436-1443.
     
  404. Turpin SM, Nicholls HT, Willmes DM, Mourier A, Brodesser S, Wunderlich CM, Mauer J, Xu E, Hammerschmidt P, Bronneke HS, Trifunovic A, LoSasso G, Wunderlich FT, Kornfeld JW, Bluher M, Kronke M, Bruning (2014). Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab, 20(4), 678-686.
     
  405. Mardinoglu A, Kampf C, Asplund A, Fagerberg L, Hallstrom BM, Edlund K, Bluher M, Ponten F, Uhlen M, Nielsen J (2014). Defining the human adipose tissue proteome to reveal metabolic alterations in obesity. J Proteome Res, 13(11), 5106-5119.
     
  406. Strain WD, Bluher M, Paldanius P (2014). Clinical inertia in individualising care for diabetes: is there time to do more in type 2 diabetes? Diabetes Ther, 5(2), 347-354.
     
  407. Frolov A, Bluher M, Hoffmann R (2014). Glycation sites of human plasma proteins are affected to different extents by hyperglycemic conditions in type 2 diabetes mellitus. Anal Bioanal Chem, 406(24), 5755-5763.
     
  408. Garnov N, Linder N, Schaudinn A, Bluher M, Karlas T, Schutz T, Dietrich A, Kahn T, Busse H (2014). Comparison of T1 relaxation times in adipose tissue of severely obese patients and healthy lean subjects measured by 1.5T MRI. NMR Biomed, 27(9), 1123-1128.
     
  409. Bollineni RC, Fedorova M, Bluher M, Hoffmann R (2014). Carbonylated plasma proteins as potential biomarkers of obesity induced type 2 diabetes mellitus. J Proteome Res, 13(11), 5081-5093.
     
  410. Strain WD, Cos X, Hirst M, Vencio S, Mohan V, Voko Z, Yabe D, Bluher M, Paldanius PM (2014). Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus. Diabetes Res Clin Pract, 105(3), 302-312.
     
  411. Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R, Shong YK, Sherman SI, Smit JW, Chung J, Kappeler C, Pena C, Molnar I, Schlumberger MJ (2014). Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet, 384(9940), 319-328.
     
  412. Cotillard A, Poitou C, Torcivia A, Bouillot JL, Dietrich A, Kloting N, Gregoire C, Lolmede K, Bluher M, Clement K (2014). Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulin resistance after gastric bypass. J Clin Endocrinol Metab, 99(8), 1466-1470.
     
  413. Nowicki M, Baum P, Kosacka J, Stockinger M, Kloting N, Bluher M, Bechmann I, Toyka KV (2014). Effects of isoflurane anesthesia on F-waves in the sciatic nerve of the adult rat. Muscle Nerve, 50(2), 257-261.
     
  414. Schleinitz D, Bottcher Y, Bluher M, Kovacs P (2014). The genetics of fat distribution. Diabetologia, 57(7), 1276-1286.
     
  415. Hoggart CJ, Venturini G, Mangino M, Gomez F, Ascari G, Zhao JH, Teumer A, Winkler TW, Tsernikova N, Luan J, Mihailov E, Ehret GB, Zhang W, Lamparter D, Esko T, Mace A, Rueger S, Bochud PY, Barcella M, (2014). Novel approach identifies SNPs in SLC2A10 and KCNK9 with evidence for parent-of-origin effect on body mass index. PLoS Genet, 10(7), e1004508.
     
  416. Blüher M, Körner A, Miehle K, Kiess W, Stumvoll M (2014). Typ 2 Diabetes und Metabolisches Syndrom. In: Hendrik Lehnert, Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. (S. 326-339), Stuttgart: Georg Thieme Verlag KG.
     
  417. Paschke R (2014). Endokrines System. In: Pape H C, Kurtz A, Silbernagl S, Physiologie. (S. 586-634), Stuttgart: Thieme Verlag .
     


  418. 2013


  419. Mai M, Tonjes A, Trantakis C, Wittekind C, Stumvoll M, Fuhrer D (2013). [Hirsutism and multinodular goiter in a 40-year-old female watchmaker]. Internist (Berl), 54(9), 1137-1140.
     
  420. Richter J, Focke D, Ebert T, Kovacs P, Bachmann A, Lossner U, Kralisch S, Kratzsch J, Beige J, Anders M, Bast I, Bluher M, Stumvoll M, Fasshauer M (2013). Serum levels of the adipokine progranulin depend on renal function. Diabetes Care, 36(2), 410-414.
     
  421. Kralisch S, Tonjes A, Krause K, Richter J, Lossner U, Kovacs P, Ebert T, Bluher M, Stumvoll M, Fasshauer M (2013). Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans. J Endocrinol, 216(2), 135-143.
     
  422. Ferraz C, Lorenz S, Wojtas B, Bornstein SR, Paschke R, Eszlinger M (2013). Inverse Correlation of miRNA and Cell Cycle-Associated Genes Suggests Influence of miRNA on Benign Thyroid Nodule Tumorigenesis. J Clin Endocrinol Metab, 98(1), 8-16.
     
  423. Kralisch S, Fasshauer M (2013). Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? Diabetologia, 56(1), 10-21.
     
  424. Hoffmeister A, Tuennemann J, Sommerer I, Mossner J, Rittger A, Schleinitz D, Kratzsch J, Rosendahl J, Kloting N, Stahl T, Rossner S, Paroni F, Maedler K, Kovacs P, Bluher M (2013). Genetic and biochemical evidence for a functional role of BACE1 in the regulation of insulin mRNA expression. Obesity (Silver Spring), 21(12), E626-633.
     
  425. Stepan H, Kley K, Hindricks J, Kralisch S, Jank A, Schaarschmidt W, Schrey S, Ebert T, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Richter J, Fasshauer M (2013). Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia. Cytokine, 62(2), 322-326.
     
  426. Kovacs P, Miehle K, Sandner B, Stumvoll M, Bluher M (2013). Insulin administration acutely decreases vaspin serum concentrations in humans. Obes Facts, 6(1), 86-88.
     
  427. Schlogl H, Kabisch S, Horstmann A, Lohmann G, Muller K, Lepsien J, Busse-Voigt F, Kratzsch J, Pleger B, Villringer A, Stumvoll M (2013). Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity. Diabetes Care, 36(7), 1933-1940.
     
  428. Krist J, Wieder K, Kloting N, Oberbach A, Kralisch S, Wiesner T, Schon MR, Gartner D, Dietrich A, Shang E, Lohmann T, Dressler M, Fasshauer M, Stumvoll M, Bluher M (2013). Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity. Obes Facts, 6(1), 57-69.
     
  429. Stepan H, Richter J, Kley K, Kralisch S, Jank A, Schaarschmidt W, Ebert T, Lossner U, Jessnitzer B, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2013). Serum levels of growth arrest specific protein 6 are increased in preeclampsia. Regul Pept, 182, 7-11.
     
  430. Breitfeld J, Tonjes A, Bottcher Y, Schleinitz D, Wiele N, Marzi C, Brockhaus C, Rathmann W, Huth C, Grallert H, Illig T, Bluher M, Kovacs P, Stumvoll M (2013). Genetic variation in the vaspin gene affects circulating serum vaspin concentrations. Int J Obes (Lond), 37(6), 861-866.
     
  431. Rehfeld C, Munz S, Krogdahl A, Jensen EM, Siebolts U, Ferraz C, Bosenberg E, Hegedus L, Paschke R, Eszlinger M (2013). Impact of different methodologies on the detection of point mutations in routine air-dried fine needle aspiration (FNA) smears. Horm Metab Res, 45(7), 513-517.
     
  432. Bluher M (2013). Importance of estrogen receptors in adipose tissue function. Mol Metab, 2(3), 130-132.
     
  433. Tonjes A, Kovacs P (2013). SGLT2: a potential target for the pharmacogenetics of Type 2 diabetes? Pharmacogenomics, 14(7), 825-833.
     
  434. Punkt K, Kandt K, Oberbach A, Adams V, Buchwalow I, Bluher M (2013). Nitric oxide synthase in skeletal muscle fibers of patients with type 2 diabetes. Acta Histochem, 115(4), 389-393.
     
  435. Eszlinger M, Ruschenburg I, Paschke R (2013). [Dignity of thyroid nodules: diagnostic gain by molecular fine needle aspiration cytology]. Dtsch Med Wochenschr, 138(40), 2003-2006.
     
  436. Bluher M (2013). Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab, 27(2), 163-177.
     
  437. Wienhold R, Scholz M, Adler JR, G Nster C, Paschke R (2013). The management of thyroid nodules. Dtsch Arztebl Int, 110(49), 827-834.
     
  438. Lindner TH (2013). Diabetische Nephropathie. Einführung. Diabetologe, 9(8), 611-612.
     
  439. Lindner TH (2013). Proteinurie und Blocker des Renin-Angiotensin-Aldosteron-Systems. Diabetologe, 9(8), 622-630.
     
  440. Mai M, Tonjes A, Kovacs P, Stumvoll M, Fiedler GM, Leichtle AB (2013). Serum levels of acylcarnitines are altered in prediabetic conditions. PLoS One, 8(12), e82459.
     
  441. Kottgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, Pistis G, Ruggiero D, O'Seaghdha CM, Haller T, Yang Q, Tanaka T, Johnson AD, Kutalik Z, Smith AV, Shi J, Struchalin M, et al. (2013). Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet, 45(2), 145-154.
     
  442. Horikoshi M, Yaghootkar H, Mook-Kanamori DO, Sovio U, Taal HR, Hennig BJ, Bradfield JP, St Pourcain B, Evans DM, Charoen P, Kaakinen M, Cousminer DL, Lehtimaki T, Kreiner-Moller E, Warrington NM, Bust (2013). New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat Genet, 45(1), 76-82.
     
  443. Horstmann A, Kovacs P, Kabisch S, Boettcher Y, Schloegl H, Tonjes A, Stumvoll M, Pleger B, Villringer A (2013). Common Genetic Variation near MC4R Has a Sex-Specific Impact on Human Brain Structure and Eating Behavior. PLoS One, 8(9), e74362.
     
  444. Pfeifer A, Wojtas B, Oczko-Wojciechowska M, Kukulska A, Czarniecka A, Eszlinger M, Musholt T, Stokowy T, Swierniak M, Stobiecka E, Rusinek D, Tyszkiewicz T, Kowal M, Jarzab M, Hauptmann S, Lange D, Pa (2013). Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues. BMC Med Genomics, 6, 38.
     
  445. Breitfeld J, Tonjes A, Gast MT, Schleinitz D, Bluher M, Stumvoll M, Kovacs P, Bottcher Y (2013). Role of vaspin in human eating behaviour. PLoS One, 8(1), e54140.
     
  446. Holstein JD, Patzer O, Korner A, Stumvoll M, Kovacs P, Holstein A (2013). Genetic variants in GCKR, GIPR, ADCY5 and VPS13C and the risk of severe sulfonylurea-induced hypoglycaemia in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes, 121(1), 54-57.
     
  447. Grassler J, Bluher M, Chavakis T (2013). [Obesity and inflammation]. Dtsch Med Wochenschr, 138(5), 172-175.
     
  448. Bernhard F, Landgraf K, Kloting N, Berthold A, Buttner P, Friebe D, Kiess W, Kovacs P, Bluher M, Korner A (2013). Functional relevance of genes implicated by obesity genome-wide association study signals for human adipocyte biology. Diabetologia, 56(2), 311-322.
     
  449. Klinitzke G, Steinig J, Bluher M, Kersting A, Wagner B (2013). Obesity and suicide risk in adults-A systematic review. J Affect Disord, 145, 277-284.
     
  450. Liew CW, Boucher J, Cheong JK, Vernochet C, Koh HJ, Mallol C, Townsend K, Langin D, Kawamori D, Hu J, Tseng YH, Hellerstein MK, Farmer SR, Goodyear L, Doria A, Bluher M, Hsu SI, Kulkarni RN (2013). Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance. Nat Med, 19(2), 217-226.
     
  451. Tirosh A, Golan R, Harman-Boehm I, Henkin Y, Schwarzfuchs D, Rudich A, Kovsan J, Fiedler GM, Bluher M, Stumvoll M, Thiery J, Stampfer MJ, Shai I (2013). Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care, 36(8), 2225-2232.
     
  452. Heiker JT, Kern M, Kosacka J, Flehmig G, Stumvoll M, Shang E, Lohmann T, Dressler M, Kovacs P, Bluher M, Kloting N (2013). Nicotinamide nucleotide transhydrogenase mRNA expression is related to human obesity. Obesity (Silver Spring), 21(3), 529-534.
     
  453. Berndt SI, Gustafsson S, Magi R, Ganna A, Wheeler E, Feitosa MF, Justice AE, Monda KL, Croteau-Chonka DC, Day FR, Esko T, Fall T, Ferreira T, Gentilini D, Jackson AU, Luan J, Randall JC, Vedantam S, W (2013). Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet, 45(5), 501-512.
     
  454. Ma L, Murea M, Snipes JA, Marinelarena A, Kruger J, Hicks PJ, Langberg KA, Bostrom MA, Cooke JN, Suzuki D, Babazono T, Uzu T, Tang SC, Mondal AK, Sharma NK, Kobes S, Antinozzi PA, Davis M, Das SK, Ras (2013). An ACACB variant implicated in diabetic nephropathy associates with body mass index and gene expression in obese subjects. PLoS One, 8(2), 56193.
     
  455. Heiker JT, Kloting N, Kovacs P, Kuettner EB, Strater N, Schultz S, Kern M, Stumvoll M, Bluher M, Beck-Sickinger AG (2013). Vaspin inhibits kallikrein 7 by serpin mechanism. Cell Mol Life Sci, 70(14), 2569-2583.
     
  456. Rebala K, Martinez-Cruz B, Tonjes A, Kovacs P, Stumvoll M, Lindner I, Buttner A, Wichmann HE, Sivakova D, Sotak M, Quintana-Murci L, Szczerkowska Z, Comas D (2013). Contemporary paternal genetic landscape of Polish and German populations: from early medieval Slavic expansion to post-World War II resettlements. Eur J Hum Genet, 21(4), 415-422.
     
  457. von Kampen O, Buch S, Nothnagel M, Azocar L, Molina H, Brosch M, Erhart W, von Schonfels W, Egberts J, Seeger M, Arlt A, Balschun T, Franke A, Lerch MM, Mayerle J, Kratzer W, Boehm BO, Huse K, Schniew (2013). Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus. Hepatology, 57(6), 2407-2417.
     
  458. Adams V, Heiker JT, Hollriegel R, Beck EB, Woitek FJ, Erbs S, Bluher M, Stumvoll M, Beck-Sickinger AG, Schuler G, Linke A (2013). Adiponectin promotes the migration of circulating angiogenic cells through p38-mediated induction of the CXCR4 receptor. Int J Cardiol, 167(5), 2039-2046.
     
  459. Rosendahl J, Landt O, Bernadova J, Kovacs P, Teich N, Bodeker H, Keim V, Ruffert C, Mossner J, Kage A, Stumvoll M, Groneberg D, Kruger R, Luck W, Treiber M, Becker M, Witt H (2013). CFTR, SPINK1, CTRC and PRSS1 variants in chronic pancreatitis: is the role of mutated CFTR overestimated? Gut, 62(4), 582-592.
     
  460. Keller M, Schleinitz D, Forster J, Tonjes A, Bottcher Y, Fischer-Rosinsky A, Breitfeld J, Weidle K, Rayner NW, Burkhardt R, Enigk B, Muller I, Halbritter J, Koriath M, Pfeiffer A, Krohn K, Groop L, Sp (2013). THOC5: a novel gene involved in HDL-cholesterol metabolism. J Lipid Res, 54(11), 3170-3176.
     
  461. Witt H, Beer S, Rosendahl J, Chen JM, Chandak GR, Masamune A, Bence M, Szmola R, Oracz G, Macek M Jr, Bhatia E, Steigenberger S, Lasher D, Buhler F, Delaporte C, Tebbing J, Ludwig M, Pilsak C, Saum K, (2013). Variants in CPA1 are strongly associated with early onset chronic pancreatitis. Nat Genet, 45(10), 1216-1220.
     
  462. Breitfeld J, Heiker JT, Bottcher Y, Schleinitz D, Tonjes A, Weidle K, Krause K, Kuettner EB, Scholz M, Kiess W, Strater N, Beck-Sickinger AG, Stumvoll M, Korner A, Bluher M, Kovacs P (2013). Analysis of a rare functional truncating mutation rs61757459 in vaspin (SERPINA12) on circulating vaspin levels. J Mol Med (Berl), 91(11), 1285-1292.
     
  463. Hellmuth C, Demmelmair H, Schmitt I, Peissner W, Bluher M, Koletzko B (2013). Association between Plasma Nonesterified Fatty Acids Species and Adipose Tissue Fatty Acid Composition. PLoS One, 8(10), 74927.
     
  464. Kosacka J, Nowicki M, Bluher M, Baum P, Stockinger M, Toyka KV, Kloting I, Stumvoll M, Serke H, Bechmann I, Kloting N (2013). Increased autophagy in peripheral nerves may protect Wistar Ottawa Karlsburg W rats against neuropathy. Exp Neurol, 250C, 125-135.
     
  465. Lee KY, Yamamoto Y, Boucher J, Winnay JN, Gesta S, Cobb J, Bluher M, Kahn CR (2013). Shox2 is a molecular determinant of depot-specific adipocyte function. Proc Natl Acad Sci U S A, 110(28), 11409-11414.
     
  466. Fink LN, Oberbach A, Costford SR, Chan KL, Sams A, Bluher M, Klip A (2013). Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes. Diabetologia, 56(7), 1623-1628.
     
  467. Keller M, Liu X, Wohland T, Rohde K, Gast MT, Stumvoll M, Kovacs P, Tonjes A, Bottcher Y (2013). TAS2R38 and Its Influence on Smoking Behavior and Glucose Homeostasis in the German Sorbs. PLoS One, 8(12), e80512.
     
  468. Parsa A, Fuchsberger C, Kottgen A, O'Seaghdha CM, Pattaro C, de Andrade M, Chasman DI, Teumer A, Endlich K, Olden M, Chen MH, Tin A, Kim YJ, Taliun D, Li M, Feitosa M, Gorski M, et al (2013). Common variants in mendelian kidney disease genes and their association with renal function. J Am Soc Nephrol, 24(12), 2105-2117.
     
  469. Sell H, Bluher M, Kloting N, Schlich R, Willems M, Ruppe F, Knoefel WT, Dietrich A, Fielding BA, Arner P, Frayn KN, Eckel J (2013). Adipose Dipeptidyl Peptidase-4 and Obesity: Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care, 36(12), 4083-4090.
     
  470. Thormer G, Bertram HH, Garnov N, Peter V, Schutz T, Shang E, Bluher M, Kahn T, Busse H (2013). Software for automated MRI-based quantification of abdominal fat and preliminary evaluation in morbidly obese patients. J Magn Reson Imaging, 37(5), 1144-1150.
     
  471. Ponisch W, Moll B, Bourgeois M, Andrea M, Schliwa T, Heyn S, Schmalfeld M, Edelmann T, Becker C, Hoffmann FA, Schwarzer A, Kreibich U, Egert M, Stiegler R, Krahl R, Remane Y, Bachmann A, Lindner T, We (2013). Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure. J Cancer Res Clin Oncol, 139(11), 1937-1946.
     
  472. Gast MT, Tönjes A, Keller M, Horstmann A, Steinle N, Scholz M, Müller I, Villringer A, Stumvoll M, Kovacs P, Böttcher Y (2013). The role of rs2237781 within GRM8 in eating behaviour. Brain Behav, 3(5), 495-502.
     
  473. Stefanov T, Vekova A, Bonova I, Tzvetkov S, Kurktschiev D, Bluher M, Temelkova-Kurktschiev T (2013). Effects of supervised vs non-supervised combined aerobic and resistance exercise programme on cardiometabolic risk factors. Cent Eur J Public Health, 21(1), 8-16.
     
  474. Yoo HJ, Hwang SY, Cho GJ, Hong HC, Choi HY, Hwang TG, Kim SM, Bluher M, Youn BS, Baik SH, Choi KM (2013). Association of glypican-4 with body fat distribution, insulin resistance, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab, 98(7), 2897-2901.
     
  475. Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Choi DS, Baik SH, Bluher M, Youn BS, Choi KM (2013). Implication of progranulin and C1q/TNF-related protein-3 (CTRP3) on inflammation and atherosclerosis in subjects with or without metabolic syndrome. PLoS One, 8(2), e55744.
     
  476. Shapiro H, Pecht T, Shaco-Levy R, Harman-Boehm I, Kirshtein B, Kuperman Y, Chen A, Bluher M, Shai I, Rudich A (2013). Adipose tissue foam cells are present in human obesity. J Clin Endocrinol Metab, 98(3), 1173-1181.
     
  477. Wojtas B, Pfeifer A, Jarzab M, Czarniecka A, Krajewska J, Swierniak M, Stokowy T, Rusinek D, Kowal M, Zebracka-Gala J, Tyszkiewicz T, Oczko-Wojciechowska M, Stobiecka E, Lange D, Paschke R, Jarzab B (2013). Unsupervised analysis of follicular thyroid tumours transcriptome by oligonucleotide microarray gene expression profiling. Endokrynol Pol, 64(5), 328-334.
     
  478. Evans DM, Brion MJ, Paternoster L, Kemp JP, McMahon G, Munafo M, Whitfield JB, Medland SE, Montgomery GW, Timpson NJ, St Pourcain B, Lawlor DA, Martin NG, Dehghan A, Hirschhorn J, Davey Smith G (2013). Mining the human phenome using allelic scores that index biological intermediates. PLoS Genet, 9(10), e1003919.
     
  479. Arelin M, Schulze B, Muller-Myhsok B, Horn D, Diers A, Uhlenberg B, Nurnberg P, Nurnberg G, Becker C, Mundlos S, Lindner TH, Sperling K, Hoffmann K (2013). Genome-wide linkage analysis is a powerful prenatal diagnostic tool in families with unknown genetic defects. Eur J Hum Genet, 21(4), 367-372.
     
  480. Leenhardt L, Erdogan MF, Hegedus L, Mandel SJ, Paschke R, Rago T, Russ G (2013). 2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid J, 2(3), 147-159.
     
  481. Paschke R (2013). Toxic adenoma and toxic multinodular goiter. In: Lewis E. Braverman , The Thyroid. (S. 400-409), Philadelphia: Lippincott Williams & Wilkins.
     


  482. 2012


  483. Holstein A, Patzer OM, Machalke K, Holstein JD, Stumvoll M, Kovacs P (2012). Substantial Increase in Incidence of Severe Hypoglycemia Between 1997-2000 and 2007-2010: A German longitudinal population-based study. Diabetes Care, 35(5), 972-975.
     
  484. Pazaitou-Panayiotou K, Michalakis K, Paschke R (2012). Thyroid cancer in patients with hyperthyroidism. Horm Metab Res, 44(4), 255-262.
     
  485. Chakaroun R, Raschpichler M, Kloting N, Oberbach A, Flehmig G, Kern M, Schon MR, Shang E, Lohmann T, Dressler M, Fasshauer M, Stumvoll M, Bluher M (2012). Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism, 61(5), 706-714.
     
  486. Miehle K, Stepan H, Fasshauer M (2012). Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf), 76(1), 2-11.
     
  487. Krause K, Boisnard A, Ihling C, Ludgate M, Eszlinger M, Krohn K, Sinz A, Fuhrer D (2012). Comparative proteomic analysis to dissect differences in signal transduction in activating TSH receptor mutations in the thyroid. Int J Biochem Cell Biol, 44(2), 290-301.
     
  488. Bluher M, Rudich A, Kloting N, Golan R, Henkin Y, Rubin E, Schwarzfuchs D, Gepner Y, Stampfer MJ, Fiedler M, Thiery J, Stumvoll M, Shai I (2012). Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care, 35(2), 342-349.
     
  489. Kosacka J, Nowicki M, Kloting N, Kern M, Stumvoll M, Bechmann I, Serke H, Bluher M (2012). COMP-angiopoietin-1 recovers molecular biomarkers of neuropathy and improves vascularisation in sciatic nerve of ob/ob mice. PLoS One, 7(3), e32881.
     
  490. Bluher M (2012). Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine, 41(2), 176-182.
     
  491. Stepan H, Philipp A, Roth I, Kralisch S, Jank A, Schaarschmidt W, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2012). Serum levels of the adipokine zinc-alpha2-glycoprotein are increased in preeclampsia. J Endocrinol Invest, 35(6), 562-565.
     
  492. Tonjes A, Kralisch S, Lossner U, Kovacs P, Bluher M, Stumvoll M, Fasshauer M (2012). Metabolic and genetic predictors of circulating adipocyte fatty acid-binding protein. Int J Obes (Lond), 36(6), 766-773.
     
  493. Tonjes A, Peterson S, Seiwerts M, Stumvoll M, Fuhrer D (2012). Surprising thoracic tumour mass. Emerg Med J, 29(4), 338.
     
  494. Halbritter J, Wittenburg H, Schiefke I, Amann K, Lindner T, Rasche FM (2012). MPA: a treatment option for lymphocytic colitis and mesalamine-induced interstitial nephritis. Inflamm Bowel Dis, 18(3), 599-600.
     
  495. Selig L, Reiche M, Ebert T, Krehl D, Kralisch S, Lossner U, Stach B, Bluher M, Stumvoll M, Bodeker H, Keim V, Mossner J, Fasshauer M (2012). Serum levels of adipocyte Fatty Acid-binding protein are decreased in chronic pancreatitis. Pancreas, 41(8), 1230-1234.
     
  496. Breitfeld J, Stumvoll M, Kovacs P (2012). Genetics of adiponectin. Biochimie, 94(10), 2157-2163.
     
  497. Ferraz C, Rehfeld C, Krogdahl A, Precht Jensen EM, Bosenberg E, Narz F, Hegedus L, Paschke R, Eszlinger M (2012). Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears. Thyroid, 22(10), 1025-1030.
     
  498. Holstein A, Beil W, Kovacs P (2012). CYP2C metabolism of oral antidiabetic drugs - impact on pharmacokinetics, drug interactions and pharmacogenetic aspects. Expert Opin Drug Metab Toxicol, 8(12), 1549-1563.
     
  499. Bluher M (2012). Clinical relevance of adipokines. Diabetes Metab J, 36(5), 317-327.
     
  500. Bluher M, Kurz I, Dannenmaier S, Dworak M (2012). Efficacy and safety of vildagliptin in clinical practice-results of the PROVIL-study. World J Diabetes, 3(9), 161-169.
     
  501. Weck M, Bornstein SR, Barthel A, Bluher M (2012). [Strategies for successful weight reduction]. Dtsch Med Wochenschr, 137(43), 2223-2228.
     
  502. Bluher M (2012). Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes, 19(5), 341-346.
     
  503. Kern M, Kloting N, Niessen HG, Thomas L, Stiller D, Mark M, Klein T, Bluher M (2012). Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity. PLoS One, 7(6), e38744.
     
  504. Schaarschmidt J, Paschke S, Ozerden M, Jaschke H, Huth S, Eszlinger M, Meller J, Paschke R (2012). Late Manifestation of Subclinical Hyperthyroidism After Goitrogenesis in an Index Patient with a N670S TSH Receptor Germline Mutation Masquerading as TSH Receptor Antibody Negative Graves' Disease. Horm Metab Res, 44(13), 962-965.
     
  505. Karger S, Krause K, Engelhardt C, Weidinger C, Gimm O, Dralle H, Sheu-Grabellus SY, Kurt Werner S, Fuhrer D (2012). Distinct pattern of oxidative DNA damage and DNA repair in follicular thyroid tumours. J Mol Endocrinol, 48(3), 193-202.
     
  506. Karger S, Krause K, Gutknecht M, Schierle K, Graf D, Steinert F, Dralle H, Fuhrer D (2012). ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours. Br J Cancer, 106(3), 562-568.
     
  507. Holstein A, Patzer O, Tiemann T, Vortherms J, Kovacs P (2012). Number and sex ratio of children and impact of parental diabetes in individuals with Type 1 diabetes. Diabet Med, 29(10), 1268-1271.
     
  508. Böttcher Y, Körner A, Kovacs P, Kiess W (2012). Obesity genes:implication in childhood obesity. Paediatrics and Child Health, 22(1), 31-36.
     
  509. Weis S, Jesinghaus M, Kovacs P, Schleinitz D, Schober R, Ruffert C, Herms M, Wittenburg H, Stumvoll M, Bluher M, Grutzmann R, Schulz HU, Keim V, Mossner J, Bugert P, Witt H, Drenth JP, Krohn K, Rosend (2012). Genetic Analyses of Heme Oxygenase 1 (HMOX1) in Different Forms of Pancreatitis. PLoS One, 7(5), e37981.
     
  510. Golan R, Tirosh A, Schwarzfuchs D, Harman-Boehm I, Thiery J, Fiedler GM, Bluher M, Stumvoll M, Shai I (2012). Dietary intervention induces flow of changes within biomarkers of lipids, inflammation, liver enzymes, and glycemic control. Nutrition, 28(2), 131-137.
     
  511. Beck EB, Erbs S, Mobius-Winkler S, Adams V, Woitek FJ, Walther T, Hambrecht R, Mohr FW, Stumvoll M, Bluher M, Schuler G, Linke A (2012). Exercise training restores the endothelial response to vascular growth factors in patients with stable coronary artery disease. Eur J Prev Cardiol, 19(3), 412-418.
     
  512. Nowicki M, Kosacka J, Serke H, Bluher M, Spanel-Borowski K (2012). Altered sciatic nerve fiber morphology and endoneural microvessels in mouse models relevant for obesity, peripheral diabetic polyneuropathy, and the metabolic syndrome. J Neurosci Res, 90(1), 122-131.
     
  513. Biemann R, Navarrete Santos A, Navarrete Santos A, Riemann D, Knelangen J, Bluher M, Koch H, Fischer B (2012). Endocrine disrupting chemicals affect the adipogenic differentiation of mesenchymal stem cells in distinct ontogenetic windows. Biochem Biophys Res Commun, 417(2), 747-752.
     
  514. Saalbach A, Vester K, Rall K, Tremel J, Anderegg U, Beck-Sickinger AG, Bluher M, Simon JC (2012). Vaspin - a link of obesity and psoriasis? Exp Dermatol, 21(4), 309-312.
     
  515. Pivovarova O, Gogebakan O, Kloting N, Sparwasser A, Weickert MO, Haddad I, Nikiforova VJ, Bergmann A, Kruse M, Seltmann AC, Bluher M, Pfeiffer AF, Rudovich N (2012). Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity? J Clin Endocrinol Metab, 97(5), 731-739.
     
  516. Herman MA, Peroni OD, Villoria J, Schon MR, Abumrad NA, Bluher M, Klein S, Kahn BB (2012). A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature, 484(7394), 333-338.
     
  517. Manning AK, Hivert MF, Scott RA, Grimsby JL, Bouatia-Naji N, Chen H, Rybin D, Liu CT, Bielak LF, Prokopenko I, Amin N, Barnes D, Cadby G, Hottenga JJ, ... Stumvoll M et al. (2012). A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet, 44(6), 659-669.
     
  518. Nerstedt A, Cansby E, Andersson CX, Laakso M, Stancakova A, Bluher M, Smith U, Mahlapuu M (2012). Serine/threonine protein kinase 25 (STK25): a novel negative regulator of lipid and glucose metabolism in rodent and human skeletal muscle. Diabetologia, 55(6), 1797-1807.
     
  519. Ponisch W, Andrea M, Wagner I, Hammerschmidt D, Kreibich U, Schwarzer A, Zehrfeld T, Schwarz M, Winkelmann C, Petros S, Bachmann A, Lindner T, Niederwieser D (2012). Successful treatment of patients with newly diagnosed/untreated multiple myeloma and advanced renal failure using bortezomib in combination with bendamustine and prednisone. J Cancer Res Clin Oncol, 138(8), 1405-1412.
     
  520. Yang Q, Eskurza I, Kiernan UA, Phillips DA, Bluher M, Graham TE, Kahn BB (2012). Quantitative measurement of full-length and C-terminal proteolyzed RBP4 in serum of normal and insulin-resistant humans using a novel mass spectrometry immunoassay. Endocrinology, 153(3), 1519-1527.
     
  521. Scott RA, Chu AY, Grarup N, Manning AK, Hivert MF, Shungin D, Tonjes A, Yesupriya A, Barnes D, Bouatia-Naji N, Glazer NL, Jackson AU, Kutalik Z, Lagou V, Marek D, Rasmussen-Torvik LJ, Stringham HM, Ta (2012). No Interactions Between Previously Associated 2-Hour Glucose Gene Variants and Physical Activity or BMI on 2-Hour Glucose Levels. Diabetes, 61(5), 1291-1296.
     
  522. Fox CS, Liu Y, White CC, Feitosa M, Smith AV, Heard-Costa N, Lohman K, Johnson AD, Foster MC, Greenawalt DM, Griffin P, Ding J, Newman AB, Tylavsky F, Miljkovic I, Kritchevsky SB, Launer L, Garcia M, (2012). Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women. PLoS Genet, 8(5), e1002695.
     
  523. Hubacek JA, Adamkova V, Dlouha D, Jirsa M, Sperl J, Tonjes A, Kovacs P, Pikhart H, Peasey A, Bobak M (2012). Fat mass and obesity-associated (fto) gene and alcohol intake. Addiction, 107(6), 1185-1186.
     
  524. Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, Henneman P, Heid IM, Kizer JR, Lyytikainen LP, Fuchsberger C, Tanaka T, Morris AP, Small K, ... Stumvoll M et al. (2012). Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet, 8(3), e1002607.
     
  525. Pattaro C, Kottgen A, Teumer A, Garnaas M, Boger CA, Fuchsberger C, Olden M, Chen MH, Tin A, Taliun D, Li M, Gao X, Gorski M, Yang Q, ... Stumvoll M et al. (2012). Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet, 8(3), e1002584.
     
  526. Rosendahl J, Tonjes A, Schleinitz D, Kovacs P, Wiegand J, Ruffert C, Jesinghaus M, Schober R, Herms M, Grutzmann R, Schulz HU, Stickel F, Werner J, Bugert P, Bluher M, Stumvoll M, Bohm S, Berg T, Witt (2012). A common variant of PNPLA3 (p.I148M) is not associated with alcoholic chronic pancreatitis. PLoS One, 7(1), e29433.
     
  527. Palmer ND, McDonough CW, Hicks PJ, Roh BH, Wing MR, An SS, Hester JM, Cooke JN, Bostrom MA, Rudock ME, Talbert ME, Lewis JP, ... Stumvoll et al. (2012). A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One, 7(1), e29202.
     
  528. Kern M, Knigge A, Heiker JT, Kosacka J, Stumvoll M, Kovacs P, Bluher M, Kloting N (2012). C57BL/6JRj mice are protected against diet induced obesity (DIO). Biochem Biophys Res Commun, 417(2), 717-720.
     
  529. Holstein JD, Kovacs P, Patzer O, Stumvoll M, Holstein A (2012). The Ser1369Ala variant of ABCC8 and the risk for severe sulfonylurea-induced hypoglycemia in German patients with Type 2 diabetes. Pharmacogenomics, 13(1), 5-7.
     
  530. Engeli S, Bluher M, Jumpertz R, Wiesner T, Wirtz H, Bosse-Henck A, Stumvoll M, Batkai S, Pacher P, Harvey-White J, Kunos G, Jordan J (2012). Circulating anandamide and blood pressure in patients with obstructive sleep apnea. J Hypertens, 30(12), 2345-2351.
     
  531. Yang J, Loos RJ, Powell JE, Medland SE, Speliotes EK, Chasman DI, Rose LM, Thorleifsson G, Steinthorsdottir V, Magi R, Waite L, Smith AV, Yerges-Armstrong LM, Monda KL, ...Stumvoll M, Tönjes A et al (2012). FTO genotype is associated with phenotypic variability of body mass index. Nature, 490(7419), 267-272.
     
  532. Chasman DI, Fuchsberger C, Pattaro C, Teumer A, Boger CA, Endlich K, Olden M, Chen MH, Tin A, Taliun D, Li M, Gao X, Gorski M, Yang Q, Hundertmark C, Foster MC, O'Seaghdha CM, Glazer N, et al (2012). Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. Hum Mol Genet, 21(24), 5329-5343.
     
  533. Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan J, Magi R, Strawbridge RJ, Rehnberg E, Gustafsson S, Kanoni S, Rasmussen-Torvik LJ, Yengo L, Lecoeur C, Shungin D, Sanna S, et al (2012). Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet, 44(9), 991-1005.
     
  534. Boraska V, Jeroncic A, Colonna V, Southam L, Nyholt DR, Rayner NW, Perry JR, Toniolo D, Albrecht E, Ang W, Bandinelli S, Barbalic M, Barroso I, Beckmann JS, Biffar R, Boomsma D, Campbell H, et al. (2012). Genome-wide meta-analysis of common variant differences between men and women. Hum Mol Genet, 21(21), 4805-4815.
     
  535. Maixner N, Kovsan J, Harman-Boehm I, Bluher M, Bashan N, Rudich A (2012). Autophagy in Adipose Tissue. Obes Facts, 5(5), 710-721.
     
  536. Friedrich N, Budde K, Wolf T, Jungnickel A, Grotevendt A, Dressler M, Volzke H, Bluher M, Nauck M, Lohmann T, Wallaschofksi H (2012). Short-term changes of the urine metabolome after bariatric surgery. OMICS, 16(11), 612-620.
     
  537. Ungru J, Coenen M, Vervuert I, Bluher M, Raila J, Boston R (2012). Effects of body weight reduction on blood adipokines and subcutaneous adipose tissue adipokine mRNA expression profiles in obese ponies. Vet Rec, 171, 528(21).
     
  538. Ussar S, Bezy O, Bluher M, Kahn CR (2012). Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine. Diabetes, 61(9), 2289-2298.
     
  539. Vogel H, Scherneck S, Kanzleiter T, Benz V, Kluge R, Stadion M, Kryvych S, Bluher M, Kloting N, Joost HG, Schurmann A (2012). Loss of function of Ifi202b by a microdeletion on chromosome 1 of C57BL/6J mice suppresses 11β-hydroxysteroid dehydrogenase type 1 expression and development of obesity. Hum Mol Genet, 21(17), 3845-3857.
     
  540. Boucher J, Mori MA, Lee KY, Smyth G, Liew CW, Macotela Y, Rourk M, Bluher M, Russell SJ, Kahn CR (2012). Impaired thermogenesis and adipose tissue development in mice with fat-specific disruption of insulin and IGF-1 signalling. Nat Commun, 3, 902.
     
  541. Serke H, Nowicki M, Kosacka J, Schroder T, Kloting N, Bluher M, Kallendrusch S, Spanel-Borowski K (2012). Leptin-deficient (ob/ob) mouse ovaries show fatty degeneration, enhanced apoptosis and decreased expression of steroidogenic acute regulatory enzyme. Int J Obes (Lond), 36(8), 1047-1053.
     
  542. van der Harst P, Zhang W, Mateo Leach I, Rendon A, Verweij N, Sehmi J, Paul DS, Elling U, Allayee H, Li X, Radhakrishnan A, Tan ST, Voss K, Weichenberger CX, Albers CA, Al-Hussani A, Asselbergs FW, Ci (2012). Seventy-five genetic loci influencing the human red blood cell. Nature, 492(7429), 369-375.
     
  543. Horikoshi M, Yaghootkar H, Mook-Kanamori DO, Sovio U, Taal HR, Hennig BJ, Bradfield JP, St Pourcain B, Evans DM, Charoen P, Kaakinen M, Cousminer DL, Lehtimaki T, Kreiner-Moller E, Warrington NM, Bust (2012). New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat Genet, 45(1), 76-82.
     
  544. Hollmann M, Hellrung L, Pleger B, Schlogl H, Kabisch S, Stumvoll M, Villringer A, Horstmann A (2012). Neural correlates of the volitional regulation of the desire for food. Int J Obes (Lond), 36(5), 648-655.
     
  545. Gericke MT, Schroder T, Kosacka J, Nowicki M, Kloting N, Spanel-Borowski K (2012). Neuropeptide Y impairs insulin-stimulated translocation of glucose transporter 4 in 3T3-L1 adipocytes through the Y1 receptor. Mol Cell Endocrinol, 348(1), 27-32.
     


  546. 2011


  547. Holstein A, Hahn M, Korner A, Stumvoll M, Kovacs P (2011). TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes. BMC Med Genet, 12, e30.
     
  548. Schloegl H, Percik R, Horstmann A, Villringer A, Stumvoll M (2011). Peptide hormones regulating appetite - focus on neuroimaging studies in humans. Diabetes Metab Res Rev, 27(2), 104-112.
     
  549. Baranowski T, Kralisch S, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2011). Serum levels of the adipokine fasting-induced adipose factor/angiopoietin-like protein 4 depend on renal function. Horm Metab Res, 43(2), 117-120.
     
  550. Lueblinghoff J, Eszlinger M, Jaeschke H, Mueller S, Bircan R, Gozu H, Sancak S, Akalin S, Paschke R (2011). Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations. Thyroid, 21(3), 221-229.
     
  551. Kosacka J, Schroder T, Bechmann I, Kloting N, Nowicki M, Mittag A, Gericke M, Spanel-Borowski K, Bluher M (2011). PACAP up-regulates the expression of apolipoprotein D in 3T3-L1 adipocytes. DRG/3T3-L1 co-cultures study. Neurosci Res, 69(1), 8-16.
     
  552. Muller K, Krohn K, Eszlinger M, Ludgate M, Fuhrer D (2011). Effect of iodine on early stage thyroid autonomy. Genomics, 97(2), 94-100.
     
  553. Kratzsch J, Petzold A, Raue F, Reinhardt W, Brocker-Preubeta M, Gorges R, Mann K, Karges W, Morgenthaler N, Luster M, Reiners C, Thiery J, Dralle H, Fuhrer D (2011). Basal and Stimulated Calcitonin and Procalcitonin by Various Assays in Patients with and without Medullary Thyroid Cancer. Clin Chem, 57(3), 467-474.
     
  554. Schleinitz D, Distefano JK, Kovacs P (2011). Targeted SNP genotyping using the TaqMan® assay. Methods Mol Biol, 700, 77-87.
     
  555. Stepan H, Philipp A, Roth I, Kralisch S, Jank A, Schaarschmidt W, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2011). Serum levels of the adipokine chemerin are increased in preeclampsia during and 6months after pregnancy. Regul Pept, 168(1-3), 69-72.
     
  556. Kloting N, Kovacs P, Kern M, Heiker JT, Fasshauer M, Schon MR, Stumvoll M, Beck-Sickinger AG, Bluher M (2011). Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia, 54(7), 1819-1823.
     
  557. Miehle K, Stumvoll M, Fasshauer M (2011). [Lipodystrophy. Mechanisms, clinical presentation, therapy]. Internist (Berl), 52(4), 362-368.
     
  558. Schleinitz D, Kloting N, Bottcher Y, Wolf S, Dietrich K, Tonjes A, Breitfeld J, Enigk B, Halbritter J, Korner A, Schon MR, Jenkner J, Tseng YH, Lohmann T, Dressler M, Stumvoll M, Bluher M, Kovacs P (2011). Genetic and evolutionary analyses of the human bone morphogenetic protein receptor 2 (BMPR2) in the pathophysiology of obesity. PLoS One, 6(2), e16155.
     
  559. Philipp A, Kralisch S, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2011). Serum levels of the adipokine zinc-α2-glycoprotein are increased in chronic hemodialysis. Metabolism, 60(5), 669-672.
     
  560. Kralisch S, Fasshauer M (2011). Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease. Curr Opin Clin Nutr Metab Care, 14(4), 354-359.
     
  561. Ebert T, Fasshauer M (2011). Tumor necrosis factor-related apoptosis-inducing ligand and cardiovascular disease. Atherosclerosis, 215(2), 279-280.
     
  562. Baasanjav S, Al-Gazali L, Hashiguchi T, Mizumoto S, Fischer B, Horn D, Seelow D, Ali BR, Aziz SA, Langer R, Saleh AA, Becker C, Nurnberg G, Cantagrel V, Gleeson JG, Gomez D, Michel JB, Stricker S, Lin (2011). Faulty initiation of proteoglycan synthesis causes cardiac and joint defects. Am J Hum Genet, 89(1), 15-27.
     
  563. Sancak S, Jaeschke H, Eren F, Ozlem T, Guellueoglu B, Sen LS, Sever Z, Gozu HI, Bircan R, Akalin S, Paschke R, Eszlinger M (2011). High Prevalence of TSHR/Gsα Mutation-negative Clonal Hot Thyroid Nodules (HNs) in a Turkish Cohort. Horm Metab Res, 43(8), 562-568.
     
  564. Ferraz C, Eszlinger M, Paschke R (2011). Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J Clin Endocrinol Metab, 96(7), 2016-2026.
     
  565. Jaeschke H, Eszlinger M, Lueblinghoff J, Coslovsky R, Paschke R (2011). Prolonged Inappropriate TSH Suppression During Hypothyroidism After Thyroid Ablation in a Patient with Nonautoimmune Familial Hyperthyroidism. Horm Metab Res, 43(7), 500-504.
     
  566. Paschke R (2011). Nodulogenesis and goitrogenesis. Ann Endocrinol (Paris), 72(2), 117-119.
     
  567. Singer J, Eszlinger M, Wicht J, Paschke R (2011). Evidence for a more pronounced effect of genetic predisposition than environmental factors on goitrogenesis by a case control study in an area with low normal iodine supply. Horm Metab Res, 43(5), 349-354.
     
  568. Paschke R, Hegedus L, Alexander E, Valcavi R, Papini E, Gharib H (2011). Thyroid nodule guidelines: agreement, disagreement and need for future research. Nat Rev Endocrinol, 7(6), 354-361.
     
  569. Lincke T, Orschekowski G, Singer J, Sabri O, Paschke R (2011). Increased gallium-68 DOTATOC uptake in normal thyroid glands. Horm Metab Res, 43(4), 282-286.
     
  570. Aust G, Uptaite-Patapoviene M, Scholz M, Richter O, Rohm S, Bluher M (2011). Circulating Nampt and RBP4 levels in patients with carotid stenosis undergoing carotid endarterectomy (CEA). Clin Chim Acta, 412(13-14), 1195-1200.
     
  571. Ebert T, Fasshauer M (2011). Adiponectin: Sometimes Good, Sometimes Bad? Cardiology, 118(4), 236-237.
     
  572. Fangmann J, Kathrin Al-Ali H, Sack U, Kamprad M, Tautenhahn HM, Faber S, Hauss J, Niederwieser D, Lindner T, Bachmann A (2011). Kidney transplant from the same donor without maintenance immunosuppression after previous hematopoietic stem cell transplant. Am J Transplant, 11(1), 156-162.
     
  573. Enigk U, Breitfeld J, Schleinitz D, Dietrich K, Halbritter J, Fischer-Rosinsky A, Enigk B, Muller I, Spranger J, Pfeiffer A, Stumvoll M, Kovacs P, Tonjes A (2011). Role of genetic variation in the human sodium-glucose cotransporter 2 gene (SGLT2) in glucose homeostasis. Pharmacogenomics, 12(8), 1119-1126.
     
  574. Veeramah KR, Tonjes A, Kovacs P, Gross A, Wegmann D, Geary P, Gasperikova D, Klimes I, Scholz M, Novembre J, Stumvoll M (2011). Genetic variation in the Sorbs of eastern Germany in the context of broader European genetic diversity. Eur J Hum Genet, 19(9), 995-1001.
     
  575. Klagge A, Weidinger C, Krause K, Jessnitzer B, Gutknecht M, Fuhrer D (2011). The role of FOXO3 in DNA damage response in thyrocytes. Endocr Relat Cancer, 18(5), 555-564.
     
  576. Weidinger C, Krause K, Mueller K, Klagge A, Fuhrer D (2011). FOXO3 Is Inhibited by Oncogenic PI3K/Akt Signaling but Can Be Reactivated by the NSAID Sulindac Sulfide. J Clin Endocrinol Metab, 96(6), 1361-1371.
     
  577. Mueller S, Szkudlinski MW, Schaarschmidt J, Gunther R, Paschke R, Jaeschke H (2011). Identification of novel TSH interaction sites by systematic binding analysis of the TSHR hinge region. Endocrinology, 152(8), 3268-3278.
     
  578. Halbritter J, Mayer C, Bachmann A, Rasche FM, Uhlmann D, Stumvoll M, Lindner TH (2011). Successful simultaneous pancreas kidney transplantation in maturity-onset diabetes of the young type 5. Transplantation, 92(8), 45-47.
     
  579. Krause K, Prawitt S, Eszlinger M, Ihling C, Sinz A, Schierle K, Gimm O, Dralle H, Steinert F, Sheu SY, Schmid KW, Fuhrer D (2011). Dissecting molecular events in thyroid neoplasia provides evidence for distinct evolution of follicular thyroid adenoma and carcinoma. Am J Pathol, 179(6), 3066-3074.
     
  580. Dietrich K, Birkmeier S, Schleinitz D, Breitfeld J, Enigk B, Muller I, Bottcher Y, Lindner T, Stumvoll M, Tonjes A, Kovacs P (2011). Association and evolutionary studies of the melatonin receptor 1B gene (MTNR1B) in the self-contained population of Sorbs from Germany. Diabet Med, 28(11), 1373-1380.
     
  581. Tonjes A, Wittenburg H, Halbritter J, Renner O, Harsch S, Stange EF, Lammert F, Stumvoll M, Kovacs P (2011). Effects of SLC10A2 variant rs9514089 on gallstone risk and serum cholesterol levels- meta-analysis of three independent cohorts. BMC Med Genet, 12, e149.
     
  582. Hofso D, Jenssen T, Bollerslev J, Ueland T, Godang K, Stumvoll M, Sandbu R, Roislien J, Hjelmesaeth J (2011). Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol, 164(3), e231-238.
     
  583. Fangmann J, Kathrin Al-Ali H, Sack U, Kamprad M, Tautenhahn HM, Faber S, Hauss J, Niederwieser D, Lindner T, Bachmann A (2011). Kidney transplant from the same donor without maintenance immunosuppression after previous hematopoietic stem cell transplant. Am J Transplant, 11(1), 156-162.
     
  584. Ashwal R, Hemi R, Tirosh A, Gordin R, Yissachar E, Cohen-Dayag A, Rosenberg A, Karasik A, Bluher M, Kanety H (2011). Differential expression of novel adiponectin receptor-1 transcripts in skeletal muscle of subjects with normal glucose tolerance and type 2 diabetes. Diabetes, 60(3), 936-946.
     
  585. Porta M, Hainer JW, Jansson SO, Malm A, Bilous R, Chaturvedi N, Fuller JH, Klein R, Orchard T, Parving HH, Sjolie AK (2011). Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled diabetic retinopathy candesartan trials. Diabetologia, 54(6), 1298-1303.
     
  586. Kleinau G, Mueller S, Jaeschke H, Grzesik P, Neumann S, Diehl A, Paschke R, Krause G (2011). Defining structural and functional dimensions of the extracellular thyrotropin receptor region. J Biol Chem, 286(25), 22622-22631.
     
  587. Scholz M, Kaluderovic GN, Kommera H, Paschke R, Will J, Sheldrick WS, Hey-Hawkins E (2011). Carbaboranes as pharmacophores: Similarities and differences between aspirin and asborin. Eur J Med Chem, 46, 1131-1139.
     
  588. Kovsan J, Bluher M, Tarnovscki T, Kloting N, Kirshtein B, Madar L, Shai I, Golan R, Harman-Boehm I, Schon MR, Greenberg AS, Elazar Z, Bashan N, Rudich A (2011). Altered autophagy in human adipose tissues in obesity. J Clin Endocrinol Metab, 96(2), 268-277.
     
  589. Frank-Raue K, Rybicki LA, Erlic Z, Schweizer H, Winter A, Milos I, Toledo SP, Toledo RA, Tavares MR, Alevizaki M, Mian C, Siggelkow H, Hufner M, Wohllk N, Opocher G, Dvorakova S, Bendlova B, Czetwerty (2011). Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Hum Mutat, 32(1), 51-58.
     
  590. Mueller K, Anwander A, Moller HE, Horstmann A, Lepsien J, Busse F, Mohammadi S, Schroeter ML, Stumvoll M, Villringer A, Pleger B (2011). Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging. PLoS One, 6(11), e18544.
     
  591. Horstmann A, Busse FP, Mathar D, Muller K, Lepsien J, Schlogl H, Kabisch S, Kratzsch J, Neumann J, Stumvoll M, Villringer A, Pleger B (2011). Obesity-Related Differences between Women and Men in Brain Structure and Goal-Directed Behavior. Front Hum Neurosci, 5, e58.
     
  592. Sulem P, Gudbjartsson DF, Geller F, Prokopenko I, Feenstra B, Aben KK, Franke B, den Heijer M, Kovacs P, Stumvoll M, Magi R, Yanek LR, Becker LC, Boyd HA, Stacey SN, Walters GB, Jonasdottir A, Thorlei (2011). Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. Hum Mol Genet, 20(10), 2071-2077.
     
  593. Boger CA, Chen MH, Tin A, Olden M, Kottgen A, de Boer IH, Fuchsberger C, O\'Seaghdha CM, Pattaro C, Teumer A, Liu CT, Glazer NL, Li M, O\'Connell JR, Tanaka T, Peralta CA, Kutalik Z, Luan J, Zhao JH, (2011). CUBN is a gene locus for albuminuria. J Am Soc Nephrol, 22(3), 555-570.
     
  594. Friebe D, Neef M, Kratzsch J, Erbs S, Dittrich K, Garten A, Petzold-Quinque S, Bluher S, Reinehr T, Stumvoll M, Bluher M, Kiess W, Korner A (2011). Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia, 54(5), 1200-1211.
     
  595. Erez G, Tirosh A, Rudich A, Meiner V, Schwarzfuchs D, Sharon N, Shpitzen S, Bluher M, Stumvoll M, Thiery J, Fiedler GM, Friedlander Y, Leiterstdorf E, Shai I (2011). Phenotypic and genetic variation in leptin as determinants of weight regain. Int J Obes (Lond), 35(6), 785-792.
     
  596. Nalls MA, Couper DJ, Tanaka T, van Rooij FJ, Chen MH, Smith AV, Toniolo D, Zakai NA, Yang Q, Greinacher A, Wood AR, Garcia M, Gasparini P, Liu Y, Lumley T, Folsom AR, Reiner AP, Gieger C, Lagou V, Fel (2011). Multiple Loci are associated with white blood cell phenotypes. PLoS Genet, 7(6), e1002113.
     
  597. Keuper M, Bluher M, Schon MR, Moller P, Dzyakanchuk A, Amrein K, Debatin KM, Wabitsch M, Fischer-Posovszky P (2011). An inflammatory micro-environment promotes human adipocyte apoptosis. Mol Cell Endocrinol, 339(1-2), 105-113.
     
  598. Friebe D, Neef M, Erbs S, Dittrich K, Kratzsch J, Kovacs P, Bluher M, Kiess W, Korner A (2011). Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children. Int J Pediatr Obes, 6(2-2), 345-352.
     
  599. Korner A, Neef M, Friebe D, Erbs S, Kratzsch J, Dittrich K, Bluher S, Kapellen TM, Kovacs P, Stumvoll M, Bluher M, Kiess W (2011). Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children. Int J Obes (Lond), 35(4), 578-586.
     
  600. Holstein A, Hahn M, Patzer O, Seeringer A, Kovacs P, Stingl J (2011). Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia. Eur J Clin Pharmacol, 67(5), 471-476.
     
  601. Bahr J, Follak N, Kloting N, Wilke B, Haertel B, Kloting I (2011). Iddm1 and Iddm2 Homozygous WOK.4BB Rats Develop Lymphopenia, but no Hyperglycemia like the BB/OK Rats. Exp Clin Endocrinol Diabetes, 119(7), 395-400.
     
  602. Bahr J, Kloting N, Kloting I, Follak N (2011). Transplantation of adipose tissue protects BB/OK rats from type 1 diabetes development. Transpl Immunol, 24(4), 238-240.
     
  603. Windholz J, Kovacs P, Tonjes A, Dittrich K, Bluher S, Kiess W, Stumvoll M, Korner A (2011). Effects of Genetic Variants in ADCY5, GIPR, GCKR and VPS13C on Early Impairment of Glucose and Insulin Metabolism in Children. PLoS One, 6(7), e22101.
     
  604. Ma L, Mondal AK, Murea M, Sharma NK, Tonjes A, Langberg KA, Das SK, Franks PW, Kovacs P, Antinozzi PA, Stumvoll M, Parks JS, Elbein SC, Freedman BI (2011). The Effect of ACACB cis-Variants on Gene Expression and Metabolic Traits. PLoS One, 6(8), e23860.
     
  605. Gross A, Tonjes A, Kovacs P, Veeramah KR, Ahnert P, Roshyara NR, Gieger C, Rueckert IM, Loeffler M, Stoneking M, Wichmann HE, Novembre J, Stumvoll M, Scholz M (2011). Population-genetic comparison of the Sorbian isolate population in Germany with the German KORA population using genome-wide SNP arrays. BMC Genet, 12, e67.
     
  606. Thadhani R, Kisner T, Hagmann H, Bossung V, Noack S, Schaarschmidt W, Jank A, Kribs A, Cornely OA, Kreyssig C, Hemphill L, Rigby AC, Khedkar S, Lindner TH, Mallmann P, Stepan H, Karumanchi SA, Benzing (2011). Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation, 124(8), 940-950.
     
  607. Bahr J, Kloting N, Wilke B, Kloting I, Follak N (2011). High-fat diet protects BB/OK rats from developing type 1 diabetes. Diabetes Metab Res Rev, 27(6), 552-556.
     
  608. Grussendorf M, Reiners C, Paschke R, Wegscheider K (2011). Reduction of Thyroid Nodule Volume by Levothyroxine and Iodine Alone and in Combination: A Randomized, Placebo-Controlled Trial. J Clin Endocrinol Metab, 96(9), e2786.
     
  609. Surakka I, Isaacs A, Karssen LC, Laurila PP, Middelberg RP, Tikkanen E, Ried JS, Lamina C, Mangino M, Igl W, Hottenga JJ, Lagou V, van der Harst P, Mateo Leach I, Esko T, Kutalik Z, Wainwright NW, Str (2011). A genome-wide screen for interactions reveals a new locus on 4p15 modifying the effect of waist-to-hip ratio on total cholesterol. PLoS Genet, 7(10), e1002333.
     
  610. Leichtle AB, Helmschrodt C, Ceglarek U, Shai I, Henkin Y, Schwarzfuchs D, Golan R, Gepner Y, Stampfer MJ, Bluher M, Stumvoll M, Thiery J, Fiedler GM (2011). Effects of a 2-y dietary weight-loss intervention on cholesterol metabolism in moderately obese men. Am J Clin Nutr, 94(5), 1189-1195.
     
  611. Muller K, Fuhrer D, Mittag J, Kloting N, Bluher M, Weiss RE, Many MC, Kurt Werner S, Krohn K (2011). TSH compensates thyroid-specific IGF-I receptor knockout and causes papillary thyroid hyperplasia. Mol Endocrinol, 25(11), 1867-1879.
     
  612. Oberbach A, Bluher M, Wirth H, Till H, Kovacs P, Kullnick Y, Schlichting N, Tomm JM, Rolle-Kampczyk U, Murugaiyan J, Binder H, Dietrich A, Bergen M (2011). Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Proteome Res, 10(10), 4769-4788.
     
  613. Gieger C, Radhakrishnan A, Cvejic A, Tang W, Porcu E, Pistis G, Serbanovic-Canic J, Elling U, Goodall AH, Labrune Y, Lopez LM, Magi R, Meacham S, Okada Y, Pirastu N, Sorice R, Teumer A, Voss K, Zhang (2011). New gene functions in megakaryopoiesis and platelet formation. Nature, 480(7376), 201-208.
     
  614. Engel KM, Schrock K, Teupser D, Holdt LM, Tonjes A, Kern M, Dietrich K, Kovacs P, Krugel U, Scheidt HA, Schiller J, Huster D, Brockmann GA, Augustin M, Thiery J, Bluher M, Stumvoll M, Schoneberg T, Sc (2011). Reduced Food Intake and Body Weight in Mice Deficient for the G Protein-Coupled Receptor GPR82. PLoS One, 6(12), e29400.
     
  615. Schumann G, Coin LJ, Lourdusamy A, Charoen P, Berger KH, Stacey D, Desrivieres S, Aliev FA, Khan AA, Amin N, Aulchenko YS, Bakalkin G, Bakker SJ, Balkau B, Beulens JW, Bilbao A, de Boer RA, Beury D, B (2011). Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc Natl Acad Sci U S A, 108(17), 7119-7124.
     


  616. 2010


  617. Ruschke K, Fishbein L, Dietrich A, Kloting N, Tonjes A, Oberbach A, Fasshauer M, Jenkner J, Schon MR, Stumvoll M, Bluher M, Mantzoros CS (2010). Gene expression of PPARgamma and PGC-1alpha in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training. Eur J Endocrinol, 162(3), 515-523.
     
  618. Reiche M, Bachmann A, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2010). Fibroblast growth factor 19 serum levels: relation to renal function and metabolic parameters. Horm Metab Res, 42(3), 178-181.
     
  619. Karger S, Schotz S, Stumvoll M, Berger F, Fuhrer D (2010). Impact of pregnancy on prevalence of goitre and nodular thyroid disease in women living in a region of borderline sufficient iodine supply. Horm Metab Res, 42(2), 137-142.
     
  620. Stein S, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2010). Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metabolism, 59(1), 33-37.
     
  621. Pfau D, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2010). Serum levels of the adipokine chemerin in relation to renal function. Diabetes Care, 33(1), 171-173.
     
  622. Schleinitz D, Tonjes A, Bottcher Y, Dietrich K, Enigk B, Koriath M, Scholz GH, Bluher M, Zeggini E, McCarthy MI, Kovacs P, Stumvoll M (2010). Lack of significant effects of the type 2 diabetes susceptibility loci JAZF1, CDC123/CAMK1D, NOTCH2, ADAMTS9, THADA, and TSPAN8/LGR5 on diabetes and quantitative metabolic traits. Horm Metab Res, 42(1), 14-22.
     
  623. Tonjes A, Zeggini E, Kovacs P, Bottcher Y, Schleinitz D, Dietrich K, Morris AP, Enigk B, Rayner NW, Koriath M, Eszlinger M, Kemppinen A, Prokopenko I, Hoffmann K, Teupser D, Thiery J, Krohn K, McCarth (2010). Association of FTO variants with BMI and fat mass in the self-contained population of Sorbs in Germany. Eur J Hum Genet, 18(1), 104-110.
     
  624. Eszlinger M, Schmid KW, Paschke R (2010). Clinical implications of molecular studies for the diagnosis of thyroid cancer. Hormones (Athens), 9(1), 51-56.
     
  625. Paschke R, Schmid KW, Gartner R, Mann K, Dralle H, Reiners C (2010). [Epidemiology, pathophysiology, guideline-adjusted diagnostics, and treatment of thyroid nodules] Med Klin (Munich), 105(2), 80-87.
     
  626. Mueller S, Jaeschke H, Gunther R, Paschke R (2010). The hinge region: an important receptor component for GPHR function. Trends Endocrinol Metab, 21(2), 111-122.
     
  627. Bluher M (2010). The distinction of metabolically 'healthy' from 'unhealthy' obese individuals Curr Opin Lipidol, 21(1), 38-43.
     
  628. Muller K, Weidinger C, Fuhrer D (2010). Insulin glargine and insulin have identical effects on proliferation and phosphatidylinositol 3-kinase/AKT signalling in rat thyrocytes and human follicular thyroid cancer cells. Diabetologia, 53(5), 1001-1003.
     
  629. Tonjes A, Bluher M, Stumvoll M (2010). Retinol-binding protein 4 and new adipocytokines in nonalcoholic Fatty liver disease. Curr Pharm Des, 16(17), 1921-1928.
     
  630. Stepan H, Kralisch S, Klostermann K, Schrey S, Reisenbuchler C, Verlohren M, Verlohren HJ, Drynda K, Bluher M, Stumvoll M, Kratzsch J, Kovacs P, Fasshauer M (2010). Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia. Metabolism, 59(7), 1054-1056.
     
  631. Pfau D, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2010). Circulating levels of the adipokine chemerin in gestational diabetes mellitus. Horm Res Paediatr, 74(1), 56-61.
     
  632. Sancak S, Hardt A, Gartner R, Eszlinger M, Aslan A, Eren FT, Gulluoglu BM, Sen LS, Sever Z, Akalin NS, Paschke R (2010). Comparison of Color Flow Doppler Sonography (CFDS) and immunohistologic detection of microvessels for the assessment of the malignancy of thyroid nodules. Horm Metab Res, 42(9), 670-676.
     
  633. Ruschke K, Illes M, Kern M, Kloting I, Fasshauer M, Schon MR, Kosacka J, Fitzl G, Kovacs P, Stumvoll M, Bluher M, Kloting N (2010). Repin1 maybe involved in the regulation of cell size and glucose transport in adipocytes. Biochem Biophys Res Commun, 400(2), 246-251.
     
  634. Sancak S, Hardt A, Singer J, Kloppel G, Eren FT, Gulluoglu BM, Sen LS, Sever Z, Akalin NS, Eszlinger M, Paschke R (2010). Somatostatin receptor 2 expression determined by immunohistochemistry in cold thyroid nodules exceeds that of hot thyroid nodules, papillary thyroid carcinoma, and Graves' disease. Thyroid, 20(5), 505-511.
     
  635. Paschke R, Visser T (2010). Clinical application and consequences of molecular genetics of thyroid diseases. Mol Cell Endocrinol, 322(1-2), 1.
     
  636. Gozu HI, Lublinghoff J, Bircan R, Paschke R (2010). Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism. Mol Cell Endocrinol, 322(1-2), 125-134.
     
  637. Eszlinger M, Paschke R (2010). Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Mol Cell Endocrinol, 322(1-2), 29-37.
     
  638. Sommer G, Kralisch S, Kloting N, Kamprad M, Schrock K, Kratzsch J, Tonjes A, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2010). Visfatin is a positive regulator of MCP-1 in human adipocytes in vitro and in mice in vivo. Obesity (Silver Spring), 18(8), 1486-1492.
     
  639. Weidinger C, Karger S, Krause K, Schierle K, Steinert F, Gimm O, Dralle H, Fuhrer D (2010). Distinct regulation of intrinsic apoptosis in benign and malignant thyroid tumours. Horm Metab Res, 42(8), 553-556.
     
  640. Klagge A, Krause K, Schierle K, Steinert F, Dralle H, Fuhrer D (2010). Somatostatin receptor subtype expression in human thyroid tumours. Horm Metab Res, 42(4), 237-240.
     
  641. Kloting N, Fasshauer M, Dietrich A, Kovacs P, Schon MR, Kern M, Stumvoll M, Bluher M (2010). Insulin-sensitive obesity. Am J Physiol Endocrinol Metab, 299(3), 506-515.
     
  642. Jumpertz R, Wiesner T, Bluher M, Engeli S, Batkai S, Wirtz H, Bosse-Henck A, Stumvoll M (2010). Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea--specific role of oleoylethanolamide. Exp Clin Endocrinol Diabetes, 118(9), 591-595.
     
  643. Singer J, Werner F, Koch CA, Bartels M, Aigner T, Lincke T, Fasshauer M, Paschke R (2010). Ectopic Cushing\'s syndrome caused by a well differentiated ACTH-secreting neuroendocrine carcinoma of the ileum. Exp Clin Endocrinol Diabetes, 118(8), 524-529.
     
  644. Klagge A, Jessnitzer B, Pfaeffle R, Stumvoll M, Fuhrer D (2010). A novel GNAS1 mutation in a German family with Albright's hereditary osteodystrophy. Exp Clin Endocrinol Diabetes, 118(9), 586-590.
     
  645. Bluher M, Zimmer P (2010). [Metabolic and cardiovascular effects of physical activity, exercise and fitness in patients with type 2 diabetes] Dtsch Med Wochenschr, 135(18), 930-934.
     
  646. Ebert T, Fasshauer M (2010). Does pioglitazone directly influence platelet aggregation? Cardiology, 116(4), 251-252.
     
  647. Mueller S, Jaeschke H, Paschke R (2010). Current Standards, Variations, and Pitfalls for the Determination of Constitutive TSHR Activity In Vitro. Methods Enzymol, 485, 421-436.
     
  648. Tonjes A, Kovacs P, Elliott K, Zeggini E, McCarthy MI, Stumvoll M (2010). Reply to dlouha et Al. Eur J Hum Genet, 18(12), 1275.
     
  649. Stepan H, Philipp A, Reiche M, Klostermann K, Schrey S, Reisenbuchler C, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2010). Serum levels of the adipokine lipocalin-2 are increased in preeclampsia. J Endocrinol Invest, 33(9), 629-632.
     
  650. Tonjes A, Fasshauer M, Kratzsch J, Stumvoll M, Bluher M (2010). Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS One, 5, 13911.
     
  651. Paschke R, Wuthe FG, Kuhn K, Jochmann C, Wiedemann P (2010). [Comparison of risk factors and guideline oriented prevention and therapy of diabetic retinopathy between type 2 diabetes patients undergoing laser therapy and type 2 diabetes outpatients]. Med Klin (Munich), 105(11), 772-778.
     
  652. Klagge A, Krause K, Muller K, Haag J, Fuhrer D (2010). High-efficient nonviral transfection of the rat thyroid cell line FRTL-5. Horm Metab Res, 42(12), 897-899.
     
  653. Basara N, Rasche FM, Schwalenberg T, Wickenhauser C, Maier M, Ivovic J, Niederwieser D, Lindner TH (2010). Hydronephrosis Resulting from Bilateral Ureteral Stenosis: A Late Complication of Polyoma BK Virus Cystitis? J Transplant, 2010, e297358.
     
  654. Jaeschke H, Mueller S, Eszlinger M, Paschke R (2010). Lack of in vitro constitutive activity for four previously reported TSH receptor mutations identified in patients with nonautoimmune hyperthyroidism and hot thyroid carcinomas. Clin Endocrinol (Oxf), 73(6), 815-820.
     
  655. Holstein A, Stege H, Kovacs P (2010). Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature. Expert Opin Drug Saf, 9(2), 225-231.
     
  656. Holstein A, Hammer C, Hahn M, Kulamadayil NS, Kovacs P (2010). Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients. Expert Opin Drug Saf, 9(5), 675-681.
     
  657. Bluher M, Stumvoll M, Kahn CR, Ristow M (2010). High baseline vitamin C levels do not prevent a positive outcome of a lifestyle intervention: response to Thamer et al. Diabetes Care, 33(1), e17.
     
  658. Baasanjav S, Jamsheer A, Kolanczyk M, Horn D, Latos T, Hoffmann K, Latos-Bielenska A, Mundlos S (2010). Osteopoikilosis and multiple exostoses caused by novel mutations in LEMD3 and EXT1 genes respectively - coincidence within one family. BMC Med Genet, 11, e110.
     
  659. Rosendahl J, Ronai Z, Kovacs P, Teich N, Wittenburg H, Bluher M, Stumvoll M, Mossner J, Keim V, Bradbury AR, Sahin-Toth M (2010). Sequence analysis of the human tyrosylprotein sulfotransferase-2 gene in subjects with chronic pancreatitis. Pancreatology, 10(2-3), 165-172.
     
  660. Witt H, Rosendahl J, te Morsche RH, Santhosh S, Chacko A, Schulz HU, Landt O, Teich N, Keim V, Mossner J, Gress TM, Ockenga J, Schmidt H, Kovacs P, Bluher M, Stumvoll M, Kage A, Groneberg DA, Jansen J (2010). Mutational analysis of the gene encoding the zymogen granule membrane glycoprotein 2 (GP2) in patients with chronic pancreatitis. Pancreas, 39(2), 188-192.
     
  661. Kolb H, Kempf K, Martin S, Stumvoll M, Landgraf R (2010). On what evidence-base do we recommend self-monitoring of blood glucose? Diabetes Res Clin Pract, 87(2), 150-156.
     
  662. Schleinitz D, Carmienke S, Bottcher Y, Tonjes A, Berndt J, Kloting N, Enigk B, Muller I, Dietrich K, Breitfeld J, Scholz GH, Engeli S, Stumvoll M, Bluher M, Kovacs P (2010). Role of genetic variation in the cannabinoid type 1 receptor gene (CNR1) in the pathophysiology of human obesity. Pharmacogenomics, 11(5), 693-702.
     
  663. Shai I, Spence JD, Schwarzfuchs D, Henkin Y, Parraga G, Rudich A, Fenster A, Mallett C, Liel-Cohen N, Tirosh A, Bolotin A, Thiery J, Fiedler GM, Bluher M, Stumvoll M, Stampfer MJ (2010). Dietary intervention to reverse carotid atherosclerosis. Circulation, 121(10), 1200-1208.
     
  664. Kleinau G, Jaeschke H, Worth CL, Mueller S, Gonzalez J, Paschke R, Krause G (2010). Principles and determinants of G-protein coupling by the rhodopsin-like thyrotropin receptor. PLoS One, 5(3), e9745.
     
  665. Lorenz S, Eszlinger M, Paschke R, Aust G, Weick M, Fuhrer D, Krohn K (2010). Calcium signaling of thyrocytes is modulated by TSH through calcium binding protein expression. Biochim Biophys Acta, 1803(3), 352-360.
     
  666. Hoppmann J, Perwitz N, Meier B, Fasshauer M, Hadaschik D, Lehnert H, Klein J (2010). The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses. J Endocrinol, 204(2), 153-164.
     
  667. Kosel D, Heiker JT, Juhl C, Wottawah CM, Bluher M, Morl K, Beck-Sickinger AG (2010). Dimerization of adiponectin receptor 1 is inhibited by adiponectin. J Cell Sci, 123(8), 1320-1328.
     
  668. Hommel A, Hesse D, Volker W, Jaschke A, Moser M, Engel T, Bluher M, Zahn C, Chadt A, Ruschke K, Vogel H, Kluge R, Robenek H, Joost HG, Schurmann A (2010). The ARF-like GTPase ARFRP1 is essential for lipid droplet growth and is involved in the regulation of lipolysis. Mol Cell Biol, 30(5), 1231-1242.
     
  669. Sixt S, Beer S, Bluher M, Korff N, Peschel T, Sonnabend M, Teupser D, Thiery J, Adams V, Schuler G, Niebauer J (2010). Long- but not short-term multifactorial intervention with focus on exercise training improves coronary endothelial dysfunction in diabetes mellitus type 2 and coronary artery disease. Eur Heart J, 31(1), 112-119.
     
  670. Moreno-Navarrete JM, Martinez-Barricarte R, Catalan V, Sabater M, Gomez-Ambrosi J, Ortega FJ, Ricart W, Bluher M, Fruhbeck G, Rodriguez de Cordoba S, Fernandez-Real JM (2010). Complement factor H is expressed in adipose tissue in association with insulin resistance. Diabetes, 59(1), 200-209.
     
  671. Rosendahl J, Teich N, Kovacs P, Szmola R, Bluher M, Gress TM, Hoffmeister A, Keim V, Lohr M, Mossner J, Nickel R, Ockenga J, Pfutzer R, Schulz HU, Stumvoll M, Wittenburg H, Sahin-Toth M, Witt H (2010). Complete analysis of the human mesotrypsinogen gene (PRSS3) in patients with chronic pancreatitis. Pancreatology, 10(2-3), 243-249.
     
  672. Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F, Sulem P, Rafnar T, Esko T, Walter S, Gieger C, Rawal R, Mangino M, Prokopenko I, Magi R, ... Stumvoll M, ... Stefansson K (2010). Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet, 42(5), 448-453.
     
  673. Bohnekamp J, Boselt I, Saalbach A, Tonjes A, Kovacs P, Biebermann H, Manvelyan HM, Polte T, Gasperikova D, Lkhagvasuren S, Baier L, Stumvoll M, Rompler H, Schoneberg T (2010). Involvement of the chemokine-like receptor GPR33 in innate immunity. Biochem Biophys Res Commun, 396(2), 272-277.
     
  674. Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M, Glazer NL, Parsa A, Gao X, Yang Q, Smith AV, O'Connell JR, Li M, Schmidt H, Tanaka T, Isaacs A, Ketkar S, Hwang SJ, ...Stumvoll M,...Fox CS (2010). New loci associated with kidney function and chronic kidney disease. Nat Genet, 42(5), 376-384.
     
  675. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedus L, Vitti P (2010). American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: Executive Summary of recommendations. J Endocrinol Invest, 33(5), 287-291.
     
  676. Desch S, Sonnabend M, Niebauer J, Sixt S, Sareban M, Eitel I, de Waha S, Thiele H, Bluher M, Schuler G (2010). Effects of physical exercise versus rosiglitazone on endothelial function in coronary artery disease patients with prediabetes. Diabetes Obes Metab, 12(9), 825-828.
     
  677. Heiker JT, Kloting N, Bluher M, Beck-Sickinger AG (2010). Access to gram scale amounts of functional globular adiponectin from E. coli inclusion bodies by alkaline-shock solubilization. Biochem Biophys Res Commun, 398(1), 32-37.
     
  678. Desch S, Kobler D, Schmidt J, Sonnabend M, Adams V, Sareban M, Eitel I, Bluher M, Schuler G, Thiele H (2010). Low vs. higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients. Am J Hypertens, 23(6), 694-700.
     
  679. Cirak S, von Deimling F, Sachdev S, Errington WJ, Herrmann R, Bonnemann C, Brockmann K, Hinderlich S, Lindner TH, Steinbrecher A, Hoffmann K, Prive GG, Hannink M, Nurnberg P, Voit T (2010). Kelch-like homologue 9 mutation is associated with an early onset autosomal dominant distal myopathy. Brain, 133(7), 2123-2135.
     
  680. Weise A, Timmermann B, Grabherr M, Werber M, Heyn P, Kosyakova N, Liehr T, Neitzel H, Konrat K, Bommer C, Dietrich C, Rajab A, Reinhardt R, Mundlos S, Lindner TH, Hoffmann K (2010). High-throughput sequencing of microdissected chromosomal regions. Eur J Hum Genet, 18(4), 457-462.
     
  681. Shahar DR, Schwarzfuchs D, Fraser D, Vardi H, Thiery J, Fiedler GM, Bluher M, Stumvoll M, Stampfer MJ, Shai I (2010). Dairy calcium intake, serum vitamin D, and successful weight loss. Am J Clin Nutr, 92(5), 1017-1022.
     
  682. Kirch W, Gold R, Hensel M, Fasshauer M, Pittrow D, Huscher D, Reiser M, Stangel M, Baumann U, Borte M (2010). [Assessment of immunoglobulins in a long-term non-interventional study (SIGNS Study). Rationale, design, and methods] Med Klin (Munich), 105(9), 647-651.
     
  683. Erlic Z, Ploeckinger U, Cascon A, Hoffmann MM, von Duecker L, Winter A, Kammel G, Bacher J, Sullivan M, Isermann B, Fischer L, Raffel A, Knoefel WT, Schott M, Baumann T, Schaefer O, Keck T, Baum RP, M (2010). Systematic comparison of sporadic and syndromic pancreatic islet cell tumors. Endocr Relat Cancer, 17(4), 875-883.
     
  684. Kursawe R, Eszlinger M, Narayan D, Liu T, Bazuine M, Cali AM, D\'Adamo E, Shaw M, Pierpont B, Shulman GI, Cushman SW, Sherman A, Caprio S (2010). Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis. Diabetes, 59(9), 2288-2296.
     
  685. Oberbach A, Kirsch K, Lehmann S, Schlichting N, Fasshauer M, Zarse K, Stumvoll M, Ristow M, Bluher M, Kovacs P (2010). Serum vaspin concentrations are decreased after exercise-induced oxidative stress. Obes Facts, 3(5), 328-331.
     
  686. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, ... Stumvoll M ...Ingelsson E, Loos RJ (2010). Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet, 42(11), 937-948.
     
  687. Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L, Steinthorsdottir V, Thorleifsson G, ... Stumvoll M ..., Mohlke KL, Lindgren CM (2010). Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet, 42(11), 949-960.
     
  688. Fassnacht M, Johanssen S, Fenske W, Weismann D, Agha A, Beuschlein F, Fuhrer D, Jurowich C, Quinkler M, Petersenn S, Spahn M, Hahner S, Allolio B (2010). Improved Survival in Patients with Stage II Adrenocortical Carcinoma Followed Up Prospectively by Specialized Centers. J Clin Endocrinol Metab, 95(11), 4925-4932.
     
  689. Schleinitz D, Kloting N, Korner A, Berndt J, Reichenbacher M, Tonjes A, Ruschke K, Bottcher Y, Dietrich K, Enigk B, Filz M, Schon MR, Jenkner J, Kiess W, Stumvoll M, Bluher M, Kovacs P (2010). Effect of genetic variation in the human fatty acid synthase gene (FASN) on obesity and fat depot-specific mRNA expression. Obesity (Silver Spring), 18(6), 1218-1225.
     
  690. Ingelsson E, Langenberg C, Hivert MF, Prokopenko I, Lyssenko V, Dupuis J, Magi R, Sharp S, Jackson AU, Assimes TL, Shrader P, Knowles JW, Zethelius B, Abbasi FA, Bergman RN, Bergmann A, Berne C, Boehn (2010). Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes, 59(5), 1266-1275.
     
  691. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL, Lindgren CM, Magi R, Morris AP, Randall J, Johnson T, Elliott P, Rybin D, Thorlei (2010). New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet, 42(2), 105-116.
     
  692. Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, Vollenweider P, Lyssenko V, Bouatia-Naji N, Dupuis J, Jackson AU, Kao WH, Li M, Glazer NL, Manning AK, Luan J, Stringham HM, Prokopenko I, Johns (2010). Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet, 42(2), 142-148.
     
  693. Daly AF, Tichomirowa MA, Petrossians P, Heliovaara E, Jaffrain-Rea ML, Barlier A, Naves LA, Ebeling T, Karhu A, Raappana A, Cazabat L, De Menis E, Montanana CF, Raverot G, Weil RJ, Sane T, Maiter D, N (2010). Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab, 95(1), 373-383.
     
  694. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedus L, Vitti P (2010). American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocr Pract, 16(3), 468-475.
     
  695. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedus L, Vitti P (2010). American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract, 16(S1), 1-43.
     
  696. Borte S, Lanig H, Borte M, Fasshauer M, Sack U (2010). Therapeutic implications of the IL-21: IL-4 receptor system in children with common variable immunodeficiency syndrome. Klin Padiatr, 222(6), 362-367.
     
  697. Bechir M, Meierhans R, Brandi G, Sommerfeld J, Fasshauer M, Cottini SR, Stocker R, Stover JF (2010). Insulin differentially influences brain glucose and lactate in traumatic brain injured patients. Minerva Anestesiol, 76(11), 896-904.
     
  698. Marzi C, Albrecht E, Hysi PG, Lagou V, Waldenberger M, Tonjes A, Prokopenko I, Heim K, Blackburn H, Ried JS, Kleber ME, Mangino M, Thorand B, Peters A, Hammond CJ, Grallert H, Boehm BO, Kovacs P, Geis (2010). Genome-wide association study identifies two novel regions at 11p15.5-p13 and 1p31 with major impact on acute-phase serum amyloid A. PLoS Genet, 6(11), e1001213.
     
  699. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, Vedantam S, Raychaudhuri S, Ferreira T, Wood AR, Weyant RJ, Segre AV, Speliotes EK, Wheeler E, Soranzo N (2010). Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature, 467(6317), 832-838.
     
  700. Ma L, Hanson RL, Traurig MT, Muller YL, Kaur BP, Perez JM, Meyre D, Fu M, Korner A, Franks PW, Kiess W, Kobes S, Knowler WC, Kovacs P, Froguel P, Shuldiner AR, Bogardus C, Baier LJ (2010). Evaluation of A2BP1 as an obesity gene. Diabetes, 59(11), 2837-2845.
     
  701. Scherag A, Dina C, Hinney A, Vatin V, Scherag S, Vogel CI, Muller TD, Grallert H, Wichmann HE, Balkau B, Heude B, Jarvelin MR, Hartikainen AL, Levy-Marchal C, Weill J, Delplanque J, Korner A, Kiess W, (2010). Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups. PLoS Genet, 6(4), e1000916.
     
  702. Oberbach A, Schlichting N, Bluher M, Kovacs P, Till H, Stolzenburg JU, Neuhaus J (2010). Palmitate induced IL-6 and MCP-1 expression in human bladder smooth muscle cells provides a link between diabetes and urinary tract infections. PLoS One, 5(5), e10882.
     
  703. Gonsior A, Pfeiffer H, Fuhrer D, Liatsikos E, Schwalenberg T, Stolzenburg JU (2010). [Adrenal tumors. Principles of diagnostics and operative treatment]. Urologe A, 49(5), 659-668.
     
  704. Nowicki M, Serke H, Kosacka J, Muller K, Spanel-Borowski K (2010). Oxidized low-density lipoprotein (oxLDL) induces cell death in neuroblastoma and survival autophagy in schwannoma cells. Exp Mol Pathol, 89(3), 276-283.
     
  705. Nowicki M, Muller K, Serke H, Kosacka J, Vilser C, Ricken A, Spanel-Borowski K (2010). Oxidized low-density lipoprotein (oxLDL)-induced cell death in dorsal root ganglion cell cultures depends not on the lectin-like oxLDL receptor-1 but on the toll-like receptor-4. J Neurosci Res, 88(2), 403-412.
     
  706. Choi JH, Banks AS, Estall JL, Kajimura S, Bostrom P, Laznik D, Ruas JL, Chalmers MJ, Kamenecka TM, Bluher M, Griffin PR, Spiegelman BM (2010). Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature, 466(7305), 451-456.
     
  707. Mauer J, Chaurasia B, Plum L, Quast T, Hampel B, Bluher M, Kolanus W, Kahn CR, Bruning JC (2010). Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance. PLoS Genet, 6, e1000938.
     
  708. Fernandez-Real JM, Menendez JA, Moreno-Navarrete JM, Bluher M, Vazquez-Martin A, Vazquez MJ, Ortega F, Dieguez C, Fruhbeck G, Ricart W, Vidal-Puig A (2010). Extracellular fatty acid synthase: a possible surrogate biomarker of insulin resistance. Diabetes, 59(6), 1506-1511.
     
  709. Clayton P, Fischer B, Mann A, Mansour S, Rossier E, Veen M, Lang C, Baasanjav S, Kieslich M, Brossuleit K, Gravemann S, Schnipper N, Karbasyian M, Demuth I, Zwerger M, Vaya A, Utermann G, Mundlos S, S (2010). Mutations causing Greenberg dysplasia but not Pelger anomaly uncouple enzymatic from structural functions of a nuclear membrane protein. Nucleus, 1(4), e354-366.
     
  710. Graul-Neumann LM, Kienitz T, Robinson PN, Baasanjav S, Karow B, Gillessen-Kaesbach G, Fahsold R, Schmidt H, Hoffmann K, Passarge E (2010). Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3' terminus of the FBN1-gene. Am J Med Genet A, 152, 2749-2755.
     
  711. Blüher M, Körner A, Kiess W, Stumvoll M (2010). Metabolisches Syndrom. In: Lehnert H, Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. (S. 326-334), Stuttgart: Thieme Verlage.
     
  712. Stumvoll M, Stefan N, Fritsche A, Gallwitz B, Müssig K, Kiess W, Ziegler A, Börschmann M, Hummel M, Körner A (2010). Diabets mellitus. In: Hendrik Lehnert, Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. (S. 335-339), Stuttgart: Thieme Verlage.
     
  713. Paschke R, Scherbaum A (2010). Schilddrüse. In: Greten H; Rinninger F; Greten T, Innere Medizin. (S. 510-527), Stuttgart: Thieme Verlage.
     
  714. Führer D, Krause K (2010). Euthyreote Struma. In: Allolio B, Schulte H, Praktische Endokrinologie (S. 141-145), München: Urban & Fischer.
     
  715. Führer D (2010). Der Schilddrüsenknoten. In: Allolio B, Schulte H, Praktische Endokrinologie. (S. 146-153), München: Urban & Fischer.
     


  716. 2009


  717. Kloting N, Berthold S, Kovacs P, Schon MR, Fasshauer M, Ruschke K, Stumvoll M, Bluher M (2009). MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One, 4(3), e4699.
     
  718. Kralisch S, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2009). Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol, 160(1), 33-38.
     
  719. Aust G, Richter O, Rohm S, Kerner C, Hauss J, Kloting N, Ruschke K, Kovacs P, Youn BS, Bluher M (2009). Vaspin serum concentrations in patients with carotid stenosis. Atherosclerosis, 204(1), 262-266.
     
  720. Linke A, Sonnabend M, Fasshauer M, Hollriegel R, Schuler G, Niebauer J, Stumvoll M, Bluher M (2009). Effects of extended-release niacin on lipid profile and adipocyte biology in patients with impaired glucose tolerance. Atherosclerosis, 205(1), 207-213.
     
  721. Sommer G, Weise S, Kralisch S, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2009). Lipocalin-2 is induced by interleukin-1beta in murine adipocytes in vitro. J Cell Biochem, 106(1), 103-108.
     
  722. Stein S, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2009). Serum levels of the adipokine FGF21 depend on renal function. Diabetes Care, 32(1), 126-128.
     
  723. Wiedmann MW, Mossner J, Stumvoll M, Fuhrer D (2009). Case report: extreme CgA elevation under PPI confounding assessment of adrenal mass. Z Gastroenterol, 47(7), 671-673.
     
  724. Ebert T, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2009). Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis. Metabolism, 58(4), 547-551.
     
  725. Stepan H, Ebert T, Schrey S, Reisenbuchler C, Bluher M, Stumvoll M, Kratzsch J, Tonnessen P, Faber R, Fasshauer M (2009). Preliminary report: Serum levels of retinol-binding protein 4 in preeclampsia. Metabolism, 58(3), 275-277.
     
  726. Sommer G, Kralisch S, Stangl V, Vietzke A, Kohler U, Stepan H, Faber R, Schubert A, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2009). Secretory products from human adipocytes stimulate proinflammatory cytokine secretion from human endothelial cells. J Cell Biochem, 106(4), 729-737.
     
  727. Stepan H, Ebert T, Schrey S, Reisenbuchler C, Stein S, Lossner U, Bluher M, Stumvoll M, Kratzsch J, Faber R, Fasshauer M (2009). Serum levels of angiopoietin-related growth factor are increased in preeclampsia. Am J Hypertens, 22(3), 314-318.
     
  728. Youn BS, Bang SI, Kloting N, Park JW, Lee N, Oh JE, Pi KB, Lee TH, Ruschke K, Fasshauer M, Stumvoll M, Bluher M (2009). Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes, 58(3), 627-636.
     
  729. Hegedus L, Brix TH, Paschke R (2009). Etiology of simple goiter. Editorial. Thyroid, 19(3), 209-211.
     
  730. Karger S, Weidinger C, Krause K, Sheu SY, Aigner T, Gimm O, Schmid KW, Dralle H, Fuhrer D (2009). FOXO3a: a novel player in thyroid carcinogenesis? Endocr Relat Cancer, 16(1), 189-199.
     
  731. Kralisch S, Sommer G, Weise S, Lipfert J, Lossner U, Kamprad M, Schrock K, Bluher M, Stumvoll M, Fasshauer M (2009). Interleukin-1beta is a positive regulator of TIARP/STAMP2 gene and protein expression in adipocytes in vitro. FEBS Lett, 583(7), 1196-1200.
     
  732. Stumvoll M, Bogardus C (2009). Glucose allostasis: disrobing common wisdom. Diabetologia, 52(5), 779-780.
     
  733. Kralisch S, Weise S, Sommer G, Lipfert J, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2009). Interleukin-1ss induces the novel adipokine chemerin in adipocytes in vitro. Regul Pept, 154(1-3), 102-106.
     
  734. Ristow M, Zarse K, Oberbach A, Kloting N, Birringer M, Kiehntopf M, Stumvoll M, Kahn CR, Bluher M (2009). Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A, 106(21), 8665-8670.
     
  735. Hoffmann K, Planitz C, Ruschendorf F, Muller-Myhsok B, Stassen HH, Lucke B, Mattheisen M, Stumvoll M, Bochmann R, Zschornack M, Wienker TF, Nurnberg P, Reis A, Luft FC, Lindner TH (2009). A novel locus for arterial hypertension on chromosome 1p36 maps to a metabolic syndrome trait cluster in the Sorbs, a Slavic population isolate in Germany. J Hypertens, 27(5), 983-990.
     
  736. Lincke T, Singer J, Kluge R, Sabri O, Paschke R (2009). Relative quantification of indium-111 pentetreotide and gallium-68 DOTATOC uptake in the thyroid gland and association with thyroid pathologies. Thyroid, 19(4), 381-389.
     
  737. Mueller S, Kleinau G, Szkudlinski MW, Jaeschke H, Krause G, Paschke R (2009). The Superagonistic Activity of Bovine Thyroid-stimulating Hormone (TSH) and the Human TR1401 TSH Analog Is Determined by Specific Amino Acids in the Hinge Region of the Human TSH Receptor. J Biol Chem, 284(24), 16317-16324.
     
  738. Bluher M (2009). Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes, 117(2), 241-250.
     
  739. Karger S, Fuhrer-Sakel D (2009). [Thyroid diseases and pregnancy] Med Klin (Munich), 104(6), 450-456.
     
  740. Sterker I, Tegetmeyer H, Papsdorf K, Fuhrer-Sakel D (2009). Effect of combined intravenous glucocorticoids and orbital radiotherapy in restoring driving competency in patients with Graves\' orbitopathy. Horm Metab Res, 41(5), 391-396.
     
  741. Bluher M, Bashan N, Shai I, Harman-Boehm I, Tarnovscki T, Avinaoch E, Stumvoll M, Dietrich A, Kloting N, Rudich A (2009). Activated Ask1-MKK4-p38MAPK/JNK stress signaling pathway in human omental fat tissue may link macrophage infiltration to whole-body Insulin sensitivity. J Clin Endocrinol Metab, 94(7), 2507-2515.
     
  742. Mueller S, Gozu HI, Bircan R, Jaeschke H, Eszlinger M, Lueblinghoff J, Krohn K, Paschke R (2009). Cases of borderline in vitro constitutive thyrotropin receptor activity: how to decide whether a thyrotropin receptor mutation is constitutively active or not? Thyroid, 19(7), 765-773.
     
  743. Krause K, Jessnitzer B, Fuhrer D (2009). Proteomics in thyroid tumor research. J Clin Endocrinol Metab, 94(8), 2717-2724.
     
  744. Stumvoll M, Nawroth PP (2009). The insulin glargine dilemma: an opportunity for the diabetes community? Diabetologia, 52(10), 1987-1989.
     
  745. Halbritter J, Mayer C, Rasche FM, Amann K, Lindner TH (2009). [Interstitial nephritis] Internist (Berl), 50(9), 1111-1125.
     
  746. Sommer G, Kralisch S, Lipfert J, Weise S, Krause K, Jessnitzer B, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2009). Amyloid precursor protein expression is induced by tumor necrosis factor alpha in 3T3-L1 adipocytes. J Cell Biochem, 108(6), 1418-1422.
     
  747. Paschke R (2009). [Diagnostic work-up of euthyroid nodules: which nodules should undergo fine-needle aspiration biopsy? Relevance of ultrasound] Dtsch Med Wochenschr, 134(49), 2498-2503.
     
  748. Sancak S, Hardt A, Ricken A, Lorenz S, Eszlinger M, Sen LS, Gulluoglu BM, Sever Z, Eren FT, Akalin NS, Paschke R (2009). Increased percentage of microvessels but decreased density of large vessels in papillary carcinomas as compared to hot and cold thyroid nodules. Exp Clin Endocrinol Diabetes, 117(10), 637-644.
     
  749. Tonjes A, Koriath M, Schleinitz D, Dietrich K, Bottcher Y, Rayner NW, Almgren P, Enigk B, Richter O, Rohm S, Fischer-Rosinsky A, Pfeiffer A, Hoffmann K, Krohn K, Aust G, Spranger J, Groop L, Bluher M, (2009). Genetic variation in GPR133 is associated with height: genome wide association study in the self-contained population of Sorbs. Hum Mol Genet, 18(23), 4662-4668.
     
  750. Percik R, Stumvoll M (2009). Obesity and cancer. Exp Clin Endocrinol Diabetes, 117(10), 563-566.
     
  751. Paschke R, Papini E, Gharib H (2009). Guideline-oriented diagnosis of thyroid nodules. Touch Briefings, 10, 59-63.
     
  752. Blüher M (2009). Verbund ADIPOSE TARGET - Targeting adipose tissue dysfunction. Adipositas, 3(2), 104-105.
     
  753. Fasshauer M, Blüher M (2009). Adipokine: Rolle in der Pathophysiologie und Therapie von Adipositas und Typ 2 Diabetes mellitus. LaboratoriumsMedizin, 33(1), 1-6.
     
  754. Blüher M (2009). Das metabolische Syndrom und die Eizelle. J Reproduktionsmed Endokrinol, 6(S1), 4-9.
     
  755. Busse-Voigt FP, Kiess W, Stumvoll M, Hering N, Kapellen TM (2009). [Building bridges during transition of patients with type 1 diabetes. Adult medical and pediatric point of views] Internist (Berl), 50(10), 1194-1201.
     
  756. Beige J, Heipmann K, Stumvoll M, Korner A, Kratzsch J (2009). Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiology. Expert Opin Ther Targets, 13(2), 163-173.
     
  757. Sheu SY, Grabellus F, Schwertheim S, Mann K, Ensinger C, Ofner D, Bockhorn M, Fuhrer D, Schmid KW (2009). COX-2 expression in highly aggressive thyroid malignancies - indication for a possible therapeutic option? Horm Metab Res, 41(4), 314-319.
     
  758. Oleszczuk A, Spannbauer MM, Bluher M, Ott R, Pietsch UC, Schneider K, Madaj-Sterba P, Furll M, Hauss JP, Schon MR (2009). Percutaneous intragastric catheter (PIC) for administration of an unpalatable substance to large animals. J Invest Surg, 22(2), 122-128.
     
  759. Holstein A, Hahn M, Stumvoll M, Kovacs P (2009). The E23K variant of KCNJ11 and the risk for severe sulfonylurea-induced hypoglycemia in patients with type 2 diabetes. Horm Metab Res, 41(5), 387-390.
     
  760. Seifert W, Beninde J, Hoffmann K, Lindner TH, Bassir C, Aksu F, Hübner C, Verbeek NE, Mundlos S, Horn D (2009). HPGD mutations cause cranioosteoarthropathy but not autosomal dominant digital clubbing. Eur J Hum Genet, 17(12), 1570-1576.
     
  761. Scherneck S, Nestler M, Vogel H, Bluher M, Block MD, Diaz MB, Herzig S, Schulz N, Teichert M, Tischer S, Al-Hasani H, Kluge R, Schurmann A, Joost HG (2009). Positional cloning of zinc finger domain transcription factor Zfp69, a candidate gene for obesity-associated diabetes contributed by mouse locus Nidd/SJL. PLoS Genet, 5(7), e1000541.
     
  762. Baguhl R, Wilke B, Kloting N, Kloting I (2009). Genes on rat chromosomes 3, 5, 10, and 16 are linked with facets of metabolic syndrome. Obesity (Silver Spring), 17(6), 1215-1219.
     
  763. Huppertz A, Wildung D, Kemp BJ, Nentwig T, Asbach P, Rasche FM, Hamm B (2009). Nondestructive insights into composition of the sculpture of Egyptian Queen Nefertiti with CT. Radiology, 251(1), 233-240.
     
  764. Czock D, Rasche FM, Boesler B, Shipkova M, Keller F (2009). Irinotecan in cancer patients with end-stage renal failure. Ann Pharmacother, 43(2), 363-369.
     
  765. Zhang Y, Huypens P, Adamson AW, Chang JS, Henagan TM, Boudreau A, Lenard NR, Burk D, Klein J, Perwitz N, Shin J, Fasshauer M, Kralli A, Gettys TW (2009). Alternative mRNA splicing produces a novel biologically active short isoform of PGC-1alpha. J Biol Chem, 284(47), 32813-32826.
     
  766. Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ (2009). Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet, 373(9681), 2125-2135.
     
  767. Bottcher Y, Unbehauen H, Kloting N, Ruschke K, Korner A, Schleinitz D, Tonjes A, Enigk B, Wolf S, Dietrich K, Koriath M, Scholz GH, Tseng YH, Dietrich A, Schon MR, Kiess W, Stumvoll M, Bluher M, Kovac (2009). Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity. Diabetes, 58(9), 2119-2128.
     
  768. Kraemer S, Rothe K, Pfaeffle R, Fuehrer-Sakel D, Till H, Muensterer OJ (2009). Activating TSH-receptor mutation (Met453Thr) as a cause of adenomatous non-autoimmune hyperthyroidism in a 3-year-old boy. J Pediatr Endocrinol Metab, 22(3), 269-274.
     
  769. Mühlberg KS, Paschke R (2009). Iodine-induced Hyperthyroidism. In: Preddy V, The Comprehensive Handbook on Iodine. (S. 887-896), Oxford: Academic Press.
     
  770. Brauer VFH, Paschke R (2009). The relationship between population iodine statistics to iodine status of individuals. In: Preddy V, The Comprehensive Handbook on Iodine. (S. 411-420), Oxford: Academic Press.
     
  771. Krohn K, Paschke R (2009). Iodine deficiency, antioxidant responde and mutagenesis. In: Preddy V, The Comprehensive Handbook on Iodine. (S. 549-558), Oxford: Academic Press.
     


  772. 2008


  773. Kovacs P, Kress R, Rocha J, Kurtz U, Miquel JF, Nervi F, Mendez-Sanchez N, Uribe M, Bock HH, Schirin-Sokhan R, Stumvoll M, Mossner J, Lammert F, Wittenburg H (2008). Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans. J Hepatol, 48(1), 116-124.
     
  774. Kloting N, Schleinitz D, Ruschke K, Berndt J, Fasshauer M, Tonjes A, Schon MR, Kovacs P, Stumvoll M, Bluher M (2008). Inverse relationship between obesity and FTO gene expression in visceral adipose tissue in humans. Diabetologia, 51(4), 641-647.
     
  775. Mayer C, Bottcher Y, Kovacs P, Halbritter J, Stumvoll M (2008). Phenotype of a patient with a de novo mutation in the hepatocyte nuclear factor 1beta/maturity-onset diabetes of the young type 5 gene. Metabolism, 57(3), 416-420.
     
  776. Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H (2008). Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function. Eur J Endocrinol, 158(2), 197-201.
     
  777. Youn BS, Kloting N, Kratzsch J, Lee N, Park JW, Song ES, Ruschke K, Oberbach A, Fasshauer M, Stumvoll M, Bluher M (2008). Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes, 57(2), 372-377.
     
  778. Seeger J, Ziegelmeier M, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2008). Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab, 93(1), 247-251.
     
  779. Kralisch S, Sommer G, Stangl V, Kohler U, Kratzsch J, Stepan H, Faber R, Schubert A, Lossner U, Vietzke A, Bluher M, Stumvoll M, Fasshauer M (2008). Secretory products from human adipocytes impair endothelial function via nuclear factor kappaB. Atherosclerosis, 196(2), 523-531.
     
  780. Karger S, Fuhrer D (2008). [Thyroid storm--thyrotoxic crisis: an update] Dtsch Med Wochenschr, 133(10), 479-484.
     
  781. Fasshauer M, Seeger J, Waldeyer T, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H (2008). Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia. Am J Hypertens, 21(5), 582-586.
     
  782. Mayer C, Muller A, Halbritter J, Wirtz H, Stumvoll M (2008). Isolated renal relapse of sarcoidosis under low-dose glucocorticoid therapy. J Gen Intern Med, 23(6), 879-882.
     
  783. Busse F, Omidi L, Timper K, Leichtle A, Windgassen M, Kluge E, Stumvoll M (2008). Lead poisoning due to adulterated marijuana. N Engl J Med, 358(15), 1641-1642.
     
  784. Fuhrer D, Zysset S, Stumvoll M (2008). Brain activity in hunger and satiety: an exploratory visually stimulated FMRI study. Obesity (Silver Spring), 16(5), 945-950.
     
  785. Berndt J, Kralisch S, Kloting N, Ruschke K, Kern M, Fasshauer M, Schon MR, Stumvoll M, Bluher M (2008). Adipose triglyceride lipase gene expression in human visceral obesity. Exp Clin Endocrinol Diabetes, 116(4), 203-210.
     
  786. Krause K, Eszlinger M, Gimm O, Karger S, Engelhardt C, Dralle H, Fuhrer D (2008). TFF3-based candidate gene discrimination of benign and malignant thyroid tumors in a region with borderline iodine deficiency. J Clin Endocrinol Metab, 93(4), 1390-1393.
     
  787. Bircan R, Miehle K, Mladenova G, Ivanova R, Ivanova R, Sarafova A, Borissova AM, Lublinghoff J, Paschke R (2008). Multiple Relapses of Hyperthyroidism after Thyroid Surgeries in a Patient with Long Term Follow-up of Sporadic Non-autoimmune Hyperthyroidism. Exp Clin Endocrinol Diabetes, 116(6), 341-346.
     
  788. Gozu HI, Mueller S, Bircan R, Krohn K, Ekinci G, Yavuzer D, Sargin H, Sargin M, Ones T, Gezen C, Orbay E, Cirakoglu B, Paschke R (2008). A New Silent Germline Mutation of the TSH Receptor: Coexpression in a Hyperthyroid Family Member with a Second Activating Somatic Mutation. Thyroid, 18(5), 499-508.
     
  789. Paschke R (2008). Autonomie der Schilddrüse und seltene Formen der nicht autoimmunen Hyperthyreose Med Welt, 59(11), 435-440.
     
  790. Stumvoll M, Goldstein BJ, van Haeften TW (2008). Type 2 diabetes: pathogenesis and treatment. Lancet, 371(9631), 2153-2156.
     
  791. Weise S, Kralisch S, Sommer G, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2008). Tissue inhibitor of metalloproteinase-1 mRNA production and protein secretion are induced by interleukin-1 beta in 3T3-L1 adipocytes. J Endocrinol, 198(1), 169-174.
     
  792. Bluher M, Tonjes A, Stumvoll M (2008). Does retinol-binding protein 4 cause or reflect fatty liver disease? Hepatology, 48(1), 4-6.
     
  793. Sommer G, Weise S, Kralisch S, Scherer PE, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2008). The adipokine SAA3 is induced by interleukin-1beta in mouse adipocytes. J Cell Biochem, 104(6), 2241-2247.
     
  794. Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H (2008). Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol (Oxf), 69(1), 69-73.
     
  795. Kloting N, Koch L, Wunderlich T, Kern M, Ruschke K, Krone W, Brüning JC, Blüher M (2008). Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth. Diabetes, 57(8), 2074-2082.
     
  796. Mueller S, Kleinau G, Jaeschke H, Paschke R, Krause G (2008). Extended hormone binding site of the human thyroid stimulating hormone receptor: distinctive acidic residues in the hinge region are involved in bovine thyroid stimulating hormone binding and receptor activation. J Biol Chem, 283(26), 18048-18055.
     
  797. Kovacs P, Berndt J, Ruschke K, Kloting N, Schon MR, Korner A, Stumvoll M, Bluher M (2008). TCF7L2 gene expression in human visceral and subcutaneous adipose tissue is differentially regulated but not associated with type 2 diabetes mellitus. Metabolism, 57(9), 1227-1231.
     
  798. Oberbach A, Lehmann S, Kirsch K, Krist J, Sonnabend M, Linke A, Tonjes A, Stumvoll M, Bluher M, Kovacs P (2008). Long-term exercise training decreases interleukin-6 (IL-6) serum levels in subjects with impaired glucose tolerance: effect of the -174G/C variant in IL-6 gene. Eur J Endocrinol, 159(2), 129-136.
     
  799. Eszlinger M, Krohn K, Hauptmann S, Dralle H, Giordano TJ, Paschke R (2008). Perspectives for improved and more accurate classification of thyroid epithelial tumors. J Clin Endocrinol Metab, 93(9), 3286-3294.
     
  800. Krause K, Karger S, Sheu SY, Aigner T, Kursawe R, Gimm O, Schmid KW, Dralle H, Fuhrer D (2008). Evidence for a role of the amyloid precursor protein in thyroid carcinogenesis. J Endocrinol, 198(2), 291-299.
     
  801. Bluher M (2008). The inflammatory process of adipose tissue. Pediatr Endocrinol Rev, 6(1), 24-31.
     
  802. Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2008). Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis. Metabolism, 57(10), 1414-1421.
     
  803. Fasshauer M, Seeger J, Waldeyer T, Schrey S, Ebert T, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H (2008). Endogenous soluble receptor for advanced glycation endproducts is increased in preeclampsia. J Hypertens, 26(9), 1824-1828.
     
  804. Gharib H, Papini E, Paschke R (2008). Thyroid nodules: a review of current guidelines, practices, and prospects. Eur J Endocrinol, 159(5), 493-505.
     
  805. Sommer G, Garten A, Petzold S, Beck-Sickinger AG, Bluher M, Stumvoll M, Fasshauer M (2008). Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clin Sci (Lond), 115(1), 13-23.
     
  806. Busse F, Fuhrer D, Stumvoll M, Schneider JP, Neid M, Kluge R, Sterker I (2008). Metastasis of neuroendocrine colon carcinoma mimicking Graves' ophthalmopathy. Thyroid, 18(11), 1237-1238.
     
  807. Sommer G, Ziegelmeier M, Bachmann A, Kralisch S, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2008). Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD). Clin Endocrinol (Oxf), 69(6), 901-905.
     
  808. Kralisch S, Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2008). Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease. Atherosclerosis, 199(2), 440-444.
     
  809. Bluher M, Hamann A (2008). Adipositas und metabolisches Syndrom Diabetologie und Stoffwechsel, 3(1), 1-18.
     
  810. Karger S, Totsch M, Krause K, Fuhrer D (2008). [Thy thyroid nodule--differential diagnostics and treatment concepts] Med Klin (Munich), 103(8), 575-588.
     
  811. Weidinger C, Krause K, Klagge A, Karger S, Fuhrer D (2008). Forkhead box-O transcription factor: critical conductors of cancer\'s fate. Endocr Relat Cancer, 15(4), 917-929.
     
  812. Fuhrer D, Han S, Ludgate M (2008). Enhancement of Glycoprotein Hormone Alpha Subunit Promoter Reporter Gene Activity in Co-transfection Studies - A Cautionary Reminder. Horm Metab Res, 40(11), 787-793.
     
  813. Bluher M (2008). Efficacy and safety of the weight-loss drug rimonabant. Lancet, 371(9612), 555-556.
     
  814. Blüher M (2008). Rolle des Fettgewebes in der Pathogenese des Typ 2 Diabetes. Diabetologie und Stoffwechsel, 3(4), 225-228.
     
  815. Bluher M (2008). Adipositas Grad III. Herzmedizin, 25, 43-46.
     
  816. Bluher M (2008). Fat Tissue and Long Life. Obestiy Facts, 1(4), 176-182.
     
  817. Bluher M (2008). Innovative Behandlungskonzepte des Typ 2 Diabetes. Klinikarzt, 37(12), 588-593.
     
  818. Jaeschke H, Kleinau G, Sontheimer J, Mueller S, Krause G, Paschke R (2008). Preferences of transmembrane helices for cooperative amplification of G(alpha)s and G (alpha)q signaling of the thyrotropin receptor. Cell Mol Life Sci, 65(24), 4028-4038.
     
  819. Busse FP , Fiedler GM , Leichtle A, Hentschel H, Stumvoll M (2008). Bleiintoxikationen durch gestecktes Marihuana in Leipzig Deutsches Ärzteblatt, 105(44), 757-762.
     
  820. Karger S, Krause K, Tötsch M, Weidinger C, Fuhrer D (2008). Rationelle Differenzialdiagnostik des Schilddrüsenknotens. CME Innere Medizin , 1(1), 2-16.
     
  821. Rosendahl J, Witt H, Szmola R, Bhatia E, Ozsvari B, Landt O, Schulz HU, Gress TM, Pfutzer R, Lohr M, Kovacs P, Bluher M, Stumvoll M, Choudhuri G, Hegyi P, te Morsche RH, Drenth JP, Truninger K, Macek (2008). Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet, 40(1), 78-82.
     
  822. Kemmer F, Halle M, Stumvoll M, Thurm U, Zimmer P (2008). Diabetes, Sport und Bewegung. Diabetologie, 3(supll2), 191-194.
     
  823. Korner A, Kiess W, Stumvoll M, Kovacs P (2008). Polygenic contribution to obesity: genome-wide strategies reveal new targets. Front Horm Res, 36, 12-36.
     
  824. Werner M, Tonjes A, Stumvoll M, Thiery J, Kratzsch J (2008). Assay-dependent variability of serum insulin levels during oral glucose tolerance test: influence on reference intervals for insulin and on cut-off values for insulin sensitivity indices. Clin Chem Lab Med, 46(2), 240-246.
     
  825. Westphal S, Perwitz N, Iwen KA, Kraus D, Schick R, Fasshauer M, Klein J (2008). Expression of ATRAP in Adipocytes and Negative Regulation by beta-Adrenergic Stimulation of JAK/STAT. Horm Metab Res, 40(3), 165-171.
     
  826. Bottcher Y, Schleinitz D, Tonjes A, Bluher M, Stumvoll M, Kovacs P (2008). R1467H variant in the rho guanine nucleotide exchange factor 11 (ARHGEF11) is associated with impaired glucose tolerance and type 2 diabetes in German Caucasians. J Hum Genet, 53(4), 365-367.
     
  827. Cantagrel V, Silhavy JL, Bielas SL, Swistun D, Marsh SE, Bertrand JY, Audollent S, Attie-Bitach T, Holden KR, Dobyns WB, Traver D, Al-Gazali L, Ali BR, Lindner TH, Caspary T, Otto EA, Hildebrandt F, G (2008). Mutations in the cilia gene ARL13B lead to the classical form of Joubert syndrome. Am J Hum Genet, 83(2), 170-179.
     
  828. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, Brickner D, Schwartz Z, Sheiner E, Marko R, Katorza (2008). Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med, 359(3), 229-241.
     
  829. Dietrich A, Mueller T, Paschke R, Kalinowski B, Behlendorf T, Reipsch F, Fruehauf A, Schmoll HJ, Kloft C, Voigt W (2008). 2-(4-(tetrahydro-2H-pyran-2-yloxy)-undecyl)-propane-1,3-diamminedichloroplatinum(II): A Novel Platinum Compound that Overcomes Cisplatin Resistance and Induces Apoptosis by Mechanisms Different from that of Cisplatin. J Med Chem, 51(17), 5413-5422.
     
  830. Hokema F, Pietsch UC, Fuhrer D, Kaisers U (2008). [Anesthesia and bodybuilding] Anasthesiol Intensivmed Notfallmed Schmerzther, 43(3), 354-358.
     
  831. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, Fischer-Posovszky P, Barth TF, Dragun D, Skurk T, Hauner H, Bluher M, Unger T, Wolf AM, Knippschild U, Hombach V, Marx N (2008). T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol, 28(7), 1304-1310.
     
  832. Georgitsi M, Heliovaara E, Paschke R, Kumar AV, Tischkowitz M, Vierimaa O, Salmela P, Sane T, De Menis E, Cannavo S, Gundogdu S, Lucassen A, Izatt L, Aylwin S, Bano G, Hodgson S, Koch CA, Karhu A, Aal (2008). Large genomic deletions in AIP in pituitary adenoma predisposition. J Clin Endocrinol Metab, 93(10), 4146-4151.
     
  833. Georgitsi M, De Menis E, Cannavo S, Makinen MJ, Tuppurainen K, Pauletto P, Curto L, Weil RJ, Paschke R, Zielinski G, Wasik A, Lubinski J, Vahteristo P, Karhu A, Aaltonen LA (2008). Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas. Clin Endocrinol (Oxf), 69(4), 621-627.
     
  834. Kleinau G, Jaeschke H, Mueller S, Raaka BM, Neumann S, Paschke R, Krause G (2008). Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor. FASEB J, 22(8), 2798-2808.
     
  835. Kleinau G, Jaeschke H, Mueller S, Worth CL, Paschke R, Krause G (2008). Molecular and structural effects of inverse agonistic mutations on signaling of the thyrotropin receptor--a basally active GPCR. Cell Mol Life Sci, 65(22), 3664-3676.
     
  836. Kovacs P, Kress R, Rocha J, Kurtz U, Miquel JF, Nervi F, Mendez-Sanchez N, Uribe M, Bock HH, Schirin-Sokhan R, Stumvoll M, Mossner J, Lammert F, Wittenburg H (2008). Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans. J Hepatol, 48(1), 116-124.
     
  837. Kindler S, Siegemund T, Fuhrer D, Petros S (2008). Thrombin generation assay in a patient with acquired factor V inhibitor. J Thromb Haemost, 6(11), 1985-1987.
     
  838. Fischer-Rosinsky A, Fisher E, Kovacs P, Bluher M, Mohlig M, Pfeiffer AF, Boeing H, Spranger J (2008). Lack of association between the tagging SNP A+930-->G of SOCS3 and type 2 diabetes mellitus: meta-analysis of four independent study populations. PLoS ONE, 3(12), 3852-3855.
     
  839. Fritzsche K, Bluher M, Schering S, Buchwalow IB, Kern M, Linke A, Oberbach A, Adams V, Punkt K (2008). Metabolic profile and nitric oxide synthase expression of skeletal muscle fibers are altered in patients with type 1 diabetes. Exp Clin Endocrinol Diabetes, 116(10), 606-613.
     
  840. Blüher S, Münsterer O, Beckert-Zieglschmid C, Rohde C, Blüher M, Stumvoll M, Klitzing K, Till H, Kiess W (2008). Adipositaschirurgie bei morbid adipösen Jugendlichen - Vorschlag für ein interdisziplinäres Konzept Adipositas, 2(1), 36-40.
     
  841. Benzinou M, Creemers JW, Choquet H, Lobbens S, Dina C, Durand E, Guerardel A, Boutin P, Jouret B, Heude B, Balkau B, Tichet J, Marre M, Potoczna N, Horber F, Le Stunff C, Czernichow S, Sandbaek A, Lau (2008). Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet, 40(8), 943-945.
     
  842. Stumvoll M, Goldstein Barry J, van Haeften TW (2008). Pathogenesis of Type 2 Diabetes. In: Goldstein Barry J, Müller-Wieland D, Type 2 Diabets Principles and Practice. (S. 13-26), New York: Informa Healthcare .
     
  843. Stumvoll M, Häring H-U, Matthaei S (2008). Metformin. In: Goldstein Barry J, Müller-Wieland D, Type 2 Diabets Principles and Practice. (S. 107-120), New York: Informa Healthcare.
     
  844. Karger S, Fuhrer D (2008). Die thyreotoxische Krise. In: Eckart Forst Burchardi, Intensivmedizin. (S. 9-15), Hamburg: Akademos Verlag.
     


  845. 2007


  846. Korner A, Ma L, Franks PW, Kiess W, Baier LJ, Stumvoll M, Kovacs P (2007). Sex-specific effect of the Val1483Ile polymorphism in the fatty acid synthase gene (FAS) on body mass index and lipid profile in Caucasian children. Int J Obes (Lond), 31(2), 353-358.
     
  847. Bluher M, Brennan AM, Kelesidis T, Kratzsch J, Fasshauer M, Kralisch S, Williams CJ, Mantzoros CS (2007). Total and High-Molecular Weight Adiponectin in Relation to Metabolic Variables at Baseline and in Response to an Exercise Treatment Program: Comparative evaluation of three assays. Diabetes Care, 30(2), 280-285.
     
  848. Stumvoll M (2007). Insulinresistenz: Kombination von Rosiglitazon und Fenofibrat vorteilhaft. (Kommentar) Diabetologie, 2(1), 84.
     
  849. Fasshauer M, Bluher M, Stumvoll M, Tonessen P, Faber R, Stepan H (2007). Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol (Oxf), 66(3), 434-439.
     
  850. Kralisch S, Bluher M, Tonjes A, Lossner U, Paschke R, Stumvoll M, Fasshauer M (2007). Tissue inhibitor of metalloproteinase-1 predicts adiposity in humans. Eur J Endocrinol, 156(2), 257-261.
     
  851. Busse FP, Denti V, Stumvoll M (2007). Awareness of pathophysiological concepts of type 2 diabetes-A survey in 847 physicians. Diabetes Res Clin Pract, 76(3), 445-448.
     
  852. Kralisch S, Bluher M, Paschke R, Stumvoll M, Fasshauer M (2007). Adipokines and adipocyte targets in the future management of obesity and the metabolic syndrome. Mini Rev Med Chem, 7(1), 39-45.
     
  853. Kloting N, Stumvoll M, Bluher M (2007). [The biology of visceral fat.] Internist (Berl), 48(2), 126-133.
     
  854. Kralisch S, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M (2007). Growth hormone induces apelin mRNA expression and secretion in mouse 3T3-L1 adipocytes. Regul Pept, 139(1), 84-89.
     
  855. Krause K, Karger S, Schierhorn A, Poncin S, Many MC, Fuhrer D (2007). Proteomic profiling of cold thyroid nodules. Endocrinology, 148(4), 1754-1763.
     
  856. Krause K, Karger S, Gimm O, Sheu SY, Dralle H, Tannapfel A, Schmid KW, Dupuy C, Fuhrer D (2007). Characterisation of DEHAL1 expression in thyroid pathologies. Eur J Endocrinol, 156(3), 295-301.
     
  857. Tonjes A, Stumvoll M (2007). The role of the Pro12Ala polymorphism in peroxisome proliferatoraactivated receptor gamma in diabetes risk. Curr Opin Clin Nutr Metab Care, 10(4), 410-414.
     
  858. Korner A, Bottcher Y, Enigk B, Kiess W, Stumvoll M, Kovacs P (2007). Effects of genetic variation in the visfatin gene (PBEF1) on obesity, glucose metabolism, and blood pressure in children. Metabolism, 56(6), 772-777.
     
  859. Berndt J, Kovacs P, Ruschke K, Kloting N, Fasshauer M, Schon MR, Korner A, Stumvoll M, Bluher M (2007). Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia, 50(7), 1472-1480.
     
  860. Kloting N, Graham TE, Berndt J, Kralisch S, Kovacs P, Wason CJ, Fasshauer M, Schon MR, Stumvoll M, Bluher M, Kahn BB (2007). Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab, 6(1), 79-87.
     
  861. Busse FP, Hiermann P, Galler A, Stumvoll M, Wiessner T, Kiess W, Kapellen TM (2007). Evaluation of patients\' opinion and metabolic control after transfer of young adults with type 1 diabetes from a pediatric diabetes clinic to adult care. Horm Res, 67(3), 132-138.
     
  862. Kursawe R, Paschke R (2007). Modulation of TSHR signaling by posttranslational modifications. Trends Endocrinol Metab, 18(5), 199-207.
     
  863. Maier J, van Steeg H, van Oostrom C, Paschke R, Weiss RE, Krohn K (2007). Iodine deficiency activates antioxidant genes and causes DNA damage in the thyroid gland of rats and mice. Biochim Biophys Acta, 1773(6), 990-999.
     
  864. Eszlinger M, Krohn K, Kukulska A, Jarzab B, Paschke R (2007). Perspectives and limitations of microarray-based gene expression profiling of thyroid tumors. Endocr Rev, 28(3), 322-338.
     
  865. Lorenz S, Frenzel R, Paschke R, Breitwieser GE, Miedlich SU (2007). Functional desensitization of the extracellular calcium-sensing receptor is regulated via distinct mechanisms: role of G protein-coupled receptor kinases, protein kinase C and beta-arrestins. Endocrinology, 148(5), 2398-2404.
     
  866. Tonjes A, Scholz M, Fasshauer M, Kratzsch J, Rassoul F, Stumvoll M, Bluher M (2007). Beneficial effects of a 4-week exercise program on plasma concentrations of adhesion molecules. Diabetes Care, 30(3), e1.
     
  867. Paschke R (2007). [Thyroid nodules] MMW Fortschr Med, 149(13), 39-43.
     
  868. Kreißig C, Bachmann A, Stumvoll M, Schröcke G (2007). PD Dr. med. habil. Harald Achenbach zum 65. Geburtstag Ärzteblatt Sachsen, 18(9), 480.
     
  869. Kralisch S, Sommer G, Deckert CM, Linke A, Bluher M, Stumvoll M, Fasshauer M (2007). Adipokines in diabetes and cardiovascular diseases. Minerva Endocrinol, 32(3), 161-171.
     
  870. Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2007). Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care, 30(10), 2588-2592.
     
  871. Voigt C, Prodinger C, Paschke R (2007). The TSH Receptor is Linked with AP1 and NFkappaB Signaling in COS7 Cells. Exp Clin Endocrinol Diabetes, 115(9), 590-593.
     
  872. Eszlinger M, Jaeschke H, Paschke R (2007). Insights from molecular pathways: potential pharmacologic targets of benign thyroid nodules. Curr Opin Endocrinol Diabetes Obes, 14(5), 393-397.
     
  873. Krohn K, Maier J, Paschke R (2007). Mechanisms of disease: Hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors. Nat Clin Pract Endocrinol Metab, 3(10), 713-720.
     
  874. Paschke R (2007). 32(nd) Annual Meeting of the European Thyroid Association in Leipzig, Germany. Editorial. Thyroid, 17(7), 601.
     
  875. Bluher M, Williams CJ, Kloting N, Hsi A, Ruschke K, Oberbach A, Fasshauer M, Berndt J, Schon MR, Wolk A, Stumvoll M, Mantzoros CS (2007). Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training. Diabetes Care, 30(12), 3110-3115.
     
  876. Kovacs P, Geyer M, Berndt J, Kloting N, Graham TE, Bottcher Y, Enigk B, Tonjes A, Schleinitz D, Schon MR, Kahn BB, Bluher M, Stumvoll M (2007). Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression. Diabetes, 56(12), 3095-3100.
     
  877. Wiedmann M, Kassahun W, Deckert F, Troltzsch M, Sturmvoll M, Fuhrer D (2007). [65-year old female patient with persistent hypercalcemia.] Internist (Berl), 48(12), 1436-1441.
     
  878. Kloting N, Wilke B, Kloting I (2007). Triplet repeat in the Repin1 3'-untranslated region on rat chromosome 4 correlates with facets of the metabolic syndrome. Diabetes Metab Res Rev, 23(5), 406-410.
     
  879. Stumvoll M, Goldstein BJ, van Haeften TW (2007). Pathogenesis of type 2 diabetes. Endocr Res, 32(1-2), 19-37.
     
  880. Busse FP, Mössner J, Stumvoll M, Kluge R, Schoppmeyer K (2007). Nichtoperative Therapiemöglichkeiten gastroenteropankreatischer neuroendokriner Tumoren Chir Gastroenterol, 23(2), 158-165.
     
  881. Stumvoll M, Haring HU, Matthaei S (2007). Metformin. Endocr Res, 32(1-2), 39-57.
     
  882. Kantartzis K, Fritsche A, Machicao F, Stumvoll M, Machann J, Schick F, Haring HU, Stefan N (2007). Upstream transcription factor 1 gene polymorphisms are associated with high antilipolytic insulin sensitivity and show gene-gene interactions. J Mol Med, 85(1), 55-61.
     
  883. Kleinau G, Claus M, Jaeschke H, Mueller S, Neumann S, Paschke R, Krause G (2007). Contacts between extracellular loop two and transmembrane helix six determine basal activity of the thyroid-stimulating hormone receptor. J Biol Chem, 282(1), 518-525.
     
  884. Klein J, Permana PA, Owecki M, Chaldakov GN, Bohm M, Hausman G, Lapiere CM, Atanassova P, Sowinski J, Fasshauer M, Hausman DB, Maquoi E, Tonchev AB, Peneva VN, Vlachanov KP, Fiore M, Aloe L, Slominski (2007). What are subcutaneous adipocytes really good for? Exp Dermatol, 16(1), 45-47.
     
  885. Graham TE, Wason CJ, Bluher M, Kahn BB (2007). Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia, 50(4), 814-823.
     
  886. Pliquett RU, Eichfeld U, Stumvoll M, Koch CA (2007). Long QT syndrome under mitotane therapy. J Endocrinol Invest, 30(2), 167-168.
     
  887. Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E, Shai I, Kloting N, Stumvoll M, Bashan N, Rudich A (2007). Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab, 92(6), 2240-2247.
     
  888. Bashan N, Dorfman K, Tarnovscki T, Harman-Boehm I, Liberty IF, Bluher M, Ovadia S, Maymon-Zilberstein T, Potashnik R, Stumvoll M, Avinoach E, Rudich A (2007). Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. Endocrinology, 148(6), 2955-2962.
     
  889. Korner A, Berndt J, Stumvoll M, Kiess W, Kovacs P (2007). TCF7L2 gene polymorphisms confer an increased risk for early impairment of glucose metabolism and increased height in obese children. J Clin Endocrinol Metab, 92(5), 1956-1960.
     
  890. Bottcher Y, Paufler T, Stehr T, Bertschat FL, Paschke R, Koch CA (2007). Thyroid hormone resistance without mutations in thyroid hormone receptor beta. Med Sci Monit, 13(6), CS67-70.
     
  891. Mauser W, Perwitz N, Meier B, Fasshauer M, Klein J (2007). Direct adipotropic actions of atorvastatin: differentiation state-dependent induction of apoptosis, modulation of endocrine function, and inhibition of glucose uptake. Eur J Pharmacol, 564(1-3), 37-46.
     
  892. Lopez-Orduna E, Garcia-Mena J, Garcia-Macedo R, Stumvoll M, Cruz M (2007). CAPN10 mRNA splicing and decay is not affected by a SNP associated with susceptibility to type 2 diabetes. Biochem Biophys Res Commun, 358(3), 831-836.
     
  893. Georgitsi M, Raitila A, Karhu A, van der Luijt RB, Aalfs CM, Sane T, Vierimaa O, Makinen MJ, Tuppurainen K, Paschke R, Gimm O, Koch CA, Gundogdu S, Lucassen A, Tischkowitz M, Izatt L, Aylwin S, Bano G (2007). Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab, 92(8), 3321-3325.
     
  894. Bottcher Y, Tonjes A, Enigk B, Scholz GH, Bluher M, Stumvoll M, Kovacs P (2007). A SNP haplotype of the forkhead transcription factor FOXO1A gene may have a protective effect against type 2 diabetes in German Caucasians. Diabetes Metab, 33(4), 277-283.
     
  895. Fujarewicz K, Jarzab M, Eszlinger M, Krohn K, Paschke R, Oczko-Wojciechowska M, Wiench M, Kukulska A, Jarzab B, Swierniak A (2007). A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping. Endocr Relat Cancer, 14, 809-826.
     
  896. Jurgens HS, Neschen S, Ortmann S, Scherneck S, Schmolz K, Schuler G, Schmidt S, Bluher M, Klaus S, Perez-Tilve D, Tschop MH, Schurmann A, Joost HG (2007). Development of diabetes in obese, insulin-resistant mice: essential role of dietary carbohydrate in beta cell destruction. Diabetologia, 50(7), 1481-1489.
     
  897. Rudovich N, Kaiser S, Engeli S, Osterhoff M, Gogebakan O, Bluher M, Pfeiffer AF (2007). GIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women. Regul Pept, 142(3), 138-145.
     
  898. Kropf S, Lux A, Eszlinger M, Heuer H, Smalla K (2007). Comparison of independent samples of high-dimensional data by pairwise distance measures. Biom J, 49(2), 230-241.
     
  899. Neuhaus J, Schwalenberg T, Schlichting N, Schulze M, Horn LC, Stolzenburg JU (2007). [New methods of patient selection for improved anticholinergic therapy] Urologe A, 46(9), 1202-1206.
     
  900. Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P, Carlsson LM, Kiess W, Vatin V, Lecoeur C, Delplanque J, Vaillant E, Pattou F, Ruiz J, Weill J, Levy-Marchal C, Horber F, Potoczna N, Hercber (2007). Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet, 39(6), 724-726.
     
  901. Oleszczuk A, Spannbauer M, Tannapfel A, Bluher M, Hengstler J, Pietsch UC, Schuhmacher A, Wittekind C, Hauss JP, Schon MR (2007). Regenerative capacity differs between micro- and macrovesicular hepatic steatosis. Exp Toxicol Pathol, 59(3-4), 205-213.
     
  902. Falk S, Kratzsch J, Paschke R, Koch CA (2007). Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D. Med Sci Monit, 13(11), CS133-136.
     
  903. Neuhaus J, Heinrich M, Schlichting N, Oberbach A, Fitzl G, Schwalenberg T, Horn LC, Stolzenburg JU (2007). [Structure and function of suburothelial myofibroblasts in the human urinary bladder under normal and pathological conditions.] Urologe A, 46(9), 1197-1202.
     
  904. Neuhaus J, Schlichting N, Oberbach A, Stolzenburg JU (2007). [Lipopolysaccharide-mediated regulation of interleukin-6 in cultured human detrusor smooth muscle cells.] Urologe A, 46(9), 1193-1197.
     
  905. Katic M, Kennedy AR, Leykin I, Norris A, McGettrick A, Gesta S, Russell SJ, Bluher M, Maratos-Flier E, Kahn CR (2007). Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice. Aging Cell, 6(6), 827-839.
     
  906. Korner A, Garten A, Bluher M, Tauscher R, Kratzsch J, Kiess W (2007). Molecular characteristics of serum visfatin and differential detection by immunoassays. J Clin Endocrinol Metab, 92(12), 4783-4791.
     
  907. Kuttler B, Wanka H, Kloting N, Gerstmayer B, Volk HD, Sawitzki B, Ritter T (2007). Ex vivo gene transfer of viral interleukin-10 to BB rat islets: no protection after transplantation to diabetic BB rats. J Cell Mol Med, 11(4), 868-880.
     
  908. Georgitsi M, Raitila A, Karhu A, Tuppurainen K, Makinen MJ, Vierimaa O, Paschke R, Saeger W, van der Luijt RB, Sane T, Robledo M, De Menis E, Weil RJ, Wasik A, Zielinski G, Lucewicz O, Lubinski J, Lau (2007). Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations. Proc Natl Acad Sci U S A, 104(19), 4101-4105.
     
  909. Stumvoll M, Kiess W (2007). 24 Pathophysiologie der Adipositas - Integaration neuroendokriner Konzepte. In: Rainer H. Straub, Lehrbuch der klinischen Pathophysiologie komplexer chronischer Erkrankungen. (S. 35-45), Göttingen: Vandenhoeck & Ruprecht GmbH & Co. KG.
     


  910. 2006


  911. Kloting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schon MR, Stumvoll M, Bluher M (2006). Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun, 339(1), 430-436.
     
  912. Klein J, Perwitz N, Kraus D, Fasshauer M (2006). Adipose tissue as source and target for novel therapies. Trends Endocrinol Metab, 17, 26-32.
     
  913. Mayer C, Achenbach H, Stumvoll M, Fiedler GM (2006). [Renal anemia - an important secondary disease in renal insufficiency.] Internist (Berl), 47(3), 233-241.
     
  914. Oberbach A, Tonjes A, Kloting N, Fasshauer M, Kratzsch J, Busse MW, Paschke R, Stumvoll M, Bluher M (2006). Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol, 154(4), 577-585.
     
  915. Jaeschke H, Neumann S, Kleinau G, Mueller S, Claus M, Krause G, Paschke R (2006). An aromatic environment in the vicinity of serine 281 is a structural requirement for thyrotropin receptor function. Endocrinology, 147(4), 1753-1760.
     
  916. Brauer VF, Below H, Kramer A, Fuhrer D, Paschke R (2006). The role of thiocyanate in the etiology of goiter in an industrial metropolitan area. Eur J Endocrinol, 154(2), 229-235.
     
  917. Kralisch S, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M (2006). Tissue inhibitor of metalloproteinase 1 expression and secretion are induced by beta-adrenergic stimulation in 3T3-L1 adipocytes. J Endocrinol, 189(3), 665-670.
     
  918. Bluher M, Stumvoll M (2006). [Metabolic syndrome - myths, mechanisms, management.] Dtsch Med Wochenschr, 131(20), 1167-1172.
     
  919. Wiesner T, Fuhrer D, Stumvoll M (2006). Vanished decimal point as cause of weight gain. Lancet, 367(9521), 1485-1485.
     
  920. Kovacs P, Stumvoll M, Bogardus C, Hanson RL, Baier LJ (2006). A functional Tyr1306Cys variant in LARG is associated with increased insulin action in vivo. Diabetes, 55(5), 1497-1503.
     
  921. Fasshauer M, Lincke T, Witzigmann H, Kluge R, Tannapfel A, Moche M, Buchfelder M, Petersenn S, Kratzsch J, Paschke R, Koch CA (2006). Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery. BMC Cancer, 6, 108.
     
  922. Eszlinger M, Krohn K, Beck M, Kipling D, Forbes-Robertson S, Lauter J, Toenjes A, Wynford-Thomas D, Paschke R (2006). Comparison of differential gene expression of hot and cold thyroid nodules with primary epithelial cell culture models by investigation of co-regulated gene sets. Biochim Biophys Acta, 1763(3), 263-271.
     
  923. Frenzel R, Voigt C, Paschke R (2006). The Human Thyrotropin Receptor Is Predominantly Internalized by {beta}-Arrestin 2. Endocrinology, 147(6), 3114-3122.
     
  924. Jaschke H, Neumann S, Moore S, Thomas CJ, Colson AO, Costanzi S, Kleinau G, Jiang JK, Paschke R, Raaka BM, Krause G, Gershengorn MC (2006). A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR). J Biol Chem, 281(15), 9841-9844.
     
  925. Eszlinger M, Wiench M, Jarzab B, Krohn K, Beck M, Lauter J, Gubala E, Fujarewicz K, Swierniak A, Paschke R (2006). Meta- and reanalysis of gene expression profiles of hot and cold thyroid nodules and papillary thyroid carcinoma for gene groups. J Clin Endocrinol Metab, 91(5), 1934-1942.
     
  926. Kloting N, Bluher M, Kloting I (2006). The polygenetically inherited metabolic syndrome of WOKW rats is associated with insulin resistance and altered gene expression in adipose tissue. Diabetes Metab Res Rev, 22(2), 146-154.
     
  927. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M (2006). Isoproterenol stimulates monocyte chemoattractant protein-1 expression and secretion in 3T3-L1 adipocytes. Regul Pept, 135(1-2), 12-16.
     
  928. Koch CA, Brouwers FM, Vortmeyer AO, Tannapfel A, Libutti SK, Zhuang Z, Pacak K, Neumann HP, Paschke R (2006). Somatic VHL gene alterations in MEN2-associated medullary thyroid carcinoma. BMC Cancer, 6, 131.
     
  929. Maier J, van Steeg H, van Oostrom C, Karger S, Paschke R, Krohn K (2006). Deoxyribonucleic Acid damage and spontaneous mutagenesis in the thyroid gland of rats and mice. Endocrinology, 147(7), 3391-3397.
     
  930. Bluher M, Bullen JW Jr, Lee JH, Kralisch S, Fasshauer M, Kloting N, Niebauer J, Schon MR, Williams CJ, Mantzoros CS (2006). Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J Clin Endocrinol Metab, 91(6), 2310-2316.
     
  931. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M (2006). Plasminogen activator inhibitor-1 expression and secretion are stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes. Mol Cell Endocrinol, 253(1-2), 56-62.
     
  932. Bottcher Y, Teupser D, Enigk B, Berndt J, Kloting N, Schon MR, Thiery J, Bluher M, Stumvoll M, Kovacs P (2006). Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans. J Clin Endocrinol Metab, 91(7), 2725-2731.
     
  933. Holstein A, Plaschke A, Bottcher Y, Stumvoll M, Kovacs P (2006). The Insertion/Deletion Polymorphism in the Angiotensin-converting Enzyme Gene and Hypoglycemia Awareness in Patients with Type 1 Diabetes. Horm Metab Res, 38(9), 603-606.
     
  934. Pliquett RU, Fuhrer D, Falk S, Zysset S, von Cramon DY, Stumvoll M (2006). The effects of insulin on the central nervous system--focus on appetite regulation. Horm Metab Res, 38(7), 442-446.
     
  935. Gozu HI, Bircan R, Krohn K, Muller S, Vural S, Gezen C, Sargin H, Yavuzer D, Sargin M, Cirakoglu B, Paschke R (2006). Similar prevalence of somatic TSH receptor and Gs{alpha} mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. Eur J Endocrinol, 155(4), 535-545.
     
  936. Uhlmann K, Kovacs P, Boettcher Y, Hammes HP, Paschke R (2006). Genetics of diabetic retinopathy. Exp Clin Endocrinol Diabetes, 114(6), 275-294.
     
  937. Fuhrer D (2006). [Cushing's disease and prolactinoma] Dtsch Med Wochenschr, 131, 82-86.
     
  938. Karger S, Krause K, Fuhrer D (2006). [Molecular pathogenesis of thyroid tumors] Dtsch Med Wochenschr, 131(30), 1671-1674.
     
  939. Paschke R (2006). [In Process Citation] Internist (Berl), 47(11), 1193-1194.
     
  940. Tonjes A, Karger S, Koch CA, Paschke R, Tannapfel A, Stumvoll M, Fuhrer D (2006). Impaired enteral levothyroxine absorption in hypothyroidism refractory to oral therapy after thyroid ablation for papillary thyroid cancer: case report and kinetic studies. Thyroid, 16(10), 1047-1051.
     
  941. Claus M, Neumann S, Kleinau G, Krause G, Paschke R (2006). Structural determinants for G-protein activation and specificity in the third intracellular loop of the thyroid-stimulating hormone receptor. J Mol Med, 84(11), 943-954.
     
  942. Mueller S, Kleinau G, Jaeschke H, Neumann S, Krause G, Paschke R (2006). Significance of ectodomain cysteine boxes 2 and 3 for the activation mechanism of the thyroid-stimulating hormone receptor. J Biol Chem, 281(42), 31638-31646.
     
  943. Bluher M, Engeli S, Kloting N, Berndt J, Fasshauer M, Batkai S, Pacher P, Schon MR, Jordan J, Stumvoll M (2006). Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes, 55(11), 3053-3060.
     
  944. Tonjes A, Scholz M, Loeffler M, Stumvoll M (2006). Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care, 29(11), 2489-2497.
     
  945. Karger S, Engelhardt C, Eszlinger M, Tonjes A, Herrmann F, Muller P, Schmidt T, Weiss CL, Dralle H, Lippitzsch F, Tannapfel A, Fuhrer D (2006). Cytology and mRNA expression analysis of fine needle aspirates of thyroid nodules in an East german region with borderline iodine deficiency. Horm Metab Res, 38(10), 662-667.
     
  946. Hoffmeister A, Wittenburg H, Teich N, Bachmann A, Borte G, Mossner J, Achenbach H (2006). [A 32-year-old patient with diarrhoe and acute kidney failure.] Internist (Berl), 47(10), 1063-1067.
     
  947. Bottcher Y, Korner A, Reinehr T, Enigk B, Kiess W, Stumvoll M, Kovacs P (2006). ENPP1 Variants and Haplotypes Predispose to Early Onset Obesity and Impaired Glucose and Insulin Metabolism in German Obese Children. J Clin Endocrinol Metab, 91(12), 4948-4952.
     
  948. Brauer VF, Schweizer U, Kohrle J, Paschke R (2006). Selenium and goiter prevalence in borderline iodine sufficiency. Eur J Endocrinol, 155(6), 807-812.
     
  949. Krause K, Schierhorn A, Sinz A, Wissmann JD, Beck-Sickinger AG, Paschke R, Fuhrer D (2006). Toward the application of proteomics to human thyroid tissue. Thyroid, 16(11), 1131-1143.
     
  950. Bluher M, Stumvoll M (2006). [Role of muscle and fat in the pathogenesis of type 2 diabetes.] Dtsch Med Wochenschr, 131(Suppl.), 231-235.
     
  951. Führer D (2006). Genetics of benign and malignant thyroid tumours. Thyroid Intern, , 1-14.
     
  952. Oberbach A, Bossenz Y, Lehmann S, Niebauer J, Adams V, Paschke R, Schon MR, Bluher M, Punkt K (2006). Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes. Diabetes Care, 29(4), 895-900.
     
  953. Führer D (2006). Molecular determination of benign and malignant thyroid tumours. Expert Rev Endocrinol Metab, 1(6), 763-775.
     
  954. Böttcher Y, Stumvoll M (2006). Typ 2 Diabetes - Gesunder Lebensstil kann genetisch bedingtes Risiko aufwiegen. Diabetologie und Stoffwechsel, 1, 350-351.
     
  955. Kovacs P, Stumvoll M (2006). Sulfonylharnstoffe bei Kir6.2-Mutation wahrscheinlich effektiver als Insulin. Diabetologie und Stoffwechsel, 1, 351-352.
     
  956. Stumvoll M (2006). Dieser Begriff hat keinen Sinn. Cardio Vasc, 3, 25.
     
  957. Wiesner T, Stumvoll M (2006). Obstructive sleep apnea and insulin resistance:correlation or causation? Expert Rev Mol Diagn, (6)5, 575-578.
     
  958. Rosendahl J, Teich N, Mossner J, Edelmann J, Koch CA (2006). Compound heterozygous mutations of the SBDS gene in a patient with Shwachman-Diamond syndrome, type 1 diabetes mellitus and osteoporosis. Pancreatology, 6(6), 549-554.
     
  959. Ott R, Bussenius-Kammerer M, Reck T, Hering C, Muller V, Riese J, Koch CA (2006). Does the inactivation of leukocytes in blood transfusions during and following liver transplantation by gamma-irradiation have an impact on rejection and infection rate? Med Sci Monit, 12(12), 514-520.
     
  960. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB (2006). Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med, 354(24), 2552-2563.
     
  961. Schubert S, Achenbach H, Engelmann L, Borte G, Stumvoll M, Koch CA (2006). Central diabetes insipidus in a patient with malaria tropica. J Endocrinol Invest, 29(3), 265-266.
     
  962. Perwitz N, Fasshauer M, Klein J (2006). Cannabinoid receptor signaling directly inhibits thermogenesis and alters expression of adiponectin and visfatin. Horm Metab Res, 38(5), 356-358.
     
  963. Gesta S, Bluher M, Yamamoto Y, Norris AW, Berndt J, Kralisch S, Boucher J, Lewis C, Kahn CR (2006). Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci U S A, 103(17), 6676-6681.
     
  964. Moore S, Jaeschke H, Kleinau G, Neumann S, Costanzi S, Jiang JK, Childress J, Raaka BM, Colson A, Paschke R, Krause G, Thomas CJ, Gershengorn MC (2006). Evaluation of Small-Molecule Modulators of the Luteinizing Hormone/Choriogonadotropin and Thyroid Stimulating Hormone Receptors: Structure-Activity Relationships and Selective Binding Patterns. J Med Chem, 49(13), 3888-3896.
     
  965. Tschritter O, Preissl H, Hennige AM, Stumvoll M, Porubska K, Frost R, Marx H, Klosel B, Lutzenberger W, Birbaumer N, Haring HU, Fritsche A (2006). The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study. Proc Natl Acad Sci U S A, 103(32), 12103-12108.
     
  966. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gundogdu S, De Menis E, Makinen MJ, Launonen V, Karhu A, Aaltonen LA (2006). Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science, 312(5777), 1228-1230.
     
  967. Zhang L, Baker G, Janus D, Paddon CA, Fuhrer D, Ludgate M (2006). Biological effects of thyrotropin receptor activation on human orbital preadipocytes. Invest Ophthalmol Vis Sci, 47(12), 5197-5203.
     
  968. Stobe J, Siegemund A, Achenbach H, Preiss C, Preiss R (2006). Evaluation of the pharmacokinetics of dalteparin in patients with renal insufficiency. Int J Clin Pharmacol Ther, 44(10), 455-465.
     
  969. Neuhaus J, Oberbach A, Schwalenberg T, Stolzenburg JU (2006). Cultured smooth muscle cells of the human vesical sphincter are more sensitive to histamine than are detrusor smooth muscle cells. Urology, 67(5), 1086-1092.
     
  970. Raile K, Klammt J, Garten A, Laue S, Bluher M, Kralisch S, Kloting N, Kiess W (2006). Glucose regulates expression of the nerve growth factor (NGF) receptors TrkA and p75NTR in rat islets and INS-1E beta-cells. Regul Pept, 135(1-2), 30-38.
     
  971. Brauer V,Below H,Kramer A,Paschke R (2006). Die Rolle von Thiozyanat in der Strumagenese unter beosnderer Berücksichtigung des Rauchens. In: Hehrmann R,Ploner O, Schilddrüse 2005, Hypothyreose. (S. 19-22), Berlin: de Gruyter.
     
  972. Führer D (2006). Konnatale Hypothyreose - Genetik und molekularbiologische Grundlagen. In: Hehrmann R, Ploner O, Schilddrüse 2005, Hypothyreose. (S. 3-14), Berlin: de Gruyter.
     
  973. A Böttner, J Kratzsch, A Beck-Sickinger, M Stumvoll, W Kiess (2006). Rolle von endokrinen und metabolischen Faktoren des Fettgewebes in der Pathophysiologie des metabolischen Syndroms. In: Ganten D, Ruckpaul K., Molekularmedizinische Grundlagen von para- und autokrinien Regulationsstörungen. (S. 411-443), Berlin: Springer Verlag.
     


  974. 2005


  975. Tonjes A, Bottcher Y, Neumann S, Miehle K, Brauer V, Paschke R (2005). [Elucidation of genetic predisposition of euthyroid goiter using linkage- and association analyses.] Dtsch Med Wochenschr, 130(7), 340-343.
     
  976. Eszlinger M, Krohn K, Berger K, Lauter J, Kropf S, Beck M, Fuhrer D, Paschke R (2005). Gene expression analysis reveals evidence for increased expression of cell cycle-associated genes and Gq-protein-protein kinase C signaling in cold thyroid nodules. J Clin Endocrinol Metab, 90(2), 1163-1170.
     
  977. Neumann S, Krause G, Claus M, Paschke R (2005). Structural determinants for g protein activation and selectivity in the second intracellular loop of the thyrotropin receptor. Endocrinology, 1468/9, 477-485.
     
  978. Stumvoll M, Tataranni PA, Bogardus C (2005). The hyperbolic law-a 25-year perspective. Diabetologia, 48(2), 207-209.
     
  979. Bluher M, Fasshauer M, Kralisch S, Schon MR, Krohn K, Paschke R (2005). Regulation of adiponectin receptor R1 and R2 gene expression in adipocytes of C57BL/6 mice. Biochem Biophys Res Commun, 329(3), 1127-1132.
     
  980. Paschke R (2005). TSH-Erniedrgung durch Stress? Dtsch Med Wochenschr, 130(21), 1337.
     
  981. Fuhrer D, Eszlinger M, Karger S, Krause K, Engelhardt C, Hasenclever D, Dralle H, Paschke R (2005). Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours. Eur J Endocrinol, 152(5), 785-790.
     
  982. Brauer VF, Brauer WH, Fuhrer D, Paschke R (2005). Iodine nutrition, nodular thyroid disease, and urinary iodine excretion in a german university study population. Thyroid, 15(4), 364-370.
     
  983. Wiesner TD, Trantakis C, Meixensberger J, Koch CA, Zimmer C, Paschke R (2005). [Structure of an interdisciplinary pituitary outpatient care unit at the University Hospital of Leipzig and results for treatment of prolactin and growth hormone secreting pituitary tumors] Med Klin (Munich), 100(4), 173-179.
     
  984. Neumann S, Claus M, Paschke R (2005). Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation. Eur J Endocrinol, 152(4), 625-634.
     
  985. Tonjes A, Paschke R (2005). [Diagnosis and therapy of thyroid nodules.] Internist (Berl), 46(5), 565-574.
     
  986. Fuhrer D, Mugge C, Paschke R (2005). Questionnaire on management of nodular thyroid disease (annual meeting of the thyroid section of the german society of endocrinology 2003). Exp Clin Endocrinol Diabetes, 113(3), 152-159.
     
  987. Voigt C, Holzapfel HP, Paschke R (2005). Decreased expression of G-protein coupled receptor kinase 2 in cold thyroid nodules. Exp Clin Endocrinol Diabetes, 113(2), 102-106.
     
  988. Krohn K, Fuhrer D, Bayer Y, Eszlinger M, Brauer V, Neumann S, Paschke R (2005). Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev, 26(4), 504-524.
     
  989. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M (2005). Isoproterenol, TNFalpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes. Mol Cell Endocrinol, 240, 43-49.
     
  990. Kralisch S, Klein J, Bluher M, Paschke R, Stumvoll M, Fasshauer M (2005). Therapeutic perspectives of adipocytokines. Expert Opin Pharmacother, 6(6), 863-872.
     
  991. Thamer C, Tschritter O, Haap M, Shirkavand F, Machann J, Fritsche A, Schick F, Haring H, Stumvoll M (2005). Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res, 37(4), 246-251.
     
  992. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M (2005). Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol, 185(3), 1-8.
     
  993. Bottcher Y, Kovacs P, Tonjes A, Stumvoll M (2005). [Genetics of type 2 diabetes] Internist (Berl), 46(7), 741-742.
     
  994. Stumvoll M, Goldstein BJ, van Haeften TW (2005). Type 2 diabetes: principles of pathogenesis and therapy. Lancet, 365(9467), 1333-1346.
     
  995. Miehle K, Paschke R, Koch CA (2005). Citalopram therapy as a risk factor for symptomatic hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): a case report. Pharmacopsychiatry, 38(4), 181-182.
     
  996. Koch CA, Li PC, Utkhede RS (2005). Evaluation of thin films of agarose on glass for hybridization of DNA to identify plant pathogens with microarray technology. Anal Biochem, 342(1), 93-102.
     
  997. Fuhrer D, Koch CA, Trantakis C, Tannapfel A, Paschke R (2005). TSHoma with low alpha subunit in a patient with long-standing asymptomatic hyperthyroidism. Thyroid, 15(5), 489-490.
     
  998. Koch CA (2005). Molecular pathogenesis of MEN2-associated tumors. Fam Cancer, 4(1), 3-7.
     
  999. Bottcher Y, Eszlinger M, Tonjes A, Paschke R (2005). The genetics of euthyroid familial goiter. Trends Endocrinol Metab, 16(7), 314-319.
     
  1000. Paschke R, Reiners C, Fuhrer D, Schmid KW, Dralle H, Brabant G (2005). [Recommendations and unanswered questions in the diagnosis and treatment of thyroid nodules. Opinion of the Thyroid Section of the German Society for Endocrinology] Dtsch Med Wochenschr, 130(31), 1831-1836.
     
  1001. Bluher M, Fasshauer M, Tonjes A, Kratzsch J, Schon MR, Paschke R (2005). Association of Interleukin-6, C-reactive Protein, Interleukin-10 and Adiponectin Plasma Concentrations with Measures of Obesity, Insulin Sensitivity and Glucose Metabolism. Exp Clin Endocrinol Diabetes, 113(9), 534-537.
     
  1002. Kovacs P, Stumvoll M (2005). Fatty acids and insulin resistance in muscle and liver. Best Pract Res Clin Endocrinol Metab, 19, 625-635.
     
  1003. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M (2005). Proinflammatory adipocytokines induce TIMP-1 expression in 3T3-L1 adipocytes. FEBS Lett, 579(28), 6417-6422.
     
  1004. Holstein A, Stumvoll M (2005). Contraindications can damage your health-is metformin a case in point? Diabetologia, 48(12), 2454-2459.
     
  1005. Claus M, Maier J, Paschke R, Kujat C, Stumvoll M, Fuhrer D (2005). Novel Thyrotropin Receptor Germline Mutation (Ile568Val) in a Saxonian Family with Hereditary Nonautoimmune Hyperthyroidism. Thyroid, 15(9), 1089-1094.
     
  1006. Berndt J, Kloting N, Kralisch S, Kovacs P, Fasshauer M, Schon MR, Stumvoll M, Bluher M (2005). Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes, 54(10), 2911-2916.
     
  1007. Holstein A, Plaschke A, Stumvoll M, Kovacs P (2005). The Glu23Lys polymorphism in KCNJ11 and impaired hypoglycaemia awareness in patients with type 1 diabetes. J Hum Genet, 50, 530-533.
     
  1008. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M (2005). Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab, 289, 586-590.
     
  1009. Karger S, Berger K, Eszlinger M, Tannapfel A, Dralle H, Paschke R, Fuhrer D (2005). Evaluation of Peroxisome Proliferator-Activated Receptor-gamma Expression in Benign and Malignant Thyroid Pathologies. Thyroid, 15(9), 997-1003.
     
  1010. Frenzel R, Krohn K, Eszlinger M, Tonjes A, Paschke R (2005). Sialylation of human thyrotropin receptor improves and prolongs its cell-surface expression. Mol Pharmacol, 68, 1106-1113.
     
  1011. Claus M, Jaeschke H, Kleinau G, Neumann S, Krause G, Paschke R (2005). A hydrophobic cluster in the center of the third extracellular loop is important for thyrotropin receptor signaling. Endocrinology, 146(12), 5197-5203.
     
  1012. Klemm T, Mehnert AK, Siegemund A, Wiesner TD, Gelbrich G, Bluher M, Paschke R (2005). Impact of the Thr789Ala Variant of the von Willebrand Factor Levels, on Ristocetin Co-Factor and Collagen Binding Capacity and its Association with Coronary Heart Disease in Patients With Diabetes Mellitus Type 2. Exp Clin Endocrinol Diabetes, 113(10), 568-572.
     
  1013. Kloting N, Bluher M (2005). Extended longevity and insulin signaling in adipose tissue. Exp Gerontol, 40(11), 878-883.
     
  1014. Brauer VF, Eder P, Miehle K, Wiesner TD, Hasenclever H, Paschke R (2005). Interobserver variation for ultrasound determination of thyroid nodule volumes. Thyroid, 15(4), 1169-1175.
     
  1015. Bluher M (2005). Transgenic animal models for the study of adipose tissue biology. Best Pract Res Clin Endocrinol Metab, 19, 605-623.
     
  1016. Pliquett R (2005). Therapy of chronic renal insufficiency: from renal physiology to cardivascular outcomes. Therapy, 2(3), 425-437.
     
  1017. Kovacs P, Ma L, Hanson RL, Franks P, Stumvoll M, Bogardus C, Baier LJ (2005). Genetic variation in UCP2 (uncoupling protein-2) is associated with energy metabolism in Pima Indians. Diabetologia, 48(11), 2292-2295.
     
  1018. Kovacs P, Stumvoll M (2005). Fatty acids and insulin resistance in muscle and liver. Best Pract Res Clin Endocrinol Metab, 19(4), 625-635.
     
  1019. Läuter J, Glimm E, Eszlinger M (2005). Search for relevant sets of variables in a high-dimensional setup keeping the familywise error rate. Statistica Neerlandica, 59(3), 298-312.
     
  1020. Blüher M (2005). Zuviel Fett - Schützt es uns oder bringt es uns um MedReport, 29(16), 5.
     
  1021. Al-Khafaji F, Wiltshire M, Fuhrer D, Mazziotti G, Lewis MD, Smith PJ, Ludgate M (2005). Biological activity of activating thyrotrophin receptor mutants: modulation by iodide. J Mol Endocrinol, 34, 209-220.
     
  1022. Djalilian AR, Mahesh SP, Koch CA, Nussenblatt RB, Shen D, Zhuang Z, Holland EJ, Chan CC (2005). Survival of donor epithelial cells after limbal stem cell transplantation. Invest Ophthalmol Vis Sci, 46, 803-807.
     
  1023. Weigert C, Thamer C, Brodbeck K, Guirguis A, Machicao F, Machann J, Schick F, Stumvoll M, Fritsche A, Haring HU, Schleicher ED (2005). The -913 g/a glutamine:fructose-6-phosphate aminotransferase gene polymorphism is associated with measures of obesity and intramyocellular lipid content in nondiabetic subjects. J Clin Endocrinol Metab, 90(3), 1639-1643.
     
  1024. Gozu H, Avsar M, Bircan R, Claus M, Sahin S, Sezgin O, Deyneli O, Paschke R, Cirakoglu B, Akalin S (2005). Two novel mutations in the sixth transmembrane segment of the thyrotropin receptor gene causing hyperfunctioning thyroid nodules. Thyroid, 15(4), 389-397.
     
  1025. Spannbauer MM, Oleszczuk A, Tannapfel A, Bluher M, Pietsch UC, Hengstler J, Donaubauer B, Madaj-Sterba P, Furll M, Schuhmacher A, Thiery J, Hauss JP, Schon MR (2005). Micro- and macrovesicular steatotic liver model for transplantation induced by ethanol and protein-deficient diet. Transplant Proc, 37(1), 210-211.
     
  1026. Machann J, Thamer C, Schnoedt B, Stefan N, Stumvoll M, Haring HU, Claussen CD, Schick F, Fritsche A (2005). Age and gender related effects on adipose tissue compartments of subjects with increased risk for type 2 diabetes: a whole body MRI / MRS study. MAGMA, 18(3), 128-137.
     
  1027. Haap M, Machicao F, Stefan N, Thamer C, Tschritter O, Schnuck F, Wallwiener D, Stumvoll M, Haring HU, Fritsche A (2005). Genetic determinants of insulin action in polycystic ovary syndrome. Exp Clin Endocrinol Diabetes, 113(5), 275-281.
     
  1028. Stefan N, Schafer S, Machicao F, Machann J, Schick F, Claussen CD, Stumvoll M, Haring HU, Fritsche A (2005). Liver fat and insulin resistance are independently associated with the -514C>T polymorphism of the hepatic lipase gene. J Clin Endocrinol Metab, 90(7), 4238-4243.
     
  1029. Kaltenbach S, Staiger H, Weisser M, Haas C, Stumvoll M, Machicao F, Haring HU (2005). Adiponectin receptor gene expression in human skeletal muscle cells is not regulated by fibrates and thiazolidinediones. Int J Obes (Lond), 29(7), 760-765.
     
  1030. Krohn K, Eszlinger M, Paschke R, Roeder I, Schuster E (2005). Increased power of microarray analysis by use of an algorithm based on a multivariate procedure. Bioinformatics, 21(17), 3530-3534.
     
  1031. Kraus D, Jager J, Meier B, Fasshauer M, Klein J (2005). Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes. Horm Metab Res, 37(7), 455-459.
     
  1032. Korner A, Wabitsch M, Seidel B, Fischer-Posovszky P, Berthold A, Stumvoll M, Bluher M, Kratzsch J, Kiess W (2005). Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight. Biochem Biophys Res Commun, 337(2), 540-550.
     
  1033. Kantartzis K, Fritsche A, Tschritter O, Thamer C, Haap M, Schafer S, Stumvoll M, Haring HU, Stefan N (2005). The Association between Plasma Adiponectin and Insulin Sensitivity in Humans Depends on Obesity. Obes Res, 13(10), 1683-1691.
     
  1034. Stefan N, Machicao F, Staiger H, Machann J, Schick F, Tschritter O, Spieth C, Weigert C, Fritsche A, Stumvoll M, Haring HU (2005). Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia, 48(11), 2282-2291.
     
  1035. Machann J, Thamer C, Schnoedt B, Haap M, Haring HU, Claussen CD, Stumvoll M, Fritsche A, Schick F (2005). Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging, 21, 455-462.
     
  1036. Thamer C, Stefan N, Stumvoll M, Haring H, Fritsche A (2005). Reduced adiponectin serum levels in smokers. Atherosclerosis, 179, 421-422.
     
  1037. Raile K, Klammt J, Laue S, Garten A, Bluher M, Kralisch S, Kloting N, Kiess W (2005). Glucose concentration and AMP-dependent kinase activation regulate expression of insulin receptor family members in rat islets and INS-1E beta cells. Diabetologia, 48(9), 1798-1809.
     
  1038. Klimes I, Weston K, Gasperikova D, Kovacs P, Kvetnansky R, Jezova D, Dixon R, Thompson JR, Sebokova E, Samani NJ (2005). Mapping of genetic determinants of the sympathoneural response to stress. Physiol Genomics, 20(2), 183-187.
     
  1039. Staiger K, Stefan N, Staiger H, Brendel MD, Brandhorst D, Bretzel RG, Machicao F, Kellerer M, Stumvoll M, Fritsche A, Haring HU (2005). Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis. J Clin Endocrinol Metab, 90(12), 6707-6713.
     
  1040. Moche M, Hui DS, Huse K, Chan KS, Choy DK, Scholz GH, Gosse H, Winkler J, Schauer J, Sack U, Hoheisel G (2005). [Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion] Pneumologie, 59(8), 523-528.
     
  1041. Führer D, Krohn K, Paschke R (2005). Toxic Adenoma and Toxic Multinodular Goiter. In: Braverman LE, The Thyroid, A Fundamental and Clinical Text. (S. 508-518), Philadelphia: Lippincott Williams & Wilkins.
     
  1042. Krause K, Fuhrer D (2005). Funktionelle Proteomanalyse zur Detektion neuer Kandidatenproteine in Schilddrüsenknoten In: BIOforum, BIO-Forum (S. 30-31), Deutschland: GIT Verlag.
     


  1043. 2004


  1044. Eszlinger M, Holzapfel HP, Voigt C, Arkenau C, Paschke R (2004). EXPERIMENTAL STUDY: RGS 2 expression is regulated by TSH and inhibits TSH receptor signaling Eur J Endocrinol, 151(3), 383-390.
     
  1045. Meyer KG, Fasshauer M, Nebel IT, Paschke R (2004). Comparative analysis of conventional training and a computer-based interactive training program for celiac disease patients Patient Educ Couns, 54(3), 353-360.
     
  1046. Bayer Y, Neumann S, Meyer B, Ruschendorf F, Reske A, Brix T, Hegedus L, Langer P, Nurnberg P, Paschke R (2004). Genome-wide linkage analysis reveals evidence for four new susceptibility loci for familial euthyroid goiter J Clin Endocrinol Metab, 89(8), 4044-4052.
     
  1047. Miehle K, Tannapfel A, Lamesch P, Borte G, Schenker E, Kluge R, Ott RA, Wiechmann V, Koch M, Kassahun W, Paschke R, Koch CA (2004). Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production upon second recurrence J Clin Endocrinol Metab, 89(8), 3731-3736.
     
  1048. Brauer VF, Scholz GH, Neumann S, Lohmann T, Paschke R, Koch CA (2004). RET germline mutation in codon 791 in a family representing 3 generations from age 5 to age 70 years: should thyroidectomy be performed? Endocr Pract, 10(1), 5-9.
     
  1049. Voigt C, Holzapfel HP, Meyer S, Paschke R (2004). Increased expression of G-protein-coupled receptor kinases 3 and 4 in hyperfunctioning thyroid nodules J Endocrinol, 182(1), 173-182.
     
  1050. Nebel IT, Klemm T, Fasshauer M, Muller U, Verlohren HJ, Klaiberg A, Paschke R (2004). Comparative analysis of conventional and an adaptive computer-based hypoglycaemia education programs Patient Educ Couns, 53(3), 315-318.
     
  1051. Krohn K, Paschke R (2004). BRAF mutations are not an alternative explanation for the molecular etiology of ras-mutation negative cold thyroid nodules Thyroid, 14(5), 359-361.
     
  1052. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, Paschke R (2004). Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes J Endocrinol, 181(1), 129-138.
     
  1053. Neumann S, Schuchardt K, Reske A, Reske A, Emmrich P, Paschke R (2004). Lack of correlation for sodium iodide symporter mRNA and protein expression and analysis of sodium iodide symporter promoter methylation in benign cold thyroid nodules Thyroid, 14(2), 99-111.
     
  1054. Fasshauer M, Klein J, Kralisch S, Klier M, Lossner U, Bluher M, Paschke R (2004). Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes Biochem Biophys Res Commun, 317(2), 598-604.
     
  1055. Bayer Y, Fasshauer M, Paschke R (2004). The novel missense mutation methionine 442 threonine in the thyroid hormone receptor beta causes thyroid hormone resistance: a case report Exp Clin Endocrinol Diabetes, 112(2), 95-97.
     
  1056. Pliquett R, Fasshauer M, Bluher M, Paschke R (2004). Neurohumoral stimulation in type-2-diabetes as an emerging disease concept Cardiovasc Diabetol, 3(1), 1-8.
     
  1057. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Chambaut-Guerin AM, Klein J, Paschke R (2004). Interleukin-6 is a positive regulator of tumor necrosis factor alpha-induced adipose-related protein in 3T3-L1 adipocytes FEBS Lett, 560(1-3), 153-157.
     
  1058. Fasshauer M, Klein J, Kralisch S, Klier M, Lossner U, Bluher M, Paschke R (2004). Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. FEBS Lett, 558(1-3), 27-32.
     
  1059. Eszlinger M, Krohn K, Frenzel R, Kropf S, Tonjes A, Paschke R (2004). Gene expression analysis reveals evidence for inactivation of the TGF-beta signaling cascade in autonomously functioning thyroid nodules. Oncogene, 23(3), 795-804.
     
  1060. Lachmund P, Nebel IT, Fuhrer D, Paschke R (2004). The pedigree tool: web-based visualization of a family tree. Hum Mutat, 23(2), 103-105.
     
  1061. Stefan N, Fritsche A, Machicao F, Tschritter O, Haring HU, Stumvoll M (2004). The Gly1057Asp polymorphism in IRS-2 interacts with obesity to affect beta cell function. Diabetologia, 47(4), 759-761.
     
  1062. Fasshauer M, Klein J, Blüher M, Paschke R (2004). Adipokine: Mögliches Bindeglied zwischen Insulinresistenz und Adipositas? Dt Ärzteblatt, 101(51), 3491-3495.
     
  1063. Fasshauer M, Paschke R, Stumvoll M (2004). Adiponectin, obesity, and cardiovascular disease. Biochimie, 86(11), 779-784.
     
  1064. Fritsche A, Machicao F, Staiger H, Haring HU, Stumvoll M (2004). Lack of association between metabolic traits and the -512 polymorphism in FOXC2 in german people with normal glucose tolerance. Diabetologia, 47(4), 756-757.
     
  1065. Stumvoll M, Fritsche A, t'Hart LM, Machann J, Thamer C, Tschritter O, Van Haeften TW, Jacob S, Dekker JM, Maassen JA, Machicao F, Schick F, Heine RJ, Haring H (2004). The Gly482Ser variant in the peroxisome proliferator-activated receptor gamma coactivator-1 is not associated with diabetes-related traits in non-diabetic German and Dutch populations. Exp Clin Endocrinol Diabetes, 112(5), 253-257.
     
  1066. Stumvoll M (2004). Control of glycaemia: from molecules to men. Minkowski Lecture 2003. Diabetologia, 47(5), 770-781.
     
  1067. Thamer C, Haap M, Fritsche A, Haering H, Stumvoll M (2004). Relationship between moderate alcohol consumption and adiponectin and insulin sensitivity in a large heterogeneous population. Diabetes Care, 27(5), 1240-.
     
  1068. Stumvoll M, Tataranni PA, Bogardus C (2004). The role of glucose allostasis in type 2 diabetes. Rev Endocr Metab Disord, 5(2), 99-103.
     
  1069. Haap M, Siewecke C, Thamer C, Machann J, Schick F, Haring HU, Szeimies RM, Stumvoll M (2004). Multiple symmetric lipomatosis: a paradigm of metabolically innocent obesity? Diabetes Care, 27(3), 794-795.
     
  1070. Stefan N, Haring HU, Stumvoll M (2004). Letter: Regulation of synovial adipocytokines. JAMA, 291(6), 694-5.
     
  1071. Fritsche A, Haring H, Stumvoll M (2004). [White blood cell count as a predictor of glucose tolerance and insulin sensitivity. The role of inflammation in the pathogenesis of type 2 diabetes mellitus] Dtsch Med Wochenschr, 129(6), 244-248.
     
  1072. Machann J, Haring H, Schick F, Stumvoll M (2004). Intramyocellular lipids and insulin resistance. Diabetes Obes Metab, 6(4), 239-248.
     
  1073. Fasshauer M, Klein J, Kralisch S, Klier M, Lossner U, Bluher M, Paschke R (2004). Serum amyloid A3 expression is stimulated by dexamethasone and interleukin-6 in 3T3-L1 adipocytes. J Endocrinol, 183(3), 561-567.
     
  1074. Kropf S, Läuter J, Eszlinger M, Krohn K, Paschke R (2004). Nonparametric multiple test procedures with data-driven order of hypotheses and with weighted hypotheses Journal of Statistical Planning and Inference, 125(1-2), 31-47.
     
  1075. Bluher M, Wilson-Fritch L, Leszyk J, Laustsen PG, Corvera S, Kahn CR (2004). Role of insulin action and cell size on protein expression patterns in adipocytes. J Biol Chem, 279(30), 31902-31909.
     
  1076. Bluher M, Patti ME, Gesta S, Kahn BB, Kahn CR (2004). Intrinsic heterogeneity in adipose tissue of fat-specific insulin receptor knock-out mice is associated with differences in patterns of gene expression. J Biol Chem, 279(30), 31891-31901.
     
  1077. Miedlich SU, Gama L, Seuwen K, Wolf RM, Breitwieser GE (2004). Homology modeling of the transmembrane domain of the human calcium sensing receptor and localization of an allosteric binding site. J Biol Chem, 279(8), 7254-7263.
     
  1078. Zucker IH, Patel KP, Schultz HD, Li YF, Wang W, Pliquett RU (2004). Exercise training and sympathetic regulation in experimental heart failure. Exerc Sport Sci Rev, 32, 107-111.
     
  1079. Brauer VF, Paschke R (2004). [Molecular aetiology of nodular goitre -- consequences for therapy?] Zentralbl Chir, 129(5), 356-362.
     
  1080. Berger K, Wissmann D, Ihling C, Kalkhof S, Beck-Sickinger A, Sinz A, Paschke R, Fuhrer D (2004). Quantitative proteome analysis in benign thyroid nodular disease using the fluorescent ruthenium II tris(bathophenanthroline disulfonate) stain. Mol Cell Endocrinol, 227(1-2), 21-30.
     
  1081. Pohlink C, Tannapfel A, Eichfeld U, Schmidt F, Fuhrer D, Paschke R, Koch CA (2004). Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors? J Endocrinol Invest, 27(6), 565-569.
     
  1082. Falk S, Blüher M, Oberbach A, Busse M, Paschke R (2004). Bewegungstherapie in der Behandlung des Diabetes mellitus Typ 2. Ärzteblatt Sachsen, 15(9), 438-440.
     
  1083. Tonjes A, Miedlich S, Holzapfel HP, Eszlinger M, Arkenau C, Paschke R (2004). Expression of regulators of g protein signaling mRNA is differentially regulated in hot and cold thyroid nodules. Thyroid, 14, 896-901.
     
  1084. Thamer C, Machann J, Haap M, Stefan N, Heller E, Schnodt B, Stumvoll M, Claussen C, Fritsche A, Schick F, Haring H (2004). Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjects. Diabetes Care, 27(11), 2726-2729.
     
  1085. Wietek BM, Machann J, Mader I, Thamer C, Haring HU, Claussen CD, Stumvoll M, Schick F (2004). Muscle type dependent increase in intramyocellular lipids during prolonged fasting of human subjects: a proton MRS study. Horm Metab Res, 36(9), 639-644.
     
  1086. Stefan N, Stumvoll M, Weyer C, Bogardus C, Tataranni PA, Pratley RE (2004). Exaggerated insulin secretion in Pima Indians and African-Americans but higher insulin resistance in Pima Indians compared to African-Americans and Caucasians. Diabet Med, 21(10), 1090-1095.
     
  1087. Staiger H, Kaltenbach S, Staiger K, Stefan N, Fritsche A, Guirguis A, Peterfi C, Weisser M, Machicao F, Stumvoll M, Haring HU (2004). Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism. Diabetes, 53(9), 2195-2201.
     
  1088. Stefan N, Weyer C, Levy-Marchal C, Stumvoll M, Knowler WC, Tataranni PA, Bogardus C, Pratley RE (2004). Endogenous glucose production, insulin sensitivity, and insulin secretion in normal glucose-tolerant Pima Indians with low birth weight. Metabolism, 53(7), 904-911.
     
  1089. Thamer C, Haap M, Bachmann O, Zur Nieden T, Tschritter O, Stefan N, Fritsche A, Jacob S, Stumvoll M, Haring H (2004). Serum adiponectin levels predict the effect of short-term dietary interventions on insulin sensitivity in humans. Diabetologia, 47(7), 1303-1305.
     
  1090. Stefan N, Stumvoll M, Haring HU, Fritsche A (2004). Adiponectin in youth: response to Bacha et al. Diabetes Care, 27(6), 1519-20.
     
  1091. Machicao F, Staiger H, Fritsche A, Guirguis A, Weisser M, Stumvoll M, Haring HU (2004). Association of the -514C-->T polymorphism in the hepatic lipase gene (LIPC) promoter with elevated fasting insulin concentrations, but not insulin resistance, in non-diabetic Germans. Horm Metab Res, 36(5), 303-306.
     
  1092. Stefan N, Stumvoll M, Machicao F, Koch M, Haring HU, Fritsche A (2004). C825T polymorphism of the G protein beta3 subunit is associated with obesity but not with insulin sensitivity. Obes Res, 12(4), 679-683.
     
  1093. Thamer C, Machann J, Haap M, Bachmann O, Wietek B, Dahl D, Tschritter O, Fritsche A, Jacob S, Schick F, Stumvoll M, Haring H (2004). [Reduced insulin effect in subclinical fatty liver] Dtsch Med Wochenschr, 129(16), 872-875.
     
  1094. Hart LM, Fritsche A, Rietveld I, Dekker JM, Nijpels G, Machicao F, Stumvoll M, van Duijn CM, Haring HU, Heine RJ, Maassen JA, van Haeften TW (2004). Genetic factors and insulin secretion: gene variants in the IGF genes. Diabetes, 53 Suppl 1, S26-S30.
     
  1095. Chen D, Mauvais-Jarvis F, Bluher M, Fisher SJ, Jozsi A, Goodyear LJ, Ueki K, Kahn CR (2004). p50alpha/p55alpha phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity. Mol Cell Biol, 24(1), 320-329.
     
  1096. Ott V, Fasshauer M, Meier B, Dalski A, Kraus D, Gettys TW, Perwitz N, Klein J (2004). Ciliary neurotrophic factor influences endocrine adipocyte function: inhibition of leptin via PI 3-kinase. Mol Cell Endocrinol, 224(1-2), 21-27.
     
  1097. Klein J, Westphal S, Kraus D, Meier B, Perwitz N, Ott V, Fasshauer M, Klein HH (2004). Metformin inhibits leptin secretion via a mitogen-activated protein kinase signalling pathway in brown adipocytes. J Endocrinol, 183(2), 299-307.
     
  1098. Perwitz N, Fasshauer M, Klein J (2004). Die neue Sicht des Fettgewebe:"Master Mind" hinter Pathogenese und Therapie des Metabolischen Syndroms Focus MUL, 21, 12-21.
     
  1099. Kleinau G, Jaschke H, Neumann S, Lattig J, Paschke R, Krause G (2004). Identification of a novel epitope in the thyroid-stimulating hormone receptor ectodomain acting as intramolecular signaling interface. J Biol Chem, 279(49), 51590-51600.
     
  1100. Roick C, Thierfelder K, Heider D, Klemm T, Paschke R, Angermeyer MC (2004). [Quality of life instruments and health state preferences to assess effects of medical interventions for mentally and medically ill patients] Psychiatr Prax, 31(3), 128-137.
     
  1101. Bottner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, Keller E, Bluher M, Kiess W (2004). Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab, 89(8), 4053-4061.
     
  1102. Breitwieser GE, Miedlich SU, Zhang M (2004). Calcium sensing receptors as integrators of multiple metabolic signals. Cell Calcium, 35, 209-216.
     
  1103. Yu J, Koch CA, Patsalides A, Chang R, Altemus RM, Nieman LK, Pacak K (2004). Ectopic Cushing's syndrome caused by an esthesioneuroblastoma. Endocr Pract, 10(2), 119-124.
     
  1104. Gimm O, Koch CA, Januszewicz A, Opocher G, Neumann HP (2004). The genetic basis of pheochromocytoma. Front Horm Res, 31, 45-60.
     
  1105. Ott R, Bussenius-Kammerer M, Reck T, Koch CA, Kissler H, Hohenberger W, Muller V (2004). Impact of changing immunosuppressive monotherapy from Cyclosporine to Tacrolimus in long-term, stable liver transplant recipients. Transpl Int, 17(1), 39-43.
     
  1106. Meurer M, Stumvoll M, Szeimies R M (2004). Hautveränderungen bei Diabetes mellitus Der Hautarzt, 55, 428-435.
     
  1107. Hammerschmidt S, Pohlink C, Wirtz H, Rother T (2004). [Alternating electric heart axis in a patient with small cell lung cancer] Dtsch Med Wochenschr, 129(1-2), 19-22.
     
  1108. Neumann B, Paschke R (2004). Schilddrüsenstörungen: die richtige Aufklärung dank Checklisten ; wirksame Hilfe und Vorbeugung In: , So heile ich mich selbst (S. 1-144), Deutschland: Knaur Verlag.
     
  1109. Derwahl M, Paschke R, Belge G, Oriola J, Studer H (2004). Follicular adenoma: Somatic genetics In: DeLellis R, WHO Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs (S. 98-103), Lyon, France: IARC Press.
     
  1110. Kimura N, Chetty R, Capella C, Young WF, Koch CA, Lam KY, DeLellis RA, Kawashima A, Komminoth P, Tischler AS (2004). Extraadrenal paraganglioma. Carotid body, jugulotympanic, vagal, laryngeal, aotico/pulmonary. In: DeLellis R, Lloyd R, Heitz P, Eng C, WHO Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs (S. 159-161), Lyon, France: IARCPress.
     
  1111. Sasano H, Young WF Jr, Chrousos GP, Koch CA, Giordano TJ, Kawashima A (2004). Adrenal cortical adenoma. In: DeLellis R, Lloyd R, Heitz P, Eng C, WHO Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs (S. 143-146), Lyon, France: IARCPress.
     
  1112. Reincke M, Paschke R, Schaaf L, Usadel KH (2004). Physiologische und pathophysiologische Prinzipien der Hormonsekretion und deren Diagnose- und Therapieprinzipien. Hypophysenerkrankungen. Pluriglanduläre Autoimmunerkrankungen. Multiple endokrine Neoplasien. In: Classen M, Diehl V, Kochsiek K, Berdel WE, Innere Medizin (S. 1432-1450,1522-1527), München, Jena: Urban und Fischer.
     
  1113. Krohn K, Führer D, Paschke R (2004). Toxic adenoma. Toxic multinodular goiter. In: Martini L, Encyclopedia of endocrine diseases. (S. 594-604), San Diego: Academic Press.
     
  1114. Koch CA, Pacak K (2004). Adrenal Cortex, physiology. Adrenal tumors, molecular pathogenesis. Multiple endocrine neoplasia type 2. Pheochromocytoma. In: Martini L, Encyclopedia of Endocrine Diseases. (S. 68-74, 90-98, 278-28), San Diego: Academic Press.
     
  1115. Weiss LM, Bertagna X, Chrousos GP, Kawashima A, Kleihues P, Koch CA, Giordano TJ, Medeiros LJ, Merino MJ, Ordonez NG, Sasano H (2004). Adrenal cortical carcinoma. In: DeLellis R, Lloyd R, Heitz P, Eng C, WHO Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs (S. 139-142), Lyon, France: IARCPress.